{"id":"NCBIGene:2048","apiVersionInfo":"monarch-api-2014-12-19","xrefs":[{"ids":[{"id":"Ensembl:ENSG00000133216"}],"source":"Ensembl"},{"ids":[{"id":"HGNC:3393"}],"source":"HGNC"},{"ids":[{"id":"HPRD:02997"}],"source":"HPRD"},{"ids":[{"id":"KEGG:hsa:2048"}],"source":"KEGG"},{"ids":[{"id":"MIM:600997"}],"source":"MIM"},{"ids":[{"id":"NCBIGene:530360907"},{"id":"NCBIGene:530360901"},{"id":"NCBIGene:111118979"},{"id":"NCBIGene:111118977"},{"id":"NCBIGene:2048"},{"id":"NCBIGene:ETG2048"},{"id":"NCBIGene:530360905"},{"id":"NCBIGene:530360903"}],"source":"NCBIGene"},{"ids":[{"id":"OMIM:600997"}],"source":"OMIM"},{"ids":[{"id":"PharmGKB:PA27825"}],"source":"PharmGKB"},{"ids":[{"id":"Swiss-Prot:P29323"}],"source":"Swiss-Prot"},{"ids":[{"id":"Uniprot:P29323"}],"source":"Uniprot"},{"ids":[{"id":"Vega:OTTHUMG00000002881"}],"source":"Vega"}],"ncbi_id":2048,"label":"EPHB2","description":"EPH receptor B2","summary":"This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants.","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"},"references":[{"id":"NCBIGene:2048","source":"NCBIGene"}],"sources":[{"label":"MyGene"}],"location":"1p36.1-p35","synonyms":["CAPB"," DRT"," EK5"," EPHT3"," ERK"," Hek5"," PCBC"," Tyro5"],"pathway_associations":[{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"pathway":{"id":"KEGG:path:map04360","label":"Axon guidance","source":{"id":"nlx_31015-3","label":"KEGG"}},"source":{"id":"nlx_31015-3","label":"KEGG"},"resource":{"id":"nlx_31015-3","label":"KEGG"}}],"type":"gene","phenotype_associations":[{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"phenotype":{"id":"HP:0012125","label":"Prostate cancer"},"disease":{"id":"OMIM:603688","label":"Prostate Cancer/Brain Cancer Susceptibility"},"references":[{"id":"OMIM:603688"}],"source":{"id":"nlx_151835-1","label":"HPO"},"resource":"nlx_151835-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"phenotype":{"id":"HP:0100006","label":"Neoplasm of the central nervous system"},"disease":{"id":"OMIM:603688","label":"Prostate Cancer/Brain Cancer Susceptibility"},"references":[{"id":"OMIM:603688"}],"source":{"id":"nlx_151835-1","label":"HPO"},"resource":"nlx_151835-1"}],"phenotype_list":[{"id":"HP:0012125","label":"Prostate cancer","observed":"positive"},{"id":"HP:0100006","label":"Neoplasm of the central nervous system","observed":"positive"}],"genotype_associations":[],"alleles":[{"id":"monarch:disco/934bafdd-2c13-5b3c-8456-851632c2c3ed","type":"Association","variant":{"id":"dbSNP:121912582","label":"NM_004442.6(EPHB2):c.2167C>T (p.Gln723Ter)","variant_type":{"label":["Single nucleotide variant"]},"pathogenicity":"Pathogenic","coordinates":{"band":"1p36.12"},"sources":[{"label":"OMIM"}]},"references":[{"id":"PMID:15300251","label":"PMID:15300251","url":"http://www.ncbi.nlm.nih.gov/pubmed/15300251"}],"source":{"id":"nlx_151671-1","label":"ClinVar","col":"sequence_alteration"},"resource":"nlx_151671-1"},{"id":"monarch:disco/fdb3f73d-3991-5da1-b281-6890519cf8e5","type":"Association","variant":{"id":"dbSNP:35882952","label":"NM_004442.6(EPHB2):c.835G>T (p.Ala279Ser)","variant_type":{"label":["Single nucleotide variant"]},"pathogenicity":"Pathogenic","coordinates":{"band":"1p36.12"},"sources":[{"label":"OMIM"}]},"references":[{"id":"PMID:15300251","label":"PMID:15300251","url":"http://www.ncbi.nlm.nih.gov/pubmed/15300251"}],"source":{"id":"nlx_151671-1","label":"ClinVar","col":"sequence_alteration"},"resource":"nlx_151671-1"},{"id":"monarch:disco/6c1ec408-7d34-59b8-8711-c897bd2526e0","type":"Association","variant":{"id":"dbSNP:76826147","label":"NM_004442.6(EPHB2):c.*187A>T","variant_type":{"label":["Single nucleotide variant"]},"pathogenicity":"Risk factor","coordinates":{"band":"1p36.12"},"sources":[{"label":"OMIM"}]},"references":[{"id":"PMID:16155194","label":"PMID:16155194","url":"http://www.ncbi.nlm.nih.gov/pubmed/16155194"}],"source":{"id":"nlx_151671-1","label":"ClinVar","col":"sequence_alteration"},"resource":"nlx_151671-1"},{"id":"monarch:disco/63f9c57d-c24c-526c-ae39-5f2f3bdc8c2e","type":"Association","variant":{"id":"dbSNP:28936395","label":"NM_004442.6(EPHB2):c.2035G>A (p.Asp679Asn)","variant_type":{"label":["Single nucleotide variant"]},"pathogenicity":"Pathogenic","coordinates":{"band":"1p36.12"},"sources":[{"label":"OMIM"}]},"references":[{"id":"PMID:15300251","label":"PMID:15300251","url":"http://www.ncbi.nlm.nih.gov/pubmed/15300251"}],"source":{"id":"nlx_151671-1","label":"ClinVar","col":"sequence_alteration"},"resource":"nlx_151671-1"}],"orthologs":[{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:100558640","label":"LOC100558640"},"organism":"Anolis carolinensis","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:487380","label":"EPHB2"},"organism":"Canis lupus familiaris","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:554232","label":"ephb2b"},"organism":"Danio rerio","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:562176","label":"ephb2"},"organism":"Danio rerio","orthology_class":"Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:43803","label":"Eph"},"organism":"Drosophila melanogaster","orthology_class":"Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:396513","label":"EPHB2"},"organism":"Gallus gallus","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2042","label":"EPHA3"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2046","label":"EPHA8"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:285220","label":"EPHA6"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:1969","label":"EPHA2"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2044","label":"EPHA5"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2041","label":"EPHA1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2047","label":"EPHB1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2049","label":"EPHB3"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:284656","label":"EPHA10"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2050","label":"EPHB4"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4915","label":"NTRK2"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:10461","label":"MERTK"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:3815","label":"KIT"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2264","label":"FGFR4"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4921","label":"DDR2"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:6259","label":"RYK"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4486","label":"MST1R"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:22853","label":"LMTK2"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:5979","label":"RET"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:558","label":"AXL"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4920","label":"ROR2"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:238","label":"ALK"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:3643","label":"INSR"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2066","label":"ERBB4"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:1436","label":"CSF1R"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4919","label":"ROR1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4914","label":"NTRK1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:780","label":"DDR1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:3645","label":"INSRR"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4593","label":"MUSK"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2324","label":"FLT4"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:6098","label":"ROS1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4058","label":"LTK"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2065","label":"ERBB3"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:7075","label":"TIE1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2263","label":"FGFR2"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2261","label":"FGFR3"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2260","label":"FGFR1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:3480","label":"IGF1R"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4916","label":"NTRK3"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2064","label":"ERBB2"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:1956","label":"EGFR"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:5156","label":"PDGFRA"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2045","label":"EPHA7"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:7301","label":"TYRO3"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2321","label":"FLT1"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:4233","label":"MET"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2051","label":"EPHB6"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:5159","label":"PDGFRB"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2043","label":"EPHA4"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:7010","label":"TEK"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:2322","label":"FLT3"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:3791","label":"KDR"},"organism":"Homo sapiens","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:100025347","label":"EPHB2"},"organism":"Monodelphis domestica","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:13844","label":"Ephb2"},"organism":"Mus musculus","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:456613","label":"EPHB2"},"organism":"Pan troglodytes","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:313633","label":"Ephb2"},"organism":"Rattus norvegicus","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:100519549","label":"EPHB2"},"organism":"Sus scrofa","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:2048","label":"EPHB2"},"ortholog":{"id":"NCBIGene:100623509","label":"LOC100623509"},"organism":"Sus scrofa","orthology_class":"Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"}],"interactions":[{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:27","label":"ABL2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"two hybrid","references":[{"id":"PMID:11494128"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:25","label":"ABL1","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"two hybrid","references":[{"id":"PMID:11494128"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:6714","label":"SRC","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"two hybrid","references":[{"id":"PMID:10644995"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:51765","label":"MST4","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"additive genetic interaction defined by inequality"},"interaction_detection":"genetic interference","references":[{"id":"PMID:11641781"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:1948","label":"EFNB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"pull down","references":[{"id":"PMID:11780069"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:5335","label":"PLCG1","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"two hybrid","references":[{"id":"PMID:9632142"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:596","label":"BCL2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"enzymatic study","references":[{"id":"PMID:15225643"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"enzymatic study","references":[{"id":"PMID:18797457"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:5921","label":"RASA1","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:9233798"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:52","label":"ACP1","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:9499402"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:7525","label":"YES1","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"pull down","references":[{"id":"PMID:9632142"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:7316","label":"UBC","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:17428795"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:1398","label":"CRK","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"pull down","references":[{"id":"PMID:10644995"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:6453","label":"ITSN1","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:12389031"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:3161","label":"HMMR","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:22610405"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:6259","label":"RYK","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:11956217"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:4301","label":"MLLT4","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"direct interaction"},"interaction_detection":"two hybrid","references":[{"id":"PMID:9707552"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:2048","label":"EPHB2","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"geneb":{"id":"NCBIGene:238","label":"ALK","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:14968112"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"}],"disease_associations":[{"disease":{"id":"OMIM:603688","label":"Prostate Cancer/Brain Cancer Susceptibility"},"gene":{"id":"NCBIGene:2048","label":"EPHB2"},"references":[],"source":[{"id":"nlx_151671-2","label":"ClinVar"},{"id":"nif-0000-03216-7","label":"OMIM"},{"id":"nif-0000-02683-4","label":"CTD"}]},{"disease":{"id":"ORPHANET:1331","label":"Familial prostate cancer"},"gene":{"id":"NCBIGene:2048","label":"EPHB2"},"references":[],"source":[{"id":"nif-0000-21306-2","label":"ORPHANET"}]},{"disease":{"id":"MESH:D004806","label":"Ependymoma"},"gene":{"id":"NCBIGene:2048","label":"EPHB2"},"references":[],"source":[{"id":"nif-0000-02683-4","label":"CTD"}]}],"analyze_phenotypes":"/analyze/phenotypes/?input_items=HP:0012125+HP:0100006&limit=100&target_species=Homo sapiens","annotation_sufficiency":0.4706278333333333,"literature":[{"type":"gene","pub":"11494128"},{"type":"gene","pub":"11494128"},{"type":"gene","pub":"10644995"},{"type":"gene","pub":"11641781"},{"type":"gene","pub":"11780069"},{"type":"gene","pub":"9632142"},{"type":"gene","pub":"15225643"},{"type":"gene","pub":"18797457"},{"type":"gene","pub":"9233798"},{"type":"gene","pub":"9499402"},{"type":"gene","pub":"9632142"},{"type":"gene","pub":"17428795"},{"type":"gene","pub":"10644995"},{"type":"gene","pub":"12389031"},{"type":"gene","pub":"22610405"},{"type":"gene","pub":"11956217"},{"type":"gene","pub":"9707552"},{"type":"gene","pub":"14968112"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10537323"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10570155"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10542222"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10572014"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9696046"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8589679"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9632142"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9267020"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8878483"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9233798"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9576626"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9499402"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9530499"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10207129"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9707552"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10053012"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9883737"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9933164"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10508479"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10330152"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10480933"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10523848"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7898931"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8033077"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10730216"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7601466"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"1648701"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7688222"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7816602"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10648599"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10644995"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8798570"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8755474"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21503576"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21387540"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21292437"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21161727"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12546821"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12477932"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11585923"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11580899"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11042694"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10839360"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11494128"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11128993"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11256076"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12389031"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11641781"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11940661"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11799243"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11754835"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11780069"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12297313"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12039842"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11956217"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12136247"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12058067"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12063024"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17234965"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14968112"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15848800"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21139048"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12972619"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15821731"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15225643"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15107857"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15126357"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15722342"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15300251"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15718372"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17192257"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15951569"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16166419"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16155194"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15973414"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16840724"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16582626"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16272170"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16298995"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16819508"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16710414"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16740153"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20838624"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17318185"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18797457"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17295683"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17255949"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18713744"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17655843"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17428795"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17443671"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18695888"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18628988"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18682749"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20634891"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18957513"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19661068"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19597185"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19366806"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19454503"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20628086"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19962662"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19913121"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20339854"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20046096"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20233847"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23383108"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23000965"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21809346"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21737611"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21603658"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22723427"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22233626"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21987572"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22010211"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22610405"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22310282"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22374425"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23887168"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23835497"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23413357"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23711177"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24439224"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24211352"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24222164"},{"type":"gene","obj":{"id":"NCBIGene:2048","label":"EPHB2"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24803541"}],"pmidinfo":[{"pmid":"18797457","pmcid":"2567084","title":"Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.","authors":["Chang Q","Jorgensen C","Pawson T","Hedley DW"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"British journal of cancer","journalShort":"Br. J. Cancer","day":7,"month":10,"year":2008,"meshHeadings":["Animals","Cell Line, Tumor","Humans","Male","Mice","Mice, SCID","Microscopy, Fluorescence","Pancreatic Neoplasms","Protein Kinase Inhibitors","Pyrimidines","Receptor, EphA2","Signal Transduction","Thiazoles"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph receptors constitute the largest family of receptor tyrosine kinases in the human genome. EphA2 is one prominent member that is overexpressed and functionally altered in many invasive cancers, including pancreatic cancer. Dasatinib, which is a multi-targeted kinase inhibitor mainly developed for Bcr-Abl and Src family kinases, has recently been shown to have significant activity against EphA2. As selective small molecule EphA2 inhibitors are not currently available, we investigated the therapeutic potential to target EphA2 by dasatinib in pancreatic cancer cell lines. Using in vitro kinase assays, we found that EphA2 receptor tyrosine kinase was inhibited directly by dasatinib in a dose-dependent manner. Stimulation with ephrinA1 produced rapid increases of EphA2 phosphorylation that were inhibited by dasatinib, although the effects on activation of downstream signalling differed among the pancreatic cancer cell lines. Dasatinib also inhibited ligand-induced binding of EphA2 to the ubiquitin ligase Cbl, and the internalisation and degradation of EphA2, suggesting that these processes are dependent on kinase activity. Treatment with dasatinib decreased EphA2 phosphorylation in BxPC-3 xenografts, suggesting that dasatinib might have activity in pancreatic cancer due to EphA2 inhibition, besides its effects on Src.","affiliation":[]},{"pmid":"11641781","pmcid":null,"title":"MST4, a new Ste20-related kinase that mediates cell growth and transformation via modulating ERK pathway.","authors":["Lin JL","Chen HC","Fang HI","Robinson D","Kung HJ","Shih HM"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":4,"month":10,"year":2001,"meshHeadings":["Amino Acid Sequence","Cell Division","Cell Transformation, Neoplastic","Cloning, Molecular","Humans","MAP Kinase Kinase 1","MAP Kinase Signaling System","Mitogen-Activated Protein Kinase Kinases","Mitogen-Activated Protein Kinases","Models, Biological","Molecular Sequence Data","Neoplasms","Phylogeny","Protein-Serine-Threonine Kinases","RNA, Messenger","Sequence Homology, Amino Acid","Tissue Distribution","Tumor Cells, Cultured"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In this study, we report the cloning and characterization of a novel human Ste20-related kinase that we designated MST4. The 416 amino acid full-length MST4 contains an amino-terminal kinase domain, which is highly homologous to MST3 and SOK, and a unique carboxy-terminal domain. Northern blot analysis indicated that MST4 is highly expressed in placenta, thymus, and peripheral blood leukocytes. Wild-type but not kinase-dead MST4 can phosphorylate myelin basic protein in an in vitro kinase assay. MST4 specifically activates ERK but not JNK or p38 MAPK in transient transfected cells or in stable cell lines. Overexpression of dominant negative MEK1 or treatment with PD98059 abolishes MST4-induced ERK activity, whereas dominant-negative Ras or c-Raf-1 mutants failed to do so, indicating MST4 activates MEK1/ERK via a Ras/Raf-1 independent pathway. HeLa and Phoenix cell lines overexpressing wild-type, but not kinase-dead, MST4 exhibit increased growth rate and form aggressive soft-agar colonies. These phenotypes can be inhibited by PD98059. These results provide the first evidence that MST4 is biologically active in the activation of MEK/ERK pathway and in mediating cell growth and transformation.","affiliation":[]},{"pmid":"11780069","pmcid":null,"title":"Crystal structure of an Eph receptor-ephrin complex.","authors":["Himanen JP","Rajashankar KR","Lackmann M","Cowan CA","Henkemeyer M","Nikolov DB"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature","journalShort":"Nature","day":7,"month":1,"year":2002,"meshHeadings":["Amino Acid Sequence","Animals","Crystallography, X-Ray","Dimerization","Ephrin-B2","Escherichia coli","Ligands","Macromolecular Substances","Membrane Proteins","Mice","Models, Molecular","Molecular Sequence Data","Protein Binding","Protein Conformation","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Proteins","Sequence Alignment"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph family of receptor tyrosine kinases and their membrane-anchored ephrin ligands are important in regulating cell-cell interactions as they initiate a unique bidirectional signal transduction cascade whereby information is communicated into both the Eph-expressing and the ephrin-expressing cells. Initially identified as regulators of axon pathfinding and neuronal cell migration, Ephs and ephrins are now known to have roles in many other cell-cell interactions, including those of vascular endothelial cells and specialized epithelia. Here we report the crystal structure of the complex formed between EphB2 and ephrin-B2, determined at 2.7 A resolution. Each Eph receptor binds an ephrin ligand through an expansive dimerization interface dominated by the insertion of an extended ephrin loop into a channel at the surface of the receptor. Two Eph-Ephrin dimers then join to form a tetramer, in which each ligand interacts with two receptors and each receptor interacts with two ligands. The Eph and ephrin molecules are precisely positioned and orientated in these complexes, promoting higher-order clustering and the initiation of bidirectional signalling.","affiliation":[]},{"pmid":"15225643","pmcid":null,"title":"The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria.","authors":["Tamura Y","Simizu S","Osada H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"FEBS letters","journalShort":"FEBS Lett.","day":2,"month":7,"year":2004,"meshHeadings":["Apoptosis","Carcinoma, Hepatocellular","Cell Line, Tumor","Enzyme Inhibitors","HeLa Cells","Humans","Kinetics","Liver Neoplasms","Mitochondria","Mitogen-Activated Protein Kinase 1","Mitogen-Activated Protein Kinases","Mutagenesis","Phosphoprotein Phosphatases","Phosphorylation","Plasmids","Protein Phosphatase 2","Proto-Oncogene Proteins c-bcl-2","Recombinant Proteins","Sequence Deletion"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bcl-2 protein play important roles in the regulation of apoptosis. We previously reported that the phosphorylation of Bcl-2 was augmented by treatment with protein phosphatase 2A (PP2A) inhibitor; however, the kinase responsible for Bcl-2 phosphorylation had not yet been identified. In this study, we identified extracellular-signal-regulated kinase (ERK) as the responsible kinase for the phosphorylation of Bcl-2. We also found that the transmembrane region (TM) deleted form of Bcl-2 (Bcl-2DeltaTM), which was unable to localize on the mitochondria was constitutively phosphorylated, whereas wild-type Bcl-2 that localized on the mitochondria, was present in its hypophosphorylated form. The phosphorylation of Bcl-2DeltaTM was retarded by treatment with MAP kinase ERK kinase (MEK) inhibitor and PP2A did not bind to Bcl-2DeltaTM. These observations suggest that Bcl-2DeltaTM is constitutively phosphorylated by ERK, but is not dephosphorylated by PP2A in human tumor cell lines. The phosphorylation of Bcl-2 resulted in a reduction in anti-apoptotic function, implying that dephosphorylation promoted the anti-apoptotic activity of Bcl-2 protein in human tumor cell lines. Thus, the present findings suggest that ERK and PP2A are physiological regulators of Bcl-2 phosphorylation, and these enzymes exert an influence on the anti-apoptotic function of Bcl-2.","affiliation":[]},{"pmid":"9632142","pmcid":null,"title":"Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.","authors":["Zisch AH","Kalo MS","Chong LD","Pasquale EB"],"grantIds":["EY105576","HD25938"],"grantAgencies":["NEI NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":29,"month":5,"year":1998,"meshHeadings":["Animals","Binding Sites","Chickens","Escherichia coli","Mutagenesis, Site-Directed","Neurons","Peptide Mapping","Phosphorylation","Proteins","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Fusion Proteins","Retina","Tyrosine","src Homology Domains"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The cellular components of the neuronal signaling pathways of Eph receptor tyrosine kinases are only beginning to be elucidated. Here we show that in vivo tyrosine phosphorylation sites of the Eph receptors EphA3, EphA4, and EphB2 in embryonic retina serve as binding sites for the Src-homology 2 (SH2) domain of Src kinase. Furthermore, tyrosine-phosphorylated EphB2 was detected in Src immunoprecipitates from transfected Cos cells, indicating that EphB2 and Src can physically associate. Interestingly, a form of Src with reduced electrophoretic mobility and increased tyrosine phosphorylation was detected in Cos cells expressing tyrosine-phosphorylated EphB2, suggesting a functional interaction between EphB2 and Src. Yeast two-hybrid analysis in conjunction with site-directed mutagenesis demonstrated that phosphorylated tyrosine 611 in the juxtamembrane region of EphB2 is crucial for the interaction with the SH2 domain of Src. In contrast, binding of the carboxy-terminal SH2 domain of phospholipase Cgamma was not abolished upon mutation of tyrosine 611 in EphB2. Phosphopeptide mapping of autophosphorylated full-length EphB2, and wild-type and tyrosine to phenylalanine mutants of the EphB2 cytoplasmic domain fused to LexA, showed tyrosine 611 in the sequence motif YEDP as a major site of autophosphorylation in EphB2. Our mutational analysis also indicated that tyrosines 605 and 611 are important for EphB2 kinase activity. We propose Src kinase as a downstream effector that mediates the neuron's response to Eph receptor activation.","affiliation":[]},{"pmid":"11494128","pmcid":null,"title":"Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.","authors":["Yu HH","Zisch AH","Dodelet VC","Pasquale EB"],"grantIds":["HD25938","HD26351"],"grantAgencies":["NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":5,"month":7,"year":2001,"meshHeadings":["Actins","Animals","Brain","Brain Chemistry","COS Cells","Cells, Cultured","Cercopithecus aethiops","Chick Embryo","Cytoskeleton","Eye Proteins","Humans","Kidney","Macromolecular Substances","Mice","Nerve Tissue Proteins","Neurons","Phosphorylation","Protein Binding","Protein Processing, Post-Translational","Protein-Tyrosine Kinases","Proto-Oncogene Proteins c-abl","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Fusion Proteins","Retina","Saccharomyces cerevisiae","Signal Transduction","Two-Hybrid System Techniques","src Homology Domains"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph family of receptor tyrosine kinases and the Abl family of non-receptor tyrosine kinases have both been implicated in tissue morphogenesis. They regulate the organization of the actin cytoskeleton in the developing nervous system and participate in signaling pathways involved in axon growth. Both Eph receptors and Abl are localized in the neuronal growth cone, suggesting that they play a role in axon pathfinding. Two-hybrid screens identified regions of Abl and Arg that bind to the EphB2 and EphA4 receptors, suggesting a novel signaling connection involving the two kinase families. The association of full-length Abl and Arg with EphB2 was confirmed by co-immunoprecipitation and found to involve several distinct protein interactions. The SH2 domains of Abl and Arg bind to tyrosine-phosphorylated motifs in the juxtamembrane region of EphB2. A second, phosphorylation-independent interaction with EphB2 involves non-conserved sequences in the C-terminal tails of Abl and Arg. A third interaction between Abl and EphB2 is probably mediated by an intermediary protein because it requires tyrosine phosphorylation of EphB2, but not the binding sites for the Abl SH2 domain. The connection between EphB2 and Abl/Arg appears to be reciprocal. Activated EphB2 causes tyrosine phosphorylation of Abl and Arg, and vice versa. Interestingly, treatment of COS cells and B35 neuronal-like cells with ephrin-B1 to activate endogenous EphB2 decreased the kinase activity of endogenous Abl. These data are consistent with the opposite effects that Eph receptors and Abl have on neurite ougrowth and suggest that Eph receptors and Abl family kinases have shared signaling activities.","affiliation":[]},{"pmid":"10644995","pmcid":null,"title":"Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.","authors":["Zisch AH","Pazzagli C","Freeman AL","Schneller M","Hadman M","Smith JW","Ruoslahti E","Pasquale EB"],"grantIds":["HD25938","HD26351"],"grantAgencies":["NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":13,"month":1,"year":2000,"meshHeadings":["3T3 Cells","Actins","Amino Acid Substitution","Animals","COS Cells","Cell Size","Conserved Sequence","Enzyme Activation","Glutamic Acid","Humans","Mice","Mice, Knockout","Mitogen-Activated Protein Kinases","Mutagenesis","Phenylalanine","Phosphorylation","Protein Binding","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Tyrosine","src Homology Domains","src-Family Kinases"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph receptor tyrosine kinases play key roles in pattern formation during embryonic development, but little is known about the mechanisms by which they elicit specific biological responses in cells. Here, we investigate the role of tyrosines 605 and 611 in the juxtamembrane region of EphB2, because they are conserved Eph receptor autophosphorylation sites and demonstrated binding sites for the SH2 domains of multiple signaling proteins. Mutation of tyrosines 605 and 611 to phenylalanine impaired EphB2 kinase activity, complicating analysis of their function as SH2 domain binding sites and their contribution to EphB2-mediated signaling. In contrast, mutation to the negatively charged glutamic acid disrupted SH2 domain binding without reducing EphB2 kinase activity. By using a panel of EphB2 mutants, we found that kinase activity is required for the changes in cell-matrix and cell - cell adhesion, cytoskeletal organization, and activation of mitogen-activated protein (MAP) kinases elicited by EphB2 in transiently transfected cells. Instead, the two juxtamembrane SH2 domain binding sites were dispensable for these effects. These results suggest that phosphorylation of tyrosines 605 and 611 is critical for EphB2-mediated cellular responses because it regulates EphB2 kinase activity.","affiliation":[]},{"pmid":"9499402","pmcid":null,"title":"Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses.","authors":["Stein E","Lane AA","Cerretti DP","Schoecklmann HO","Schroff AD","Van Etten RL","Daniel TO"],"grantIds":["DK38517","DK47078","GM27003"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIGMS NIH HHS"],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":1,"month":3,"year":1998,"meshHeadings":["Animals","Cell Adhesion","Cells, Cultured","Dimerization","Endothelium, Vascular","Ephrin-B1","Fibronectins","Immunoglobulin Fc Fragments","Membrane Proteins","Mice","Molecular Weight","Mutation","Phosphorylation","Protein Tyrosine Phosphatases","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Proteins","Teratocarcinoma","Tyrosine"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph family receptor tyrosine kinases (including EphA3, EphB4) direct pathfinding of neurons within migratory fields of cells expressing gradients of their membrane-bound ligands. Others (EphB1 and EphA2) direct vascular network assembly, affecting endothelial migration, capillary morphogenesis, and angiogenesis. To explore how ephrins could provide positional labels for cell targeting, we tested whether endogenous endothelial and P19 cell EphB1 (ELK) and EphB2 (Nuk) receptors discriminate between different oligomeric forms of an ephrin-B1/Fc fusion ligand. Receptor tyrosine phosphorylation was stimulated by both dimeric and clustered multimeric ephrin-B1, yet only ephrin-B1 multimers (tetramers) promoted endothelial capillary-like assembly, cell attachment, and the recruitment of low-molecular-weight phosphotyrosine phosphatase (LMW-PTP) to receptor complexes. Cell-cell contact among cells expressing both EphB1 and ephrin-B1 was required for EphB1 activation and recruitment of LMW-PTP to EphB1 complexes. The EphB1-binding site for LMW-PTP was mapped and shown to be required for tetrameric ephrin-B1 to recruit LMW-PTP and to promote attachment. Thus, distinct EphB1-signaling complexes are assembled and different cellular attachment responses are determined by a receptor switch mechanism responsive to distinct ephrin-B1 oligomers.","affiliation":[]},{"pmid":"9233798","pmcid":null,"title":"Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.","authors":["Holland SJ","Gale NW","Gish GD","Roth RA","Songyang Z","Cantley LC","Henkemeyer M","Yancopoulos GD","Pawson T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The EMBO journal","journalShort":"EMBO J.","day":1,"month":7,"year":1997,"meshHeadings":["Adaptor Proteins, Signal Transducing","Amino Acid Sequence","Animals","COS Cells","Cell Line","Cell Membrane","DNA-Binding Proteins","Ephrin-B1","GTPase-Activating Proteins","Humans","Membrane Proteins","Mice","Molecular Sequence Data","Neurons","Oncogene Proteins","Phenylalanine","Phosphoproteins","Phosphorylation","Proteins","RNA-Binding Proteins","Rats","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Fusion Proteins","Signal Transduction","Tyrosine","ras GTPase-Activating Proteins","src Homology Domains"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph-related receptor tyrosine kinases have been implicated in the control of axonal navigation and fasciculation. To investigate the biochemical mechanisms underlying such functions, we have expressed the EphB2 receptor (formerly Nuk/Cek5/Sek3) in neuronal NG108-15 cells, and have observed the tyrosine phosphorylation of multiple cellular proteins upon activation of EphB2 by its ligand, ephrin-B1 (formerly Elk-L/Lerk2). The activated EphB2 receptor induced the tyrosine phosphorylation of a 62-64 kDa protein (p62[dok]), which in turn formed a complex with the Ras GTPase-activating protein (RasGAP) and SH2/SH3 domain adaptor protein Nck. RasGAP also bound through its SH2 domains to tyrosine-phosphorylated EphB2 in vitro, and complexed with activated EphB2 in vivo. We have localized an in vitro RasGAP-binding site to conserved tyrosine residues Y604 and Y610 in the juxtamembrane region of EphB2, and demonstrated that substitution of these amino acids abolishes ephrin-B1-induced signalling events in EphB2-expressing NG108-15 cells. These tyrosine residues are followed by proline at the + 3 position, consistent with the binding specificity of RasGAP SH2 domains determined using a degenerate phosphopeptide library. These results identify an EphB2-activated signalling cascade involving proteins that potentially play a role in axonal guidance and control of cytoskeletal architecture.","affiliation":[]},{"pmid":"17428795","pmcid":null,"title":"Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor.","authors":["Litterst C","Georgakopoulos A","Shioi J","Ghersi E","Wisniewski T","Wang R","Ludwig A","Robakis NK"],"grantIds":["AG-05138","AG-08200","AG-17926","CA088325","NS-47229"],"grantAgencies":["NIA NIH HHS","NIA NIH HHS","NIA NIH HHS","NCI NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":1,"month":6,"year":2007,"meshHeadings":["Alzheimer Disease","Amyloid Precursor Protein Secretases","Axons","Calcium Signaling","Cell Line","Cell Membrane","Endocytosis","Ephrins","Humans","Ligands","Mutation","Neovascularization, Physiologic","Neuronal Plasticity","Presenilin-1","Protease Inhibitors","Protein Processing, Post-Translational","Protein Structure, Tertiary","Receptor, EphB2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Binding of EphB receptors to ephrinB ligands on the surface of adjacent cells initiates signaling cascades that regulate angiogenesis, axonal guidance, and neuronal plasticity. These functions require processing of EphB receptors and removal of EphB-ephrinB complexes from the cell surface, but the mechanisms involved are poorly understood. Here we show that the ectodomain of EphB2 receptor is released to extracellular space following cleavage after EphB2 residue 543. The remaining membrane-associated fragment is cleaved by the presenilin-dependent gamma-secretase activity after EphB2 residue 569 releasing an intracellular peptide that contains the cytoplasmic domain of EphB2. This cleavage is inhibited by presenilin 1 familial Alzheimer disease mutations. Processing of EphB2 receptor depends on specific treatments: ephrinB ligand-induced processing requires endocytosis, and the ectodomain cleavage is sensitive to peptide inhibitor N-benzyloxycarbonyl-Val-Leu-leucinal but insensitive to metalloproteinase inhibitor GM6001. The ligand-induced processing takes place in endosomes and involves the rapid degradation of the extracellular EphB2. EphrinB ligand stimulates ubiquitination of EphB2 receptor. Calcium influx- and N-methyl-d-aspartic acid-induced processing of EphB2 is inhibited by GM6001 and ADAM10 inhibitors but not by N-benzyloxycarbonyl-Val-Leu-leucinal. This processing requires no endocytosis and promotes rapid shedding of extracellular EphB2, indicating that it takes place at the plasma membrane. Our data identify novel cleavages and modifications of EphB2 receptor and indicate that specific conditions determine the proteolytic systems and subcellular sites involved in the processing of this receptor.","affiliation":[]},{"pmid":"10537323","pmcid":null,"title":"Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin.","authors":["Campbell DH","Sutherland RL","Daly RJ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cancer research","journalShort":"Cancer Res.","day":15,"month":10,"year":1999,"meshHeadings":["Cell Adhesion","Cells, Cultured","Cortactin","Epidermal Growth Factor","Flavonoids","Humans","MAP Kinase Kinase Kinase 1","MAP Kinase Kinase Kinases","Microfilament Proteins","Neoplasm Proteins","Phosphorylation","Protein-Serine-Threonine Kinases","Serine","Structure-Activity Relationship","Threonine","src Homology Domains"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The structural characteristics of EMS1 (human cortactin) suggest that it may link signaling events to reorganization of the actin cytoskeleton. Interestingly, the EMS1 gene is commonly amplified and overexpressed in several human cancers, which may alter their invasive or metastatic properties. An 80 to 85-kDa mobility shift of EMS1 correlates with an alteration in subcellular distribution and is likely to represent an important regulatory event. In HEK 293 cells, epidermal growth factor treatment or cell detachment induced this shift, and this was blocked by the mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitor PD98059. Furthermore, expression of a constitutively active form of MEK induced the shift, indicating that MEK activation was both sufficient and necessary for this modification. The epidermal growth factor-induced shift correlated with increased phosphorylation on serine and threonine residues of the same tryptic phosphopeptides detected under basal conditions. Deletion of the helical-proline-rich region of the protein blocked the mobility shift and EMS1 phosphorylation. In vitro kinase assays demonstrated that the extracellular signal-regulated kinases represent candidate kinases for this region, although other MEK-regulated enzymes must also participate. These data identify MEK as an important intermediate involved in EMS1 phosphorylation and highlight the helical-proline-rich region as a key regulatory domain.","affiliation":[]},{"pmid":"12389031","pmcid":null,"title":"EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP.","authors":["Irie F","Yamaguchi Y"],"grantIds":["HD25938"],"grantAgencies":["NICHD NIH HHS"],"retractions":[],"journal":"Nature neuroscience","journalShort":"Nat. Neurosci.","day":29,"month":11,"year":2002,"meshHeadings":["Adaptor Proteins, Vesicular Transport","Animals","Carrier Proteins","Dendrites","Hippocampus","Mice","Nerve Tissue Proteins","Phosphorylation","Receptor, EphA4","Receptor, EphB2","Signal Transduction","Wiskott-Aldrich Syndrome Protein, Neuronal","cdc42 GTP-Binding Protein"],"hasAbstract":false,"score":0,"snippets":[],"abstract":null,"affiliation":[]},{"pmid":"10542222","pmcid":null,"title":"A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A.","authors":["Dodelet VC","Pazzagli C","Zisch AH","Hauser CA","Pasquale EB"],"grantIds":["HD25938","HD26351"],"grantAgencies":["NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":5,"month":11,"year":1999,"meshHeadings":["Adaptor Proteins, Signal Transducing","Amino Acid Sequence","Animals","Carrier Proteins","Cell Line","Cloning, Molecular","GTP Phosphohydrolases","Gene Library","Humans","Mice","Molecular Sequence Data","Nerve Tissue Proteins","Polymerase Chain Reaction","Rabbits","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Signal Transduction","rap1 GTP-Binding Proteins","ras Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph family of receptor tyrosine kinases has been implicated in many developmental patterning processes, including cell segregation, cell migration, and axon guidance. The cellular components involved in the signaling pathways of the Eph receptors, however, are incompletely characterized. Using a yeast two-hybrid screen, we have identified a novel signaling intermediate, SHEP1 (SH2 domain-containing Eph receptor-binding protein 1), which is expressed in the embryonic and adult brain. SHEP1 contains an Src homology 2 domain that binds to a conserved tyrosine-phosphorylated motif in the juxtamembrane region of the EphB2 receptor and may itself be a target of EphB2 kinase activity, since it becomes heavily tyrosine-phosphorylated in cells expressing activated EphB2. SHEP1 also contains a domain similar to Ras guanine nucleotide exchange factor domains and binds to the GTPases R-Ras and Rap1A, but not Ha-Ras or RalA. Thus, SHEP1 directly links activated, tyrosine-phosphorylated Eph receptors to small Ras superfamily GTPases.","affiliation":[]},{"pmid":"22610405","pmcid":null,"title":"Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGF receptor interaction via CD44-PKC.","authors":["Park D","Kim Y","Kim H","Kim K","Lee YS","Choe J","Hahn JH","Lee H","Jeon J","Choi C","Kim YM","Jeoung D"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecules and cells","journalShort":"Mol. Cells","day":25,"month":6,"year":2012,"meshHeadings":["Angiogenesis Inducing Agents","Animals","Antigens, CD44","Cells, Cultured","Extracellular Matrix Proteins","Extracellular Signal-Regulated MAP Kinases","Histone Deacetylases","Human Umbilical Vein Endothelial Cells","Humans","Hyaluronic Acid","Male","Matrix Metalloproteinase 2","Mice","Mice, Inbred BALB C","Neovascularization, Physiologic","Neuropeptides","Plasminogen Activator Inhibitor 1","Promoter Regions, Genetic","Protein Kinase C-delta","Receptors, Transforming Growth Factor beta","Signal Transduction","Transcription Factor AP-1","Transcriptional Activation","Vascular Endothelial Growth Factor A","rac GTP-Binding Proteins","rac1 GTP-Binding Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hyaluronic acid (HA) has been shown to promote angiogenesis. However, the mechanism behind this effect remains largely unknown. Therefore, in this study, the mechanism of HA-induced angiogenesis was examined. CD44 and PKC were shown to be necessary for induction of the receptor for HA-mediated cell motility (RHAMM), a HA-binding protein. RHAMM was necessary for HA-promoted cellular invasion and endothelial cell tube formation. Cytokine arrays showed that HA induced the expression of plasminogen activator-inhibitor-1 (PAI), a downstream target of TGF receptor signaling. The induction of PAI-1 was dependent on CD44 and PKC. HA also induced an interaction between RHAMM and TGF receptor I, and induction of PAI-1 was dependent on RHAMM and TGF receptor I. Histone deacetylase 3 (HDAC3), which is decreased by HA via rac1, reduced induction of plasminogen activator inhibitor-1 (PAI-1) by HA. ERK, which interacts with RHAMM, was necessary for induction of PAI-1 by HA. Snail, a downstream target of TGF signaling, was also necessary for induction of PAI-1. The down regulation of PAI-1 prevented HA from enhancing endothelial cell tube formation and from inducing expression of angiogenic factors, such as ICAM-1, VCAM-1 and MMP-2. HDAC3 also exerted reduced expression of MMP-2. In this study, we provide a novel mechanism of HA-promoted angiogenesis, which involved RHAMM-TGFRI signaling necessary for induction of PAI-1.","affiliation":[]},{"pmid":"9696046","pmcid":null,"title":"A variant transcript encoding an isoform of the human protein tyrosine kinase EPHB2 is generated by alternative splicing and alternative use of polyadenylation signals.","authors":["Tang XX","Pleasure DE","Brodeur GM","Ikegaki N"],"grantIds":["F32 CA75748","NS08075","NS25044"],"grantAgencies":["NCI NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":30,"month":7,"year":1998,"meshHeadings":["Alternative Splicing","Amino Acid Sequence","Base Sequence","Genetic Variation","Humans","Isoenzymes","Molecular Sequence Data","Poly A","Receptor Protein-Tyrosine Kinases","Receptor, EphB2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We previously isolated and characterized cDNA clones of DRT (EPHB2), encoding a receptor protein-tyrosine kinase of the EPH family. Northern blot analysis showed that EPHB2 transcripts are expressed in three sizes of approximately 4, 5, and 11 kb, suggesting that these transcripts are generated by alternative splicing and/or alternative use of polyadenylation sites. To explore this possibility, we isolated additional EPHB2 cDNA clones, including clone 5K-1, by re-screening the human fetal brain cDNA library. Nucleotide sequence analysis of clone 5K-1 revealed that it represents a variant transcript of EPHB2 (EPHB2v). Relative to the EPHB2 cDNA sequence previously reported, clone 5K-1 has two coding region deletions of 3 and 93 nucleotides. Nucleotide sequence analyses of EPHB2 genomic DNA fragments corresponding to these deletions suggest that the EPHB2v transcript is generated by alternative splicing. The 3' end of clone 5K-1 contains a polyadenosine stretch preceded by a potential polyadenylation signal, which is not used to generate the EPHB2 transcript. Taken together, these data indicate that EPHB2v is generated by both alternative splicing and alternative use of polyadenylation sites. The EPHB2v protein lacks one arginine residue that resides immediately following the EPHB2 transmembrane domain. In contrast, as a result of the frame shift caused by the 93 nucleotide deletion, the C-terminus of the EPHB2v protein is longer by 70 amino acids than that of EPHB2. We also show that the human neuroblastoma cell line SY5Y and NTera-2N neurons express high levels of EPHB2 and lower levels of EPHB2v. These structural variations found between the EPHB2 and EPHB2v proteins may reflect functional heterogeneity of EPHB2.","affiliation":[]},{"pmid":"11956217","pmcid":null,"title":"RYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6.","authors":["Trivier E","Ganesan TS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":21,"month":6,"year":2002,"meshHeadings":["Amino Acid Sequence","Animals","Catalytic Domain","Cell Line","Cytoplasm","Humans","Kinesin","Molecular Sequence Data","Myosins","Phosphorylation","Plasmids","Precipitin Tests","Protein Binding","Protein Structure, Tertiary","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Receptors, Cell Surface","Receptors, Eph Family","Sequence Homology, Amino Acid","Signal Transduction","Substrate Specificity","Transfection"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"RYK is an atypical orphan receptor tyrosine kinase that lacks detectable kinase activity. Nevertheless, using a chimeric receptor approach, we previously found that RYK can signal via the mitogen-activated protein kinase pathway. Recently, it has been shown that murine Ryk can bind to and be phosphorylated by the ephrin receptors EphB2 and EphB3. In this study, we show that human RYK associates with EphB2 and EphB3 but is not phosphorylated by them. This association requires both the extracellular and cytoplasmic domains of RYK and is not dependent on activation of the Eph receptors. It was also previously shown that AF-6 (afadin), a PDZ domain-containing protein, associates with murine Ryk. We show here that AF-6 does not bind to human RYK in vitro or in vivo. This suggests that there are significant functional differences between human and murine RYK. Further studies are required to determine whether RYK modulates the signaling of EphB2 and EphB3.","affiliation":[]},{"pmid":"14968112","pmcid":null,"title":"Identification of NPM-ALK interacting proteins by tandem mass spectrometry.","authors":["Crockett DK","Lin Z","Elenitoba-Johnson KS","Lim MS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":8,"month":4,"year":2004,"meshHeadings":["Amino Acid Sequence","Antibodies, Monoclonal","Blotting, Western","Cell Line, Tumor","Chromosome Aberrations","Databases as Topic","Electrophoresis, Polyacrylamide Gel","Humans","Mass Spectrometry","Molecular Sequence Data","Peptides","Precipitin Tests","Protein Binding","Protein-Tyrosine Kinases","Proteomics","Sequence Homology, Amino Acid","Signal Transduction","Spectrometry, Mass, Electrospray Ionization","Thermodynamics","Trypsin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Constitutive overexpression of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) is a key oncogenic event in anaplastic large-cell lymphomas with the characteristic chromosomal aberration t(2;5)(p23;q35). Proteins that interact with ALK tyrosine kinase play important roles in mediating downstream cellular signals, and are potential targets for novel therapies. Using a functional proteomic approach, we determined the identity of proteins that interact with the ALK tyrosine kinase by co-immunoprecipitation with anti-ALK antibody, followed by electrospray ionization and tandem mass spectrometry (MS/MS). A total of 46 proteins were identified as unique to the ALK immunocomplex using monoclonal and polyclonal antibodies, while 11 proteins were identified in the NPM immunocomplex. Previously reported proteins in the ALK signal pathway were identified including PI3-K, Jak2, Jak3, Stat3, Grb2, IRS, and PLCgamma1. More importantly, many proteins previously not recognized to be associated with NPM-ALK, but with potential NPM-ALK interacting protein domains, were identified. These include adaptor molecules (SOCS, Rho-GTPase activating protein, RAB35), kinases (MEK kinase 1 and 4, PKC, MLCK, cyclin G-associated kinase, EphA1, JNK kinase, MAP kinase 1), phosphatases (meprin, PTPK, protein phosphatase 2 subunit), and heat shock proteins (Hsp60 precursor). Proteins identified by MS were confirmed by Western blotting and reciprocal immunoprecipitation. This study demonstrates the utility of antibody immunoprecipitation and subsequent peptide identification by tandem mass spectrometry for the elucidation of ALK-binding proteins, and its potential signal transduction pathways.","affiliation":[]},{"pmid":"10572014","pmcid":null,"title":"Multiple in vivo tyrosine phosphorylation sites in EphB receptors.","authors":["Kalo MS","Pasquale EB"],"grantIds":["CA73195","HD25938","HD26351"],"grantAgencies":["NCI NIH HHS","NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Biochemistry","journalShort":"Biochemistry","day":26,"month":10,"year":1999,"meshHeadings":["Amino Acid Sequence","Animals","Binding Sites","Cells, Cultured","Chick Embryo","Humans","Kidney","Molecular Sequence Data","Mutagenesis, Site-Directed","Peptide Mapping","Phosphorylation","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Proteins","Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Tyrosine","src Homology Domains"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Autophosphorylation regulates the function of receptor tyrosine kinases. To dissect the mechanism by which Eph receptors transmit signals, we have developed an approach using matrix-assisted laser desorption-ionization (MALDI) mass spectrometry to map systematically their in vivo tyrosine phosphorylation sites. With this approach, phosphorylated peptides from receptors digested with various endoproteinases were selectively isolated on immobilized anti-phosphotyrosine antibodies and analyzed directly by MALDI mass spectrometry. Multiple in vivo tyrosine phosphorylation sites were identified in the juxtamembrane region, kinase domain, and carboxy-terminal tail of EphB2 and EphB5, and found to be remarkably conserved between these EphB receptors. A number of these sites were also identified as in vitro autophosphorylation sites of EphB5 by phosphopeptide mapping using two-dimensional chromatography. Only two in vitro tyrosine phosphorylation sites had previously been directly identified for Eph receptors. Our data further indicate that in vivo EphB2 and EphB5 are also extensively phosphorylated on serine and threonine residues. Because phosphorylation at each site can affect receptor signaling properties, the multiple phosphorylation sites identified here for the EphB receptors suggest a complex regulation of their functions, presumably achieved by autophosphorylation as well as phosphorylation by other kinases. In addition, we show that MALDI mass spectrometry can be used to determine the binding sites for Src homology 2 (SH2) domains by identifying the EphB2 phosphopeptides that bind to the SH2 domain of the Src kinase.","affiliation":[]},{"pmid":"9707552","pmcid":null,"title":"PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.","authors":["Hock B","Bhme B","Karn T","Yamamoto T","Kaibuchi K","Holtrich U","Holland S","Pawson T","Rbsamen-Waigmann H","Strebhardt K"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":18,"month":8,"year":1998,"meshHeadings":["3T3 Cells","Amino Acid Sequence","Animals","Binding Sites","COS Cells","Female","Humans","Kinesin","Male","Mice","Mutagenesis, Site-Directed","Myosins","Pregnancy","RNA, Messenger","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Saccharomyces cerevisiae","Signal Transduction","Substrate Specificity","Tissue Distribution","ras Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph-related receptor tyrosine kinases (RTKs) have been implicated in intercellular communication during embryonic development. To elucidate their signal transduction pathways, we applied the yeast two-hybrid system. We could demonstrate that the carboxyl termini of the Eph-related RTKs EphA7, EphB2, EphB3, EphB5, and EphB6 interact with the PDZ domain of the ras-binding protein AF6. A mutational analysis revealed that six C-terminal residues of the receptors are involved in binding to the PDZ domain of AF6 in a sequence-specific fashion. Moreover, this PDZ domain also interacts with C-terminal sequences derived from other transmembrane receptors such as neurexins and the Notch ligand Jagged. In contrast to the association of EphB3 to the PDZ domain of AF6, the interaction with full-length AF6 clearly depends on the kinase activity of EphB3, suggesting a regulated mechanism for the PDZ-domain-mediated interaction. These data gave rise to the idea that the binding of AF6 to EphB3 occurs in a cooperative fashion because of synergistic effects involving different epitopes of both proteins. Moreover, in NIH 3T3 and NG108 cells endogenous AF6 is phosphorylated specifically by EphB3 and EphB2 in a ligand-dependent fashion. Our observations add the PDZ domain to the group of conserved protein modules such as Src-homology-2 (SH2) and phosphotyrosine-binding (PTB) domains that regulate signal transduction through their ability to mediate the interaction with RTKs.","affiliation":[]},{"pmid":"10570155","pmcid":null,"title":"An Eph receptor regulates integrin activity through R-Ras.","authors":["Zou JX","Wang B","Kalo MS","Zisch AH","Pasquale EB","Ruoslahti E"],"grantIds":["CA09579","CA79984","HD25938"],"grantAgencies":["NCI NIH HHS","NCI NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":23,"month":11,"year":1999,"meshHeadings":["3T3 Cells","Animals","Cell Adhesion","Cell Line, Transformed","Chickens","Humans","Integrins","Mice","Mutagenesis, Site-Directed","Phosphorylation","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Fusion Proteins","Signal Transduction","ras Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The ability of integrins to mediate cell attachment to extracellular matrices and to blood proteins is regulated from inside the cell. Increased ligand-binding activity of integrins is critical for platelet aggregation upon blood clotting and for leukocyte extravasation to inflamed tissues. Decreased adhesion is thought to promote tumor cell invasion. R-Ras, a small intracellular GTPase, regulates the binding of integrins to their ligands outside the cell. Here we show that the Eph receptor tyrosine kinase, EphB2, can control integrin activity through R-Ras. Cells in which EphB2 is activated become poorly adherent to substrates coated with integrin ligands, and a tyrosine residue in the R-Ras effector domain is phosphorylated. The R-Ras phosphorylation and loss of cell adhesion are causally related, because forced expression of an R-Ras variant resistant to phosphorylation at the critical site made cells unresponsive to the anti-adhesive effect of EphB2. This is an unusual regulatory pathway among the small GTPases. Reduced adhesiveness induced through the Eph/R-Ras pathway may explain the repulsive effect of the Eph receptors in axonal pathfinding and may facilitate tumor cell invasion and angiogenesis.","affiliation":[]},{"pmid":"8878483","pmcid":null,"title":"Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.","authors":["Holland SJ","Gale NW","Mbamalu G","Yancopoulos GD","Henkemeyer M","Pawson T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature","journalShort":"Nature","day":24,"month":10,"year":1996,"meshHeadings":["Amino Acid Sequence","Animals","COS Cells","Cell Membrane","Coculture Techniques","DNA-Binding Proteins","Ephrin-B2","Ligands","Membrane Proteins","Mice","Molecular Sequence Data","Phosphorylation","Proto-Oncogene Proteins","Rats","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Fusion Proteins","Signal Transduction","Transcription Factors","Tumor Cells, Cultured","Tyrosine","ets-Domain Protein Elk-1"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Receptor tyrosine kinases of the EPH class have been implicated in the control of axon guidance and fasciculation, in regulating cell migration, and in defining compartments in the developing embryo. Efficient activation of EPH receptors generally requires that their ligands be anchored to the cell surface, either through a transmembrane (TM) region or a glycosyl phosphatidylinositol (GPI) group. These observations have suggested that EPH receptors can transduce signals initiated by direct cell-cell interaction. Genetic analysis of Nuk, a murine EPH receptor that binds TM ligands, has raised the possibility that these ligands might themselves have a signalling function. Consistent with this, the three known TM ligands have a highly conserved cytoplasmic region, with multiple potential sites for tyrosine phosphorylation. Here we show that challenging cells that express the TM ligands Elk-L or Htk-L with the clustered ectodomain of Nuk induces phosphorylation of the ligands on tyrosine, a process that can be mimicked both in vitro and in vivo by an activated Src tyrosine kinase. Co-culture of cells expressing a TM ligand with cells expressing Nuk leads to tyrosine phosphorylation of both the ligand and Nuk. These results suggest that the TM ligands are associated with a tyrosine kinase, and are inducibly phosphorylated upon binding Nuk, in a fashion reminiscent of cytokine receptors. Furthermore, we show that TM ligands, as well as Nuk, are phosphorylated on tyrosine in mouse embryos, indicating that this is a physiological process. EPH receptors and their TM ligands therefore mediate bidirectional cell signalling.","affiliation":[]},{"pmid":"10053012","pmcid":null,"title":"Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.","authors":["Gibbs M","Stanford JL","McIndoe RA","Jarvik GP","Kolb S","Goode EL","Chakrabarti L","Schuster EF","Buckley VA","Miller EL","Brandzel S","Li S","Hood L","Ostrander EA"],"grantIds":["R01 CA56678"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"American journal of human genetics","journalShort":"Am. J. Hum. Genet.","day":20,"month":3,"year":1999,"meshHeadings":["Aged","Alleles","Brain Neoplasms","Chromosomes, Human, Pair 1","Genetic Linkage","Genetic Markers","Genetic Predisposition to Disease","Genetic Testing","Humans","Lod Score","Loss of Heterozygosity","Male","Middle Aged","Pedigree","Penetrance","Prostatic Neoplasms"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Combining data from a genomic screen in 70 families with a high risk for prostate cancer (PC) with data from candidate-region mapping in these families and an additional 71 families, we have localized a potential hereditary PC-susceptibility locus to chromosome 1p36. Because an excess of cases of primary brain cancer (BC) have been observed in some studies of families with a high risk for PC, and because loss of heterozygosity at 1p36 is frequently observed in BC, we further evaluated 12 families with both a history of PC and a blood relative with primary BC. The overall LOD score in these 12 families was 3.22 at a recombination fraction (theta) of .06, with marker D1S507. On the basis of an a priori hypothesis, this group was stratified by age at diagnosis of PC. In the younger age group (mean age at diagnosis <66 years), a maximum two-point LOD score of 3.65 at straight theta = .0 was observed, with D1S407. This linkage was rejected in both early- and late-onset families without a history of BC (LOD scores -7.12 and -6.03, respectively, at straight theta = .0). After exclusion of 3 of the 12 families that had better evidence of linkage to previously described PC-susceptibility loci, linkage to the 1p36 region was suggested by a two-point LOD score of 4.74 at straight theta = .0, with marker D1S407. We conclude that a significant proportion of these families with both a high risk for PC and a family member with BC show linkage to the 1p36 region.","affiliation":[]},{"pmid":"9576626","pmcid":null,"title":"The Eph family receptors and ligands.","authors":["Zhou R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Pharmacology & therapeutics","journalShort":"Pharmacol. Ther.","day":4,"month":3,"year":1998,"meshHeadings":["Amino Acid Sequence","Animals","Axons","Gene Expression Regulation","Humans","Ligands","Molecular Sequence Data","Neoplasms","Neovascularization, Physiologic","Nervous System","Neural Pathways","Receptor Protein-Tyrosine Kinases","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph family is the largest of all known tyrosine kinase receptor-ligand systems. They are expressed in distinct, but overlapping, spatial and temporal patterns during embryonic development and postnatal life, and function in a variety of morphogenic events. The best known function is their role in the guidance of migration of axons and cells in the nervous system through repulsive interactions. They may also play a role in angiogenesis, tissue patterning, and tumor formation.","affiliation":[]},{"pmid":"9883737","pmcid":null,"title":"PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands.","authors":["Torres R","Firestein BL","Dong H","Staudinger J","Olson EN","Huganir RL","Bredt DS","Gale NW","Yancopoulos GD"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":26,"month":12,"year":1998,"meshHeadings":["Amino Acid Sequence","Animals","COS Cells","Cell Membrane","Cloning, Molecular","Consensus Sequence","Ephrin-B2","Immunohistochemistry","Ligands","Membrane Proteins","Mice","Molecular Sequence Data","Neurons","Receptor Protein-Tyrosine Kinases","Recombinant Fusion Proteins","Saccharomyces cerevisiae","Sequence Alignment","Sequence Homology, Amino Acid","Synapses","Transfection"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Localizing cell surface receptors to specific subcellular positions can be critical for their proper functioning, as most notably demonstrated at neuronal synapses. PDZ proteins apparently play critical roles in such protein localizations. Receptor tyrosine kinases have not been previously shown to interact with PDZ proteins in vertebrates. We report that Eph receptors and their membrane-linked ligands all contain PDZ recognition motifs and can bind and be clustered by PDZ proteins. In addition, we find that Eph receptors and ligands colocalize with PDZ proteins at synapses. Thus, PDZ proteins may play critical roles in localizing vertebrate receptor tyrosine kinases and/or their ligands and may be particularly important for Eph function in guidance or patterning or at the synapse.","affiliation":[]},{"pmid":"10508479","pmcid":null,"title":"Antigens recognized by autologous antibody in patients with renal-cell carcinoma.","authors":["Scanlan MJ","Gordan JD","Williamson B","Stockert E","Bander NH","Jongeneel V","Gure AO","Jger D","Jger E","Knuth A","Chen YT","Old LJ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"International journal of cancer. Journal international du cancer","journalShort":"Int. J. Cancer","day":12,"month":11,"year":1999,"meshHeadings":["Aged","Antibodies, Neoplasm","Antibody Specificity","Antigens, Neoplasm","Blotting, Northern","Carcinoma, Renal Cell","Chromosome Mapping","Female","Gene Library","Humans","Kidney Neoplasms","Male","Middle Aged","Neoplasms","Organ Specificity","RNA, Messenger","Reverse Transcriptase Polymerase Chain Reaction","Serologic Tests","Tumor Cells, Cultured"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The screening of cDNA expression libraries derived from human tumors with autologous antibody (SEREX) is a powerful method for defining the structure of tumor antigens recognized by the humoral immune system. Sixty-five distinct antigens (NY-REN-1 to NY-REN-65) reactive with autologous IgG were identified by SEREX analysis of 4 renal cancer patients and were characterized in terms of cDNA sequence, mRNA expression pattern, and reactivity with allogeneic sera. REN-9, -10, -19, and -26 have a known association with human cancer. REN-9 (LUCA-15) and REN-10 (gene 21) map to the small cell lung cancer tumor suppressor gene locus on chromosome 3p21.3. REN-19 is equivalent to LKB1/STK11, a gene that is defective in Peutz-Jeghers syndrome and cancer. REN-26 is encoded by the bcr gene involved in the [t(9:22)] bcr/abl translocation. Genes encoding 3 of the antigens in the series showed differential mRNA expression; REN-3 displays a pattern of tissue-specific isoforms, and REN-21 and REN-43 are expressed at a high level in testis in comparison to 15 other normal tissues. The other 62 antigens were broadly expressed in normal tissues. With regard to immunogenicity, 20 of the 65 antigens reacted only with autologous sera. Thirty-three antigens reacted with sera from normal donors, indicating that their immunogenicity is not restricted to cancer. The remaining 12 antigens reacted with sera from 5-25% of the cancer patients but not with sera from normal donors. Seventy percent of the renal cancer patients had antibodies directed against one or more of these 12 antigens. Our results demonstrate the potential of the SEREX approach for the analysis of the humoral immune response against human cancer.","affiliation":[]},{"pmid":"10207129","pmcid":null,"title":"Eph receptors and ephrins: effectors of morphogenesis.","authors":["Holder N","Klein R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":30,"month":5,"year":1999,"meshHeadings":["Animals","Cell Transformation, Neoplastic","Ephrin-A1","Humans","Morphogenesis","Proteins","Receptor Protein-Tyrosine Kinases","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph receptor tyrosine kinases and their ligands, the ephrins, appear to lie functionally at the interface between pattern formation and morphogenesis. We review the role of Eph and ephrin signalling in the formation of segmented structures, in the control of axon guidance and cell migration and in the development of the vasculature. We address the question of how the specificity of response is achieved and discuss the specificity of ephrin-Eph interactions and the significance of structural domains in Eph receptors.","affiliation":[]},{"pmid":"9530499","pmcid":null,"title":"The ephrins and Eph receptors in neural development.","authors":["Flanagan JG","Vanderhaeghen P"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Annual review of neuroscience","journalShort":"Annu. Rev. Neurosci.","day":4,"month":5,"year":1998,"meshHeadings":["Animals","Central Nervous System","Ephrin-A2","Ephrin-B1","Ephrin-B3","Membrane Proteins","Receptor Protein-Tyrosine Kinases","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph receptors are the largest known family of receptor tyrosine kinases. Initially all of them were identified as orphan receptors without known ligands, and their specific functions were not well understood. During the past few years, a corresponding family of ligands has been identified, called the ephrins, and specific functions have now been identified in neural development. The ephrins and Eph receptors are implicated as positional labels that may guide the development of neural topographic maps. They have also been implicated in pathway selection by axons, the guidance of cell migration, and the establishment of regional pattern in the nervous system. The ligands are anchored to cell surfaces, and most of the functions so far identified can be interpreted as precise guidance of cell or axon movement. This large family of ligands and receptors may make a major contribution to the accurate spatial patterning of connections and cell position in the nervous system.","affiliation":[]},{"pmid":"8589679","pmcid":null,"title":"Molecular characterization and chromosomal localization of DRT (EPHT3): a developmentally regulated human protein-tyrosine kinase gene of the EPH family.","authors":["Ikegaki N","Tang XX","Liu XG","Biegel JA","Allen C","Yoshioka A","Sulman EP","Brodeur GM","Pleasure DE"],"grantIds":["NS08075","NS25044","NS30606"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Human molecular genetics","journalShort":"Hum. Mol. Genet.","day":27,"month":11,"year":1995,"meshHeadings":["Amino Acid Sequence","Animals","Base Sequence","Brain","Carcinoma, Small Cell","Cell Line","Chromosome Mapping","Chromosomes, Human, Pair 1","Cloning, Molecular","DNA, Complementary","Gene Expression Regulation, Developmental","Humans","Medulloblastoma","Molecular Sequence Data","Protein-Tyrosine Kinases","Receptor, EphB2","Sequence Homology, Amino Acid","Tumor Cells, Cultured"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"By screening a human fetal brain cDNA expression library using a monoclonal antiphosphotyrosine antibody and by 5' RACE procedures, we have isolated overlapping cDNAs encoding a receptor-type tyrosine kinase belonging to the EPH family, DRT (Developmentally Regulated EPH-related Tyrosine kinase gene). The DRT gene is expressed in three different size transcripts (i.e. 4, 5 and 11 kb). DRT transcripts are expressed in human brain and several other tissues, including heart, lung, kidney, placenta, pancreas, liver and skeletal muscle, but the 11 kb DRT transcript is preferentially expressed in fetal brain. Steady-state levels of DRT mRNA in several tissues, including brain, heart, lung and kidney, are greater in the midterm fetus than those in the adult. DRT transcripts are detectable at low levels in a human teratocarcinoma cell line (NTera-2), but its expression is greatly increased after the NTera-2 cells are induced to become postmitotic neurons (NTera-2N) by retinoic acid treatment. These data suggest that DRT plays a part in human neurogenesis. A large number of tumor cell lines derived from neuroectoderm express DRT transcripts, including 12 neuroblastomas, two medulloblastomas, one primitive neuroectodermal tumor and six small cell lung carcinomas (SCLC). Interestingly, several neuroblastoma cell lines with 1p deletion and one SCLC cell line express DRT transcripts of aberrant size (i.e. 3, 6 and 8 kb) in addition to those found in normal tissues. We mapped the DRT gene to human chromosome 1p35-1p36.1 by PCR screening of human-rodent somatic cell hybrid panels and by fluorescence in situ hybridization. As the distal end of chromosome 1p is often deleted in neuroblastomas and altered in some cases in SCLCs, these chromosomal abnormalities may have resulted in the generation of aberrant size transcripts. Thus, the DRT gene may play a part in neuroblastoma and SCLC tumorigenesis.","affiliation":[]},{"pmid":"9933164","pmcid":null,"title":"Oligomeric structure of the human EphB2 receptor SAM domain.","authors":["Thanos CD","Goodwill KE","Bowie JU"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Science (New York, N.Y.)","journalShort":"Science","day":5,"month":2,"year":1999,"meshHeadings":["Binding Sites","Crystallization","Crystallography, X-Ray","Dimerization","GRB10 Adaptor Protein","Humans","Hydrogen Bonding","Kinesin","Models, Molecular","Myosins","Phosphorylation","Protein Conformation","Protein Structure, Secondary","Protein Tyrosine Phosphatases","Proteins","Receptor Aggregation","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Recombinant Proteins","Surface Properties"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The sterile alpha motif (SAM) domain is a protein interaction module that is present in diverse signal-transducing proteins. SAM domains are known to form homo- and hetero-oligomers. The crystal structure of the SAM domain from an Eph receptor tyrosine kinase, EphB2, reveals two large interfaces. In one interface, adjacent monomers exchange amino-terminal peptides that insert into a hydrophobic groove on each neighbor. A second interface is composed of the carboxyl-terminal helix and a nearby loop. A possible oligomer, constructed from a combination of these binding modes, may provide a platform for the formation of larger protein complexes.","affiliation":[]},{"pmid":"9267020","pmcid":null,"title":"Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee.","authors":[],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cell","journalShort":"Cell","day":8,"month":8,"year":1997,"meshHeadings":["Animals","Birds","Mammals","Membrane Proteins","Receptor Protein-Tyrosine Kinases","Terminology as Topic","Transcription Factors"],"hasAbstract":false,"score":0,"snippets":[],"abstract":null,"affiliation":[]},{"pmid":"7816602","pmcid":null,"title":"Phosphorylation of the c-Fos and c-Jun HOB1 motif stimulates its activation capacity.","authors":["Bannister AJ","Brown HJ","Sutherland JA","Kouzarides T"],"grantIds":[],"grantAgencies":["Wellcome Trust"],"retractions":[],"journal":"Nucleic acids research","journalShort":"Nucleic Acids Res.","day":11,"month":12,"year":1994,"meshHeadings":["Amino Acid Sequence","Calcium-Calmodulin-Dependent Protein Kinases","Cell Line","Consensus Sequence","Cyclic AMP-Dependent Protein Kinases","Mitogen-Activated Protein Kinase 1","Molecular Sequence Data","Phosphorylation","Point Mutation","Proto-Oncogene Proteins c-fos","Proto-Oncogene Proteins c-jun","Recombinant Fusion Proteins","Threonine","Transcriptional Activation","ras Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The c-Fos and c-Jun proteins bind an AP1 site and activate transcription synergistically. These two proteins have a common activation domain which has two co-operating motifs, HOB1 and HOB2. The HOB1 motif of c-Jun includes S73 which is required for Ha-Ras-induced super-activation and phosphorylation by MAP kinase-like enzymes. Since c-Fos HOB1 has a conserved Thr residue (T232) analogous to c-Jun S73 we have proposed that c-Fos HOB1 will be regulated in the same way as c-Jun HOB1. Here we show that the HOB1-containing activation domain of c-Fos is stimulated by Ha-Ras in vivo and phosphorylated by a MAP kinase family member in vitro and that mutating T232 to Ala abolishes both functions. Collectively these results suggest that phosphorylation of the HOB1 motif increases its activation capacity. To provide direct evidence for this we change the context of c-Fos T232 to a PKA recognition site, and show that HOB1 activity is now stimulated by the catalytic subunit of PKA. This 'PKA specificity' experiment represents a novel and powerful way to analyse phosphorylation events involved in a variety of biological functions.","affiliation":[]},{"pmid":"10330152","pmcid":null,"title":"Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.","authors":["Le Gallic L","Sgouras D","Beal G","Mavrothalassitis G"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular and cellular biology","journalShort":"Mol. Cell. Biol.","day":17,"month":6,"year":1999,"meshHeadings":["3T3 Cells","Animals","Calcium-Calmodulin-Dependent Protein Kinases","Cell Cycle","Cell Division","Cell Line, Transformed","Chloramphenicol O-Acetyltransferase","Chromatography, Gel","DNA-Binding Proteins","HeLa Cells","Humans","Immunoblotting","JNK Mitogen-Activated Protein Kinases","Mice","Mitogen-Activated Protein Kinases","Models, Genetic","Mutagenesis","Phosphorylation","Proto-Oncogene Protein c-ets-2","Proto-Oncogene Proteins","Repressor Proteins","Signal Transduction","Time Factors","Trans-Activators","Transcription Factors","ras Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"A limited number of transcription factors have been suggested to be regulated directly by Erks within the Ras/mitogen-activated protein kinase signaling pathway. In this paper we demonstrate that ERF, a ubiquitously expressed transcriptional repressor that belongs to the Ets family, is physically associated with and phosphorylated in vitro and in vivo by Erks. This phosphorylation determines the ERF subcellular localization. Upon mitogenic stimulation, ERF is immediately phosphorylated and exported to the cytoplasm. The export is blocked by specific Erk inhibitors and is abolished when residues undergoing phosphorylation are mutated to alanine. Upon growth factor deprivation, ERF is rapidly dephosphorylated and transported back into the nucleus. Phosphorylation-defective ERF mutations suppress Ras-induced tumorigenicity and arrest the cells at the G0/G1 phase of the cell cycle. Our findings strongly suggest that ERF may be important in the control of cellular proliferation during the G0/G1 transition and that it may be one of the effectors in the mammalian Ras signaling pathway.","affiliation":[]},{"pmid":"7898931","pmcid":null,"title":"cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases.","authors":["Fox GM","Holst PL","Chute HT","Lindberg RA","Janssen AM","Basu R","Welcher AA"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":2,"month":3,"year":1995,"meshHeadings":["Amino Acid Sequence","Animals","Base Sequence","Brain Chemistry","Cloning, Molecular","DNA, Complementary","Humans","Molecular Sequence Data","Nerve Tissue Proteins","RNA, Messenger","Rats","Receptor Protein-Tyrosine Kinases","Receptor, EphA3","Receptor, EphA8"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We have isolated cDNA clones from a human fetal brain library that encode five members of the EPH sub-family of receptor protein tyrosine kinases (PTKs). Comparison of the DNA sequences of these receptors to the Genbank database reveals that two of our clones correspond to the previously identified HEK and ERK receptors, two are apparently human homologues of the mouse receptors Sek and Bsk and one is novel. With these additions, the number of known human EPH sub-family members is nine and the total in all vertebrate species is 13 making it the largest known sub-family of PTKs. Analysis of the expression pattern of EPH sub-family mRNAs reveals that some are expressed in a wide variety of adult tissues while others are quite restricted. Consistent with the amplification of these sequences from a fetal brain cDNA library, all five members which we have isolated are expressed in the brain. We have named these receptors HEK4, HEK5, HEK7, HEK8 and HEK11, following the nomenclature of Wicks et al. (1992) and the numbering convention set forth by Sajjadi et al. (1991). Analysis of these new EPH sub-family members will increase our understanding of the biology of this receptor family and their isolation will provide reagents for the identification of ligands for this large family of orphan receptors.","affiliation":[]},{"pmid":"7601466","pmcid":null,"title":"Identification of the human ERK gene as a putative receptor tyrosine kinase and its chromosomal localization to 1p36.1: a comparative mapping of human, mouse, and rat chromosomes.","authors":["Saito T","Seki N","Matsuda Y","Kitahara M","Murata M","Kanda N","Nomura N","Yamamoto T","Hori TA"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genomics","journalShort":"Genomics","day":20,"month":3,"year":1995,"meshHeadings":["Amino Acid Sequence","Animals","Base Sequence","Chickens","Chromosome Mapping","Chromosomes, Human, Pair 1","Genes","Humans","In Situ Hybridization, Fluorescence","Mice","Molecular Sequence Data","Nerve Tissue Proteins","Rats","Receptor Protein-Tyrosine Kinases","Receptor, EphA8","Receptor, EphB2","Sequence Alignment","Sequence Homology, Amino Acid","Species Specificity"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"From a newly determined cDNA sequence of the human ERK gene, a highly hydrophobic portion was identified upstream of the putative tyrosine kinase domain. This is the first evidence that the ERK protein possesses a receptor-like membrane-spanning structure. Fluorescence in situ hybridization analysis of R-banded metaphase chromosomes revealed that the ERK gene is located in chromosome region 1p36.1. This locus is near the frequent translocation breakpoint or deletion region of neuroblastoma and some other cancers. A comparative mapping study of the mouse and rat homologues indicated that each counterpart maps to the mouse chromosome 4D2.2-D3 and rat chromosome 5q36.13 regions, both of which have conserved linkage homology to human chromosome 1p.","affiliation":[]},{"pmid":"7688222","pmcid":null,"title":"Identification of protein-tyrosine kinase genes preferentially expressed in embryo stomach and gastric cancer.","authors":["Iwase T","Tanaka M","Suzuki M","Naito Y","Sugimura H","Kino I"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Biochemical and biophysical research communications","journalShort":"Biochem. Biophys. Res. Commun.","day":30,"month":7,"year":1993,"meshHeadings":["Adenocarcinoma","Aging","Amino Acid Sequence","Animals","Base Sequence","Blotting, Northern","DNA","DNA, Neoplasm","Embryonic and Fetal Development","Gene Expression Regulation, Enzymologic","Gene Expression Regulation, Neoplastic","Gene Library","Humans","Molecular Sequence Data","Open Reading Frames","Phosphotyrosine","Poly A","Protein-Tyrosine Kinases","RNA","RNA, Messenger","Rats","Rats, Wistar","Sequence Homology, Amino Acid","Sequence Homology, Nucleic Acid","Stomach","Stomach Neoplasms","Tyrosine"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"For identification of the protein-tyrosine kinases that are expressed in embryo stomach and gastric cancer, a 16-day rat embryo stomach and two human gastric cancer cDNA expression libraries were screened with an anti-phosphotyrosine antibody. Eight cDNAs encoding protein-tyrosine kinase were isolated, and Northern blot analysis revealed that five out of eight clones were highly expressed in rat embryo stomach, but not in adult rat stomach. From nucleotide sequence analysis, these five cDNAs were identified as elk, erk, esk, TTK and fyn, respectively. We report here that the expression levels of two families of receptor type tyrosine kinase genes, elk/erk and esk/TTK are developmentally regulated in rat stomach and highly expressed in human gastric cancer tissues. These findings suggest that elk/erk and esk/TTK genes play important roles in embryonic development and carcinogenesis of the stomach.","affiliation":[]},{"pmid":"10480933","pmcid":null,"title":"90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1.","authors":["Jensen CJ","Buch MB","Krag TO","Hemmings BA","Gammeltoft S","Frdin M"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":17,"month":9,"year":1999,"meshHeadings":["3-Phosphoinositide-Dependent Protein Kinases","Amino Acid Sequence","Animals","COS Cells","Enzyme Activation","Humans","Mice","Molecular Sequence Data","Phosphorylation","Protein-Serine-Threonine Kinases","Rats","Ribosomal Protein S6 Kinases","Serine"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"90-kDa ribosomal S6 kinase-2 (RSK2) belongs to a family of growth factor-activated serine/threonine kinases composed of two kinase domains connected by a regulatory linker region. The N-terminal kinase of RSK2 is involved in substrate phosphorylation. Its activation requires phosphorylation of the linker region at Ser(369), catalyzed by extracellular signal-regulated kinase (ERK), and at Ser(386), catalyzed by the C-terminal kinase, after its activation by ERK. In addition, the N-terminal kinase must be phosphorylated at Ser(227) in the activation loop by an as yet unidentified kinase. Here, we show that the isolated N-terminal kinase of RSK2 (amino acids 1-360) is phosphorylated at Ser(227) by PDK1, a constitutively active kinase, leading to 100-fold stimulation of kinase activity. In COS7 cells, ectopic PDK1 induced the phosphorylation of full-length RSK2 at Ser(227) and Ser(386), without involvement of ERK, leading to partial activation of RSK2. Similarly, two other members of the RSK family, RSK1 and RSK3, were partially activated by PDK1 in COS7 cells. Finally, our data indicate that full activation of RSK2 by growth factor requires the cooperation of ERK and PDK1 through phosphorylation of Ser(227), Ser(369), and Ser(386). Our study extend recent findings which implicate PDK1 in the activation of protein kinases B and C and p70(S6K), suggesting that PDK1 controls several major growth factor-activated signal transduction pathways.","affiliation":[]},{"pmid":"1648701","pmcid":null,"title":"eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases.","authors":["Chan J","Watt VM"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":13,"month":6,"year":1991,"meshHeadings":["Amino Acid Sequence","Animals","Blotting, Northern","Blotting, Southern","Brain","Calcium-Calmodulin-Dependent Protein Kinases","Chromosome Mapping","Chromosomes, Human, Pair 1","DNA","Fibroblasts","Humans","Lung","Membrane Proteins","Molecular Sequence Data","Nerve Tissue Proteins","Protein-Tyrosine Kinases","Proteins","Rats","Receptor, EphA8","Receptor, Fibroblast Growth Factor, Type 3","Receptors, Cell Surface","Receptors, Fibroblast Growth Factor"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We have identified human and rat DNAs encoding two novel members of the eph subclass of putative receptor protein-tyrosine kinases. Rat cDNA clones encoding eek (eph- and elk-related kinase) were isolated from a brain cDNA library probed with DNA encoding the kinase region of the insulin receptor-related receptor. The predicted eek protein contains all the amino acid residues conserved in the catalytic domains of protein-tyrosine kinases and is most similar to two putative receptor protein-tyrosine kinases of the eph subclass, elk (69%) and eph (57%). Human genomic DNAs encoding part of eek (EEK) as well as another putative protein-tyrosine kinase most similar to elk (90%), ERK (elk-related kinase), were isolated and partially characterized. The novel identity of these two eph-family genes was further supported by Southern blot analyses and localization to human chromosome 1. In Northern blot analysis of rat RNA, DNAs encoding rat eek and human ERK hybridized to transcripts most abundant in brain and lung, respectively. These two new members of the eph subclass of receptor protein-tyrosine kinases, eek and erk, may therefore have tissue-specific functions distinct from those of other eph family members.","affiliation":[]},{"pmid":"8033077","pmcid":null,"title":"Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors.","authors":["Kiyokawa E","Takai S","Tanaka M","Iwase T","Suzuki M","Xiang YY","Naito Y","Yamada K","Sugimura H","Kino I"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cancer research","journalShort":"Cancer Res.","day":15,"month":7,"year":1994,"meshHeadings":["Amino Acid Sequence","Base Sequence","DNA, Complementary","Gene Expression Regulation, Neoplastic","Humans","In Situ Hybridization","Molecular Sequence Data","Neoplasms","RNA, Messenger","Receptor Protein-Tyrosine Kinases","Receptor, EphB2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The ERK gene has been isolated as a genomic DNA encoding a part of the receptor protein-tyrosine kinase which belongs to the EPH subfamily. We previously identified a partial complementary DNA (cDNA) encompassing the catalytic domain of ERK from the expression library of human gastric cancer with an antiphosphotyrosine antibody. Using this cDNA as a probe, the cDNAs encoding mature ERK protein were isolated. The putative mature ERK protein, a total of 967 deduced amino acid residues, showed high homology with chicken Cek5 (92.5%) and mouse Nuk (99.1%). Chromosomal in situ hybridization revealed that human ERK cDNA is localized to chromosome 1p34-35. In Northern blot analysis of normal human tissues, the ERK gene was ubiquitously expressed mainly in cells of epithelial origin but not in the brain. Studies on RNAs from 76 human tumor tissues and cell lines showed that ERK is expressed at higher levels in various tumors of epithelial origin than in corresponding normal tissues, most frequently in gastric cancers (12 of 16, 75.0%). Overexpression of ERK was also detected in one osteosarcoma cell line. These findings suggest that ERK plays some significant role in carcinogenesis in the stomach and other tissues.","affiliation":[]},{"pmid":"10730216","pmcid":null,"title":"Eph receptors and ephrins: regulators of guidance and assembly.","authors":["Wilkinson DG"],"grantIds":["P30 CA030199"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"International review of cytology","journalShort":"Int. Rev. Cytol.","day":20,"month":4,"year":2000,"meshHeadings":["Animals","Ephrin-B1","Membrane Proteins","Receptor Protein-Tyrosine Kinases","Receptor, EphA1"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Recent advances have started to elucidate the developmental functions and biochemistry of Eph receptor tyrosine kinases and their membrane-bound ligands, ephrins. Interactions between these molecules are promiscuous, but they largely fall into two groups: EphA receptors bind to GPI-anchored ephrin-A ligands, while EphB receptors bind to ephrin-B proteins that have a transmembrane and cytoplasmic domain. Remarkably, ephrin-B proteins transduce signals, such that bidirectional signaling can occur upon interaction with Eph receptor. In many tissues, specific Eph receptors and ephrins have complementary domains, whereas other family members may overlap in their expression. An important role of Eph receptors and ephrins is to mediate cell-contact-dependent repulsion. Complementary and overlapping gradients of expression underlie establishment of a topographic map of neuronal projections in the retinotectal system. Eph receptors and ephrins also act at boundaries to channel neuronal growth cones along specific pathways, restrict the migration of neural crest cells, and via bidirectional signaling prevent intermingling between hindbrain segments. Intriguingly, Eph receptors and ephrins can also trigger an adhesive response of endothelial cells and are required for the remodeling of blood vessels. Biochemical studies suggest that the extent of multimerization of Eph receptors modulates the cellular response and that the actin cytoskeleton is one major target of the intracellular pathways activated by Eph receptors. Eph receptors and ephrins have thus emerged as key regulators of the repulsion and adhesion of cells that underlie the establishment, maintenance, and remodeling of patterns of cellular organization.","affiliation":[]},{"pmid":"10523848","pmcid":null,"title":"alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase.","authors":["Yoshii S","Tanaka M","Otsuki Y","Wang DY","Guo RJ","Zhu Y","Takeda R","Hanai H","Kaneko E","Sugimura H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":7,"month":10,"year":1999,"meshHeadings":["Adaptor Proteins, Signal Transducing","Animals","COS Cells","Cell Adhesion","Cell Cycle Proteins","Cell Movement","Cercopithecus aethiops","Cytoskeleton","Extracellular Matrix","Fibronectins","GTP Phosphohydrolases","Guanine Nucleotide Exchange Factors","MAP Kinase Signaling System","Macromolecular Substances","Mesoderm","Microinjections","Models, Biological","Oncogene Proteins","Phosphatidylinositol 3-Kinases","Phosphorylation","Protein Isoforms","Protein Processing, Post-Translational","Protein-Serine-Threonine Kinases","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Receptors, Platelet-Derived Growth Factor","Rho Guanine Nucleotide Exchange Factors","Signal Transduction","Xenopus laevis","p21-Activated Kinases","src Homology Domains"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"p21-activated kinase (PAK) is a common effector protein of the small GTPases Cdc42 and Rac, leading to the activation of downstream mitogen activated protein kinases. PAK also mediates polarized cytoskeletal changes induced by these GTPases. The recently identified PAK-interacting exchange factor (PIX) acts as a guanine nucleotide exchange factor on Rac, and colocalizes with PAK in a focal complex, but little is known about the associated signaling cascades, including upstream activators of PIX. In this study, we show that one of the isoforms of PIX, alphaPIX, is activated by signaling cascades from the platelet-derived growth factor (PDGF) receptor and EphB2 receptor, and from integrin-induced signaling through phosphatidylinositol 3-kinase (PI3-kinase). alphaPIX is activated by forming a complex with these receptors either via association with PAK and Nck, or direct association with the p85 regulatory subunit of PI3-kinase. Synthetic phosphoinositide and membrane targeted PI3-kinase augmented the alphaPIX activity in vivo. In Xenopus, aggregates of mesodermal cells derived from embryos microinjected with alphaPIX significantly increased the peripheral spreading on fibronectin substrate in response to PDGF through PI3-kinase. These results indicate that alphaPIX is activated by PI3-kinase, and is involved in the receptor mediated signaling leading to the activation of the kinase activity of PAK, and the migration of mesodermal cells on extracellular matrix.","affiliation":[]},{"pmid":"12477932","pmcid":null,"title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","authors":["Strausberg RL","Feingold EA","Grouse LH","Derge JG","Klausner RD","Collins FS","Wagner L","Shenmen CM","Schuler GD","Altschul SF","Zeeberg B","Buetow KH","Schaefer CF","Bhat NK","Hopkins RF","Jordan H","Moore T","Max SI","Wang J","Hsieh F","Diatchenko L","Marusina K","Farmer AA","Rubin GM","Hong L","Stapleton M","Soares MB","Bonaldo MF","Casavant TL","Scheetz TE","Brownstein MJ","Usdin TB","Toshiyuki S","Carninci P","Prange C","Raha SS","Loquellano NA","Peters GJ","Abramson RD","Mullahy SJ","Bosak SA","McEwan PJ","McKernan KJ","Malek JA","Gunaratne PH","Richards S","Worley KC","Hale S","Garcia AM","Gay LJ","Hulyk SW","Villalon DK","Muzny DM","Sodergren EJ","Lu X","Gibbs RA","Fahey J","Helton E","Ketteman M","Madan A","Rodrigues S","Sanchez A","Whiting M","Madan A","Young AC","Shevchenko Y","Bouffard GG","Blakesley RW","Touchman JW","Green ED","Dickson MC","Rodriguez AC","Grimwood J","Schmutz J","Myers RM","Butterfield YS","Krzywinski MI","Skalska U","Smailus DE","Schnerch A","Schein JE","Jones SJ","Marra MA","Mammalian Gene Collection Program Team"],"grantIds":["U54 HG003273"],"grantAgencies":["NHGRI NIH HHS"],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":24,"month":12,"year":2002,"meshHeadings":["Algorithms","Animals","DNA, Complementary","Gene Library","Humans","Mice","Open Reading Frames","Sequence Analysis, DNA"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The National Institutes of Health Mammalian Gene Collection (MGC) Program is a multiinstitutional effort to identify and sequence a cDNA clone containing a complete ORF for each human and mouse gene. ESTs were generated from libraries enriched for full-length cDNAs and analyzed to identify candidate full-ORF clones, which then were sequenced to high accuracy. The MGC has currently sequenced and verified the full ORF for a nonredundant set of >9,000 human and >6,000 mouse genes. Candidate full-ORF clones for an additional 7,800 human and 3,500 mouse genes also have been identified. All MGC sequences and clones are available without restriction through public databases and clone distribution networks (see http:mgc.nci.nih.gov).","affiliation":[]},{"pmid":"21503576","pmcid":null,"title":"Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2.","authors":["Tanabe H","Kuribayashi K","Tsuji N","Tanaka M","Kobayashi D","Watanabe N"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"International journal of oncology","journalShort":"Int. J. Oncol.","day":16,"month":7,"year":2011,"meshHeadings":["Antineoplastic Agents","Autophagy","Cell Line, Tumor","Cell Survival","Colonic Neoplasms","Dioxoles","Gene Silencing","HT29 Cells","Humans","Lignans","Phosphorylation","Receptor, EphA1","Receptor, EphB2","Tyrosine"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Receptor tyrosine kinase EphB2 and autophagic machinery are known as tumor suppressors; however, the connection remains to be elucidated. Here, we show the link between EphB2 and autophagy. Sesamin, a major lignan in sesame oil, induced autophagy in the human colon cancer cell lines HT29 and LS180, as shown by electron microscopy, as well as Western blotting and immunofluorescence imaging using an anti-LC3 antibody. Receptor tyrosine kinase array analysis revealed that sesamin treatment increased the levels of unphosphorylated -EphA1 and -EphB2 in HT29 cells. Silencing of EphA1 and EphB2 blocked sesamin-induced autophagy as well as sesamin-induced loss of cell viability. These results show that EphA1 and EphB2 play a critical role in this process. The present study reveals a novel function for EphA1 and EphB2 in the induction of autophagy, suggesting a tumor suppressor role for these proteins in colorectal cancer.","affiliation":[]},{"pmid":"21387540","pmcid":null,"title":"Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors.","authors":["Chetcuti A","Aktas S","Mackie N","Ulger C","Toruner G","Alkan M","Catchpoole D"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Pediatric blood & cancer","journalShort":"Pediatr Blood Cancer","day":1,"month":12,"year":2011,"meshHeadings":["Child","Child, Preschool","Female","Gene Expression Profiling","Humans","Infant","MSX1 Transcription Factor","Male","Neoplasm Invasiveness","Oligonucleotide Array Sequence Analysis","Receptor, EphB2","Reverse Transcriptase Polymerase Chain Reaction","Wilms Tumor"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Wilms tumor is the most common pediatric renal malignancy, but the parameters that are important to its invasion capacity are poorly understood. The aim of this study was to identify new proteins associated with the invasion capacity of Wilms tumor. PROCEDURE: Gene expression profiles for 15 primary Wilms tumor samples were determined by Affymetrix Genechip Human Genome Ul33A microarray analysis. The gene expression profiles for selected genes was further confirmed by quantitative RT-PCR analysis. Immunohistochemical analysis was performed on 25 Wilms tumor cases to confirm expression for Bcl2A1, EphB2, MSX1, and RIN1. RESULTS: Using microarray analysis 14 genes showed differential expression (P < 0.05) comparing stage 1 non-invasive Wilms tumor to stages 2-4 invasive Wilms tumor. The differential expression for Bcl2A1, EphB2, MSX1, and RIN1 was confirmed by quantitative RT-PCR. MSX1 protein was statistically significantly lower in stages 2-4 invasive Wilms tumor cases compared to stage 1 non-invasive cases (P = 0.013). EphB2 protein was higher in stages 2-4 Wilms tumor cases compared to stage 1 cases (P = 0.006). There was no statistically significant difference between stages 1 and 2-4 Wilms tumor for Bcl2A1 (P = 0.230) or RIN1 (P = 0.969) at the protein level. CONCLUSION: Our results indicate that MSX1 may be associated with the invasion capacity of Wilms tumors. RIN1 is a downstream effector of RAS and Bcl2A1 functions as an anti-apoptotic protein. EphB2 is an ephrin receptor and is up-regulated in invasive tumors but its role needs to be confirmed in further cases of Wilms tumors.","affiliation":[]},{"pmid":"21161727","pmcid":null,"title":"Influence of A9 region mutation in EphB2 gene in the prognosis of patients with colorectal adenocarcinoma.","authors":["Vidaurreta M","Rafael S","Veganzones S","de la Orden V","Fernndez C","Gmez-Casaseca R","Cerdn J","Maestro M"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Annals of surgical oncology","journalShort":"Ann. Surg. Oncol.","day":18,"month":5,"year":2011,"meshHeadings":["Adenocarcinoma","Adenocarcinoma, Mucinous","Adult","Aged","Aged, 80 and over","Colorectal Neoplasms","Exons","Female","Humans","Male","Middle Aged","Mutation","Prognosis","Receptor, EphB2","Survival Rate"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: EphB2 is a transmembrane glycoprotein implicated in the regulation of cell growth, differentiation, and motility. It has been proposed as a tumor suppressor gene, and the role of EphB2 protein in tumorogenesis has been demonstrated. The aim of this study was to test the influence of mutation of A9 region in EphB2 gene in the prognosis of patients with sporadic CCR. MATERIALS AND METHODS: A total of 473 patients with colorectal cancer were included. A9 region in exon 17 of EphB2 was amplified using specific primer and analyzed using Genescan. All mutations were confirmed by direct sequencing. RESULTS: EphB2 mutation was detected in 13 of the 473 patients (2.7%). Mutation of EphB2 showed association with tumor site, 12 of 13 mutations were proximal tumors (P < 0.001). EphB2 mutation confers better prognosis in the adenocarcinoma group; 100% of patients carrying the mutation survived and were disease free after 72 months (P = 0.02 and 0.03, respectively). CONCLUSIONS: Despite the low frequency of EphB2 gene, we got promising results. It would be very interesting to increase the population size to verify our results. If these findings are confirmed, EphB2 could help discriminate patients with adenocarcinoma with different prognosis and to improve the election of the most suitable treatment in each case.","affiliation":[]},{"pmid":"12546821","pmcid":null,"title":"Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin.","authors":["Penzes P","Beeser A","Chernoff J","Schiller MR","Eipper BA","Mains RE","Huganir RL"],"grantIds":["DA 00266","MH 61873"],"grantAgencies":["NIDA NIH HHS","NIMH NIH HHS"],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":23,"month":1,"year":2003,"meshHeadings":["Blotting, Western","Carrier Proteins","Cells, Cultured","Dendrites","Guanine Nucleotide Exchange Factors","Hippocampus","Humans","Indicators and Reagents","Morphogenesis","Neuronal Plasticity","Phosphorylation","Receptors, Eph Family","Rho Guanine Nucleotide Exchange Factors","Signal Transduction","Synapses","Tissue Fixation","Transfection","rac1 GTP-Binding Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The morphogenesis of dendritic spines, the major sites of excitatory synaptic transmission in the brain, is important in synaptic development and plasticity. We have identified an ephrinB-EphB receptor trans-synaptic signaling pathway which regulates the morphogenesis and maturation of dendritic spines in hippocampal neurons. Activation of the EphB receptor induces translocation of the Rho-GEF kalirin to synapses and activation of Rac1 and its effector PAK. Overexpression of dominant-negative EphB receptor, catalytically inactive kalirin, or dominant-negative Rac1, or inhibition of PAK eliminates ephrin-induced spine development. This novel signal transduction pathway may be critical for the regulation of the actin cytoskeleton controlling spine morphogenesis during development and plasticity.","affiliation":[]},{"pmid":"8798570","pmcid":null,"title":"Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells.","authors":["Stein E","Cerretti DP","Daniel TO"],"grantIds":["DK38517","DK47078"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":20,"month":9,"year":1996,"meshHeadings":["Adaptor Proteins, Signal Transducing","Animals","DNA-Binding Proteins","Endothelium, Vascular","Ephrin-B1","GRB10 Adaptor Protein","GRB2 Adaptor Protein","Humans","Kidney","Ligands","Mice","Phosphorylation","Protein Binding","Proteins","Proto-Oncogene Proteins","Receptor Protein-Tyrosine Kinases","Recombinant Fusion Proteins","Saccharomyces cerevisiae","Signal Transduction","Transcription Factors","ets-Domain Protein Elk-1"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"ELK is a member of the Eph-related tyrosine kinase family that includes receptors signaling axonal guidance, neuronal bundling, and angiogenesis. We recently identified ELK expression in human renal microvascular endothelial cells and sought to identify intracellular proteins through which it signals responses. The cytoplasmic domain of ELK was used as \"bait\" in a yeast two-hybrid screen to identify interactive proteins expressed from a randomly primed embryonic murine library (E9.5-10.5). Among interactive products of 76 cDNAs characterized, 10 nonidentical, overlapping clones encoded the SH2 domain of the recently reported Grb10 adapter protein, and an additional 3 encoded Grb2. A self-phosphorylated recombinant, baculovirus-expressed GST-ELKcy fusion protein bound Grb10 and Grb2 from human renal microvascular endothelial cell extracts, while the unphosphorylated fusion form did not. Site-directed mutation identified Tyr-929 as a putative phosphorylation site required for Grb10, but not Grb2, interaction in yeast and recombinant protein assays. The ELK ligand, LERK-2/Fc, stimulated tyrosine phosphorylation of ELK, and recruitment of Grb10 and Grb2 to endothelial ELK receptors recovered by wheat germ agglutinin lectin and immunoprecipitation. These findings define ligand-activated interaction between ELK and the SH2 domains of Grb2 and the newly identified Grb10 protein that shares homology with a Caenorhabditis elegans gene product implicated in neural cell migration.","affiliation":[]},{"pmid":"11585923","pmcid":null,"title":"Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.","authors":["Elowe S","Holland SJ","Kulkarni S","Pawson T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular and cellular biology","journalShort":"Mol. Cell. Biol.","day":4,"month":11,"year":2001,"meshHeadings":["Animals","Blotting, Western","COS Cells","Cell Division","Cell Line","Cytoplasm","Cytoskeleton","DNA, Complementary","Down-Regulation","Enzyme Activation","Ephrin-B1","Fibronectins","Humans","MAP Kinase Signaling System","Membrane Proteins","Mitogen-Activated Protein Kinase 1","Mitogen-Activated Protein Kinase 3","Mitogen-Activated Protein Kinases","Neurites","Neurons","Precipitin Tests","Protein Binding","Protein Structure, Tertiary","Rats","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Receptor, EphB4","Receptors, Eph Family","Signal Transduction","Time Factors","Tumor Cells, Cultured","ras Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Activation of the EphB2 receptor tyrosine kinase by clustered ephrin-B1 induces growth cone collapse and neurite retraction in differentiated NG108 neuronal cells. We have investigated the cytoplasmic signaling events associated with EphB2-induced cytoskeletal reorganization in these neuronal cells. We find that unlike other receptor tyrosine kinases, EphB2 induces a pronounced downregulation of GTP-bound Ras and consequently of the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway. A similar inhibition of the Ras-MAPK pathway was observed on stimulation of endogenous EphB2 in COS-1 cells. Inactivation of Ras, induced by ephrin B1 stimulation of NG108 neuronal cells, requires EphB2 tyrosine kinase activity and is blocked by a truncated form of p120-Ras GTPase-activating protein (p120-RasGAP), suggesting that EphB2 signals through the SH2 domain protein p120-RasGAP to inhibit the Ras-MAPK pathway. Suppression of Ras activity appears functionally important, since expression of a constitutively active variant of Ras impaired the ability of EphB2 to induce neurite retraction. In addition, EphB2 attenuated the elevation in ERK activation induced by attachment of NG108 cells to fibronectin, indicating that the EphB2 receptor can modulate integrin signaling to the Ras GTPase. These results suggest that a primary function of EphB2, a member of the most populous family of receptor tyrosine kinases, is to inactivate the Ras-MAPK pathway in a fashion that contributes to cytoskeletal reorganization and adhesion responses in neuronal growth cones.","affiliation":[]},{"pmid":"10648599","pmcid":null,"title":"Extracellular signal-regulated kinase binds to TFII-I and regulates its activation of the c-fos promoter.","authors":["Kim DW","Cochran BH"],"grantIds":["R01-GM51551"],"grantAgencies":["NIGMS NIH HHS"],"retractions":[],"journal":"Molecular and cellular biology","journalShort":"Mol. Cell. Biol.","day":15,"month":2,"year":2000,"meshHeadings":["3T3 Cells","Amino Acid Sequence","Animals","Base Sequence","DNA Primers","DNA-Binding Proteins","Gene Expression Regulation","Genes, fos","Humans","Mice","Mitogen-Activated Protein Kinases","Molecular Sequence Data","Phosphorylation","Promoter Regions, Genetic","Recombinant Proteins","Sequence Homology, Amino Acid","Signal Transduction","Transcription Factors","ras Proteins","rho GTP-Binding Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We have previously shown that TFII-I enhances transcriptional activation of the c-fos promoter through interactions with upstream elements in a signal-dependent manner. Here we demonstrate that activated Ras and RhoA synergize with TFII-I for c-fos promoter activation, whereas dominant-negative Ras and RhoA inhibit these effects of TFII-I. The Mek1 inhibitor, PD98059 abrogates the enhancement of the c-fos promoter by TFII-I, indicating that TFII-I function is dependent on an active mitogen-activated protein (MAP) kinase pathway. Analysis of the TFII-I protein sequence revealed that TFII-I contains a consensus MAP kinase interaction domain (D box). Consistent with this, we have found that TFII-I forms an in vivo complex with extracellular signal-related kinase (ERK). Point mutations within the consensus MAP kinase binding motif of TFII-I inhibit its ability to bind ERK and its ability to enhance the c-fos promoter. Therefore, the D box of TFII-I is required for its activity on the c-fos promoter. Moreover, the interaction between TFII-I and ERK can be regulated. Serum stimulation enhances complex formation between TFII-I and ERK, and dominant-negative Ras abrogates this interaction. In addition, TFII-I can be phosphorylated in vitro by ERK and mutation of consensus MAP kinase substrate sites at serines 627 and 633 impairs the phosphorylation of TFII-I by ERK and its activity on the c-fos promoter. These results suggest that ERK regulates the activity of TFII-I by direct phosphorylation.","affiliation":[]},{"pmid":"21292437","pmcid":null,"title":"Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.","authors":["Hua YQ","Ouyang HQ","Chen Z","Meng ZQ","Luo JM","Lin JH","Zhou ZH","Chen H","Wang K","Liu LM"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Biomedicine & pharmacotherapy = Biomdecine & pharmacothrapie","journalShort":"Biomed. Pharmacother.","day":18,"month":3,"year":2011,"meshHeadings":["Animals","Apoptosis","Blotting, Western","Cell Line, Tumor","Cell Proliferation","Disease Models, Animal","Female","Genetic Vectors","Humans","Lentivirus","Mice","Mice, Inbred BALB C","Mice, Nude","Neoplasm Transplantation","Pancreatic Neoplasms","Proto-Oncogene Proteins c-bcl-2","RNA Interference","RNA, Messenger","Receptor, EphB2","Reverse Transcriptase Polymerase Chain Reaction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Several studies have reported the change of EphB2 in a variety of carcinomas and suggested a functional relation between EphB2 and tumor progression. However, its role in human pancreatic carcinoma has not been described. The aim of this study was to evaluate the significance of EphB2 in human pancreatic carcinoma CFPAC-1 cells. A lentivirus-based RNA interference (RNAi) vector was designed, synthesized and transfected into CFPAC-1 cells to inhibit EphB2 expression. WST-8 based Colorimetric Assay Cell Counting kit 8 (CCK-8) in vitro and xenograft transplantation model in nude mice was used to evaluate cell proliferation and growth respectively. Cell-cycle and apoptosis were analyzed by flow cytometry (FCM). RT-PCR and Western blot were used to assess mRNA expression and protein levels. EphB2 expression was significantly suppressed both in mRNA and protein levels using the lentivirus-based EphB2 RNAi in CFPAC-1 cells (P<0.01, P<0.01). Silencing EphB2 stimulated cell growth in vitro (P<0.05) and proliferation in vivo (P<0.01) versus Control RNAi. EphB2 RNAi significantly increased S phase cells from 18.15 to 27.18% (P<0.05), and significantly decreased G1 phase cells from 72.93 to 57.61% compared with Control RNAi (P<0.05). In addition, decreased apoptosis was observed in CFPAC-1 EphB2 RNAi cells compared with Control RNAi cells (P<0.01). The apoptosis rate was 1.63% and 7.44%, respectively. Silencing EphB2 increased CyclinD1, cyclindependent kinase 6 (CDK6) and Bcl-2 expression in both mRNA and protein levels compared with Control RNAi. A lentivirus-based EphB2 RNAi efficiently inhibited EphB2 gene and its protein expression. Silencing EphB2 stimulated pancreatic carcinoma growth by increasing cell proliferation through G1/S phase breakthrough, which relied on a CyclinD1/CDK6 cell-cycle regulated signal. Similarly, EphB2 inhibition also reduced CFPAC-1 cells apoptosis by up-regulating Bcl-2 expression. Thus, at least in the context of pancreatic carcinoma CFPAC-1 cells, EphB2 plays a tumor suppressor role in cell proliferation and apoptosis.","affiliation":[]},{"pmid":"8755474","pmcid":null,"title":"Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis.","authors":["Gale NW","Holland SJ","Valenzuela DM","Flenniken A","Pan L","Ryan TE","Henkemeyer M","Strebhardt K","Hirai H","Wilkinson DG","Pawson T","Davis S","Yancopoulos GD"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":23,"month":7,"year":1996,"meshHeadings":["Animals","Binding, Competitive","Embryo, Mammalian","Embryonic and Fetal Development","Humans","Ligands","Receptor Protein-Tyrosine Kinases","Tissue Distribution"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We report that the many Eph-related receptor tyrosine kinases, and their numerous membrane-bound ligands, can each be grouped into only two major specificity subclasses. Receptors in a given subclass bind most members of a corresponding ligand subclass. The physiological relevance of these groupings is suggested by viewing the collective distributions of all members of a subclass. These composite distributions, in contrast with less informative patterns seen with individual members of the family, reveal that the developing embryo is subdivided into domains defined by reciprocal and apparently mutually exclusive expression of a receptor subclass and its corresponding ligands. Receptors seem to encounter their ligands only at the interface between these domains. This reciprocal compartmentalization implicates the Eph family in the formation of spatial boundaries that may help to organize the developing body plan.","affiliation":[]},{"pmid":"10839360","pmcid":null,"title":"EphB2 guides axons at the midline and is necessary for normal vestibular function.","authors":["Cowan CA","Yokoyama N","Bianchi LM","Henkemeyer M","Fritzsch B"],"affiliations":["Creighton U, Omaha, NE"],"grantIds":["2P01 DC00215-14A1","DC03121","NS36671"],"grantAgencies":["NIDCD NIH HHS","NIDCD NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":23,"month":5,"year":2000,"meshHeadings":["Animals","Axons","Cochlear Nerve","Ear, Inner","Embryo, Mammalian","Endolymph","Growth Cones","Mice","Mutation","Neurons, Efferent","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Rhombencephalon","Semicircular Canals","Stereotypic Movement Disorder","Vestibular Nerve","Vestibule, Labyrinth"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Mice lacking the EphB2 receptor tyrosine kinase display a cell-autonomous, strain-specific circling behavior that is associated with vestibular phenotypes. In mutant embryos, the contralateral inner ear efferent growth cones exhibit inappropriate pathway selection at the midline, while in mutant adults, the endolymph-filled lumen of the semicircular canals is severely reduced. EphB2 is expressed in the endolymph-producing dark cells in the inner ear epithelium, and these cells show ultrastructural defects in the mutants. A molecular link to fluid regulation is provided by demonstrating that PDZ domain-containing proteins that bind the C termini of EphB2 and B-ephrins can also recognize the cytoplasmic tails of anion exchangers and aquaporins. This suggests EphB2 may regulate ionic homeostasis and endolymph fluid production through macromolecular associations with membrane channels that transport chloride, bicarbonate, and water.","affiliation":["Creighton U, Omaha, NE"]},{"pmid":"11754835","pmcid":null,"title":"Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity.","authors":["Grunwald IC","Korte M","Wolfer D","Wilkinson GA","Unsicker K","Lipp HP","Bonhoeffer T","Klein R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":20,"month":12,"year":2001,"meshHeadings":["Age Factors","Animals","Behavior, Animal","Electrophysiology","Ephrin-B1","Ephrin-B3","Gene Expression","Hippocampus","Lac Operon","Ligands","Long-Term Potentiation","Membrane Proteins","Mice","Mice, Knockout","Neural Inhibition","Neuronal Plasticity","Neurons","Protein Kinases","RNA, Messenger","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Receptors, N-Methyl-D-Aspartate","Signal Transduction","Synapses","beta-Galactosidase"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During development, Eph receptors mediate the repulsive axon guidance function of ephrins, a family of membrane attached ligands with their own receptor-like signaling potential. In cultured glutamatergic neurons, EphB2 receptors were recently shown to associate with NMDA receptors at synaptic sites and were suggested to play a role in synaptogenesis. Here we show that Eph receptor stimulation in cultured neurons modulates signaling pathways implicated in synaptic plasticity, suggesting cross-talk with NMDA receptor-activated pathways. Mice lacking EphB2 have normal hippocampal synapse morphology, but display defects in synaptic plasticity. In EphB2(-/-) hippocampal slices, protein synthesis-dependent long-term potentiation (LTP) was impaired, and two forms of synaptic depression were completely extinguished. Interestingly, targeted expression of a carboxy-terminally truncated form of EphB2 rescued the EphB2 null phenotype, indicating that EphB2 kinase signaling is not required for these EphB2-mediated functions.","affiliation":[]},{"pmid":"11940661","pmcid":null,"title":"Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.","authors":["Nguyen A","Burack WR","Stock JL","Kortum R","Chaika OV","Afkarian M","Muller WJ","Murphy KM","Morrison DK","Lewis RE","McNeish J","Shaw AS"],"grantIds":["CA90400","DK52809"],"grantAgencies":["NCI NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"Molecular and cellular biology","journalShort":"Mol. Cell. Biol.","day":9,"month":5,"year":2002,"meshHeadings":["Animals","Breast Neoplasms","Cell Division","Enzyme Activation","Fibroblasts","Flow Cytometry","Gene Deletion","Gene Targeting","Interferon-gamma","Interleukin-2","Interleukin-4","Lymphocyte Activation","Lymphocytes","MAP Kinase Kinase 1","MAP Kinase Signaling System","Mice","Mice, Knockout","Mitogen-Activated Protein Kinase Kinases","Mitogen-Activated Protein Kinases","Molecular Weight","Phenotype","Protein Kinases","Protein-Serine-Threonine Kinases","Tumor Cells, Cultured"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"While scaffold proteins are thought to be key components of signaling pathways, their exact function is unknown. By preassembling multiple components of signaling cascades, scaffolds are predicted to influence the efficiency and/or specificity of signaling events. Here we analyze a potential scaffold of the Ras/mitogen-activated protein kinase (MAPK) pathway, kinase suppressor of Ras (KSR), by generating KSR-deficient mice. KSR-deficient mice were grossly normal even though ERK kinase activation was attenuated to a degree sufficient to block T-cell activation and inhibit tumor development. Consistent with its role as a scaffold, high-molecular-weight complexes containing KSR, MEK, and ERK were lost in the absence of KSR. This demonstrates that KSR is a bona fide scaffold that is not required for but enhances signaling via the Ras/MAPK signaling pathway.","affiliation":[]},{"pmid":"12297313","pmcid":null,"title":"Glucose induced MAPK signalling influences NeuroD1-mediated activation and nuclear localization.","authors":["Petersen HV","Jensen JN","Stein R","Serup P"],"grantIds":["DK-55091","P60 DK20593"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"FEBS letters","journalShort":"FEBS Lett.","day":25,"month":9,"year":2002,"meshHeadings":["Amino Acid Substitution","Animals","Basic Helix-Loop-Helix Transcription Factors","Binding Sites","Cell Line","Cell Nucleus","Cytoplasm","DNA-Binding Proteins","Enzyme Inhibitors","Flavonoids","Glucose","Insulin","Islets of Langerhans","Mice","Mitogen-Activated Protein Kinase Kinases","Mitogen-Activated Protein Kinases","Rats","Recombinant Proteins","Signal Transduction","Trans-Activators","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The helix-loop-helix transcription factor NeuroD1 (also known as Beta2) is involved in beta-cell survival during development and insulin gene transcription in adults. Here we show NeuroD1 is primarily cytoplasmic at non-stimulating glucose concentrations (i.e. 3 mM) in MIN6 beta-cells and nuclear under stimulating conditions (i.e. 20 mM). Quantification revealed that NeuroD1 was in 40-45% of the nuclei at 3 mM and 80-90% at 20 mM. Treatment with the MEK inhibitor PD98059 or substitution of a serine for an alanine at a potential mitogen-activated protein kinase phosphorylation site (S274) in NeuroD1 significantly increased the cytoplasmic level at 20 mM glucose. The rise in NeuroD1-mediated transcription in response to glucose also correlated with the change in sub-cellular localization, a response attenuated by PD98059. The data strongly suggest that glucose-stimulation of the MEK-ERK signalling pathway influences NeuroD1 activity at least partially through effects on sub-cellular localization.","affiliation":[]},{"pmid":"11256076","pmcid":null,"title":"Multiple roles of EPH receptors and ephrins in neural development.","authors":["Wilkinson DG"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature reviews. Neuroscience","journalShort":"Nat. Rev. Neurosci.","day":20,"month":3,"year":2001,"meshHeadings":["Animals","Axons","Body Patterning","Cell Movement","Growth Cones","Ligands","Membrane Proteins","Nervous System","Neurons","Receptor Protein-Tyrosine Kinases","Receptor, EphA1","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The control of cell movement during development is essential for forming and stabilizing the spatial organization of tissues and cell types. During initial steps of tissue patterning, distinct regional domains or cell types arise at appropriate locations, and the movement of cells is constrained in order to maintain spatial relationships during growth. In other situations, the guidance of migrating cells or neuronal growth cones to specific destinations underlies the establishment or remodeling of a pattern. Eph receptor tyrosine kinases and their ephrin ligands are key players in controlling these cell movements in many tissues and at multiple stages of patterning.","affiliation":[]},{"pmid":"11799243","pmcid":null,"title":"Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors.","authors":["Takasu MA","Dalva MB","Zigmond RE","Greenberg ME"],"grantIds":["CA43855","HD18655","NS12651","NS17512","R01 NS045500"],"grantAgencies":["NCI NIH HHS","NICHD NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Science (New York, N.Y.)","journalShort":"Science","day":18,"month":1,"year":2002,"meshHeadings":["Animals","Brain-Derived Neurotrophic Factor","Calcium","Cell Line","Cells, Cultured","Cerebral Cortex","Cyclic AMP Response Element-Binding Protein","Ephrin-B2","Gene Expression Regulation","Genes, Reporter","Glutamic Acid","Humans","Immunoglobulin Fc Fragments","Membrane Proteins","Models, Neurological","Mutation","Neurons","Phosphorylation","Phosphotyrosine","Proto-Oncogene Proteins","Proto-Oncogene Proteins c-fyn","Rats","Receptor Protein-Tyrosine Kinases","Receptor, EphB4","Receptors, Eph Family","Receptors, N-Methyl-D-Aspartate","Recombinant Fusion Proteins","Signal Transduction","Synapses","Transcription, Genetic","src-Family Kinases"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Protein-protein interactions and calcium entry through the N-methyl-d-aspartate (NMDA)-type glutamate receptor regulate synaptic development and plasticity in the central nervous system. The EphB receptor tyrosine kinases are localized at excitatory synapses where they cluster and associate with NMDA receptors. We identified a mechanism whereby EphBs modulate NMDA receptor function. EphrinB2 activation of EphB in primary cortical neurons potentiates NMDA receptor-dependent influx of calcium. Treatment of cells with ephrinB2 led to NMDA receptor tyrosine phosphorylation through activation of the Src family of tyrosine kinases. These ephrinB2-dependent events result in enhanced NMDA receptor-dependent gene expression. Our findings indicate that ephrinB2 stimulation of EphB modulates the functional consequences of NMDA receptor activation and suggest a mechanism whereby activity-independent and activity-dependent signals converge to regulate the development and remodeling of synaptic connections.","affiliation":[]},{"pmid":"12039842","pmcid":null,"title":"EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.","authors":["Kim I","Ryu YS","Kwak HJ","Ahn SY","Oh JL","Yancopoulos GD","Gale NW","Koh GY"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","journalShort":"FASEB J.","day":27,"month":7,"year":2002,"meshHeadings":["Angiopoietin-1","Cell Division","Cell Movement","Cells, Cultured","Endothelial Growth Factors","Endothelium, Vascular","Ephrin-B2","Humans","Ligands","Lymphokines","MAP Kinase Signaling System","Membrane Glycoproteins","Membrane Proteins","Mitogen-Activated Protein Kinases","Models, Biological","Phosphorylation","Proto-Oncogene Proteins p21(ras)","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Receptor, EphB4","Receptors, Eph Family","Umbilical Veins","Vascular Endothelial Growth Factor A","Vascular Endothelial Growth Factors","p120 GTPase Activating Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Interaction between ephrinB2 and EphB4 in endothelial cells at the arterial-venous capillary interface is critical for proper embryonic capillary morphogenesis. However, the intracellular downstream signaling of ephrinB2-EphB in vascular endothelial cells is unknown. This study examined the effect of ephrinB2-induced activation of EphB kinases on vascular endothelial growth factor (VEGF)- and angiopoietin-1 (Ang1)-induced Ras/mitogen-activated protein kinase (MAPK) signaling cascades in human umbilical vein endothelial cells (HUVECs). Reverse transcriptase-polymer chain reaction results showed that HUVECs expressed three kinds of EphB kinases known to bind to ephrinB2: EphB2, EphB3, and EphB4. EphrinB2 not only increased the phosphorylation of EphB2 and EphB4 in a time-dependent manner but also increased recruitment of p120-Ras-GTPase-activating protein (p120-RasGAP) to EphB2 and EphB4. Accordingly, ephrinB2 inhibited VEGF- and Ang1-induced Ras-MAPK activities, whereas ephrinB2 did not alter VEGF-induced Flk phosphorylation or Ang1-induced Tie2 phosphorylation. Furthermore, ephrinB2 suppressed VEGF- and Ang1-induced proliferation and/or migration, which are mediated mainly through Ras/MAPK signaling cascades. From these results, we propose that ephrinB2-EphB, signaling through Ras/MAPK cascade, may be critical for proper morphogenesis of capillary endothelium through the arrest of endothelial cell proliferation and migration at the arterial-venous interface.","affiliation":[]},{"pmid":"11042694","pmcid":null,"title":"The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades.","authors":["Ducret C","Maira SM","Lutz Y","Wasylyk B"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":19,"month":10,"year":2000,"meshHeadings":["3T3 Cells","Amino Acid Sequence","Animals","Binding Sites","COS Cells","Calcium-Calmodulin-Dependent Protein Kinases","JNK Mitogen-Activated Protein Kinases","MAP Kinase Kinase 4","MAP Kinase Kinase 6","MAP Kinase Signaling System","Mice","Mitogen-Activated Protein Kinase Kinases","Mitogen-Activated Protein Kinases","Molecular Sequence Data","Oncogene Proteins","Peptide Mapping","Phosphorylation","Protein Structure, Tertiary","Proto-Oncogene Proteins c-ets","Sequence Homology, Amino Acid","Substrate Specificity","Transcription Factors","Transcriptional Activation","Transfection","p38 Mitogen-Activated Protein Kinases","ras Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The ternary complex factors (TCFs), Elk-1, Sap-1a and Net, are key integrators of the transcriptional response to different signalling pathways. Classically, three MAP kinase pathways, involving ERK, JNK, and p38, transduce various extracellular stimuli to the nucleus. Net is a repressor that is converted into an activator by Ras/ERK signalling. Net is also exported from the nucleus in response to stress stimuli transduced through the JNK pathway, leading to relief from repression. Here we show that ERK and p38 bind to the D box and that binding is required for phosphorylation of the adjacent C-terminally located C-domain. The D box as well as the phosphorylation sites in the C-domain (the DC element) are required for transcription activation by Ras. On the other hand, JNK binds to the J box in the middle of the protein, and binding is required for phosphorylation of the adjacent EXport motif. Both the binding and phosphorylation sites (the JEX element) are important for Net export. In conclusion, specific targeting of Net by MAP kinase pathways involves two different docking sites and phosphorylation of two different domains. These two elements, DC and JEX, mediate two distinct functional responses.","affiliation":[]},{"pmid":"11580899","pmcid":null,"title":"EphB/syndecan-2 signaling in dendritic spine morphogenesis.","authors":["Ethell IM","Irie F","Kalo MS","Couchman JR","Pasquale EB","Yamaguchi Y"],"grantIds":["GM50194","HD25938"],"grantAgencies":["NIGMS NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":27,"month":9,"year":2001,"meshHeadings":["Animals","Cells, Cultured","Dendrites","Excitatory Postsynaptic Potentials","Hippocampus","Membrane Glycoproteins","Mice","Morphogenesis","Mutagenesis, Site-Directed","Nerve Tissue Proteins","Neuronal Plasticity","Phosphorylation","Phosphotyrosine","Protein Processing, Post-Translational","Proteoglycans","Rats","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Signal Transduction","Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Syndecan-2","Transfection"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We previously reported that the cell surface proteoglycan syndecan-2 can induce dendritic spine formation in hippocampal neurons. We demonstrate here that the EphB2 receptor tyrosine kinase phosphorylates syndecan-2 and that this phosphorylation event is crucial for syndecan-2 clustering and spine formation. Syndecan-2 is tyrosine phosphorylated and forms a complex with EphB2 in mouse brain. Dominant-negative inhibition of endogenous EphB receptor activities blocks clustering of endogenous syndecan-2 and normal spine formation in cultured hippocampal neurons. This is the first evidence that Eph receptors play a physiological role in dendritic spine morphogenesis. Our observations suggest that spine morphogenesis is triggered by the activation of Eph receptors, which causes tyrosine phosphorylation of target molecules, such as syndecan-2, in presumptive spines.","affiliation":[]},{"pmid":"11128993","pmcid":null,"title":"Roles of Eph receptors and ephrins in segmental patterning.","authors":["Xu Q","Mellitzer G","Wilkinson DG"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","journalShort":"Philos. Trans. R. Soc. Lond., B, Biol. Sci.","day":29,"month":7,"year":2000,"meshHeadings":["Animals","Axons","Body Patterning","Cell Adhesion","Cell Movement","Ephrin-A4","Ephrin-B2","Fetal Proteins","Membrane Proteins","Neural Crest","Receptor Protein-Tyrosine Kinases","Receptor, EphA4","Receptor, EphB4","Receptors, Eph Family","Rhombencephalon"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph receptor tyrosine kinases and their membrane-bound ligands, ephrins, have key roles in patterning and morphogenesis. Interactions between these molecules are promiscuous, but largely fall into two groups: EphA receptors bind to glycosylphosphatidyl inositol-anchored ephrin-A ligands, and EphB receptors bind to transmembrane ephrin-B proteins. Ephrin-B proteins transduce signals, such that bidirectional signalling can occur upon interaction with the Eph receptor. In many tissues, there are complementary and overlapping expression domains of interacting Eph receptors and ephrins. An important role of Eph receptors and ephrins is to mediate cell contact-dependent repulsion, and this has been implicated in the pathfinding of axons and neural crest cells, and the restriction of cell intermingling between hindbrain segments. Studies in an in vitro system show that bidirectional activation is required to prevent intermingling between cell populations, whereas unidirectional activation can restrict cell communication via gap junctions. Recent work indicates that Eph receptors can also upregulate cell adhesion, but the biochemical basis of repulsion versus adhesion responses is unclear. Eph receptors and ephrins have thus emerged as key regulators that, in parallel with cell adhesion molecules, underlie the establishment and maintenance of patterns of cellular organization.","affiliation":[]},{"pmid":"15821731","pmcid":null,"title":"EphrinB-EphB signalling regulates clathrin-mediated endocytosis through tyrosine phosphorylation of synaptojanin 1.","authors":["Irie F","Okuno M","Pasquale EB","Yamaguchi Y"],"grantIds":["P01 HD025938","P01 HD25938"],"grantAgencies":["NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Nature cell biology","journalShort":"Nat. Cell Biol.","day":3,"month":5,"year":2005,"meshHeadings":["Adaptor Proteins, Signal Transducing","Animals","Cells, Cultured","Clathrin","Endocytosis","Ephrin-B2","Hippocampus","Humans","Mice","Mutation","N-Methylaspartate","Nerve Tissue Proteins","Neurons","Phosphatidylinositol 4,5-Diphosphate","Phosphoric Monoester Hydrolases","Phosphotyrosine","Protein Binding","Rats","Receptor, EphB2","Receptors, AMPA","Signal Transduction","Transferrin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Recent studies show that Eph receptors act mainly through the regulation of actin reorganization. Here, we show a novel mode of action for EphB receptors. We identify synaptojanin 1 - a phosphatidylinositol 5'-phosphatase that is involved in clathrin-mediated endocytosis - as a physiological substrate for EphB2. EphB2 causes tyrosine phosphorylation in the proline-rich domain of synaptojanin 1, and inhibits both the interaction with endophilin and the 5'-phosphatase activity of synaptojanin 1. Treatment with the EphB ligand, ephrinB2, elevates the cellular level of phosphatidylinositol 4,5-bisphosphate and promotes transferrin uptake. A kinase inactive mutant of EphB2 and a phosphorylation site mutant of synaptojanin 1 both neutralize the increase of transferrin uptake after ephrinB2 treatment. These mutants also inhibit AMPA glutamate receptor endocytosis in hippocampal neurons. Interestingly, incorporated transferrin does not reach endosomes, suggesting dual effects of EphB signalling on the early and late phases of clathrin-mediated endocytosis. Our results indicate that ephrinB-EphB signalling regulates clathrin-mediated endocytosis in various cellular contexts by influencing protein interactions and phosphoinositide turnover through tyrosine phosphorylation of synaptojanin 1.","affiliation":[]},{"pmid":"17234965","pmcid":null,"title":"Notch ligand Delta-like 1 is essential for postnatal arteriogenesis.","authors":["Limbourg A","Ploom M","Elligsen D","Srensen I","Ziegelhoeffer T","Gossler A","Drexler H","Limbourg FP"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Circulation research","journalShort":"Circ. Res.","day":16,"month":2,"year":2007,"meshHeadings":["Animals","Aorta","Arteries","Capillaries","Cells, Cultured","Collateral Circulation","Constriction","Culture Media, Serum-Free","Endothelial Cells","Endothelium, Vascular","Gene Expression Regulation","Gene Silencing","Hindlimb","Humans","Intercellular Signaling Peptides and Proteins","Ischemia","Membrane Proteins","Mice","Mice, Transgenic","Morphogenesis","Neovascularization, Physiologic","Organ Specificity","RNA, Small Interfering","Receptor, EphB2","Receptor, EphB4","Receptors, Notch","Veins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Growth of functional arteries is essential for the restoration of blood flow to ischemic organs. Notch signaling regulates arterial differentiation upstream of ephrin-B2 during embryonic development, but its role during postnatal arteriogenesis is unknown. Here, we identify the Notch ligand Delta-like 1 (Dll1) as an essential regulator of postnatal arteriogenesis. Dll1 expression was specifically detected in arterial endothelial cells, but not in venous endothelial cells or capillaries. During ischemia-induced arteriogenesis endothelial Dll1 expression was strongly induced, Notch signaling activated and ephrin-B2 upregulated, whereas perivascular cells expressed proangiogenic vascular endothelial growth factor, and the ephrin-B2 activator EphB4. In heterozygous Dll1 mutant mice endothelial Notch activation and ephrin-B2 induction after hindlimb ischemia were absent, arterial collateral growth was abrogated and recovery of blood flow was severely impaired, but perivascular vascular endothelial growth factor and EphB4 expression was unaltered. In vitro, angiogenic growth factors synergistically activated Notch signaling by induction of Dll1, which was necessary and sufficient to regulate ephrin-B2 expression and to induce ephrin-B2 and EphB4-dependent branching morphogenesis in human arterial EC. Thus, Dll1-mediated Notch activation regulates ephrin-B2 expression and postnatal arteriogenesis.","affiliation":[]},{"pmid":"12063024","pmcid":null,"title":"Potential roles of extracellular signal-regulated kinase but not p38 during myeloid differentiation of U937 cells stimulated by cytokines: augmentation of differentiation via prolonged activation of extracellular signal-regulated kinase.","authors":["Okuma E","Inazawa Y","Saeki K","Yuo A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Experimental hematology","journalShort":"Exp. Hematol.","day":13,"month":6,"year":2002,"meshHeadings":["Cell Differentiation","Cytokines","Enzyme Activation","Granulocyte-Macrophage Colony-Stimulating Factor","Humans","MAP Kinase Signaling System","Mitogen-Activated Protein Kinases","Phosphorylation","Recombinant Proteins","Tumor Necrosis Factor-alpha","U937 Cells","p38 Mitogen-Activated Protein Kinases"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"OBJECTIVE: To clarify the signaling mechanism of human myeloid differentiation by hematopoietic growth factors and cytokines, we investigated the role of extracellular signal-regulated kinase (ERK) during the differentiation of human monoblastic U937 cells stimulated by granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor (TNF). MATERIALS AND METHODS: Myeloid differentiation was evaluated by morphology, function (respiratory burst activity), and cell surface expression of adhesion molecule (CD11b), and activation of ERK and/or p38 was determined by Western blotting and/or in vitro kinase assay. Inhibition of the ERK pathway was performed using PD98059, a specific inhibitor of this pathway. RESULTS: U937 cells were induced to be differentiated by the combination of GM-CSF and TNF, but only minimally by either cytokine alone. Transient phosphorylation and activation of ERK was induced by both GM-CSF alone and combination of the two cytokines, whereas sustained phosphorylation and activation was induced only by the combination. In addition, PD98059, a specific inhibitor of ERK pathway, almost completely abolished this prolonged phosphorylation of ERK and completely blocked differentiation. In contrast, both TNF alone and cytokine combination equivalently phosphorylated p38 in U937 cells, which was dissociated from differentiation, and a specific inhibitor of p38 (SB203580) did not inhibit differentiation. CONCLUSIONS: The results indicate potential roles of sustained activation of ERK but not of p38 in the signaling pathways for human myeloid differentiation in U937 cells synergistically stimulated by the two physiologic cytokines GM-CSF and TNF.","affiliation":[]},{"pmid":"15107857","pmcid":null,"title":"Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.","authors":["Himanen JP","Chumley MJ","Lackmann M","Li C","Barton WA","Jeffrey PD","Vearing C","Geleick D","Feldheim DA","Boyd AW","Henkemeyer M","Nikolov DB"],"grantIds":["R01-MH66332","R01-NS38486"],"grantAgencies":["NIMH NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Nature neuroscience","journalShort":"Nat. Neurosci.","day":28,"month":5,"year":2004,"meshHeadings":["Alkaline Phosphatase","Animals","Animals, Newborn","Cell Line","Chromatography, Gel","Chromatography, Ion Exchange","Cricetinae","Cricetulus","Crystallography","Electrophoresis","Ephrin-A5","Ephrin-B2","Fluorescent Antibody Technique","Green Fluorescent Proteins","Humans","Infection","Luminescent Proteins","Mice","Neurites","Neuroblastoma","Phosphorylation","Protein Binding","Receptor, EphA3","Receptor, EphB2","Signal Transduction","Sindbis Virus","Spectrometry, Fluorescence","Surface Plasmon Resonance","Time Factors","Transfection","Video Recording"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The interactions between Eph receptor tyrosine kinases and their ephrin ligands regulate cell migration and axon pathfinding. The EphA receptors are generally thought to become activated by ephrin-A ligands, whereas the EphB receptors interact with ephrin-B ligands. Here we show that two of the most widely studied of these molecules, EphB2 and ephrin-A5, which have never been described to interact with each other, do in fact bind one another with high affinity. Exposure of EphB2-expressing cells to ephrin-A5 leads to receptor clustering, autophosphorylation and initiation of downstream signaling. Ephrin-A5 induces EphB2-mediated growth cone collapse and neurite retraction in a model system. We further show, using X-ray crystallography, that the ephrin-A5-EphB2 complex is a heterodimer and is architecturally distinct from the tetrameric EphB2-ephrin-B2 structure. The structural data reveal the molecular basis for EphB2-ephrin-A5 signaling and provide a framework for understanding the complexities of functional interactions and crosstalk between A- and B-subclass Eph receptors and ephrins.","affiliation":[]},{"pmid":"12972619","pmcid":null,"title":"Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor.","authors":["Monje P","Marinissen MJ","Gutkind JS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular and cellular biology","journalShort":"Mol. Cell. Biol.","day":15,"month":10,"year":2003,"meshHeadings":["3T3 Cells","Amino Acid Substitution","Animals","Cell Line","Cell Transformation, Neoplastic","Glutathione Transferase","Histones","Humans","Mice","Mitogen-Activated Protein Kinases","Models, Biological","Phosphorylation","Platelet-Derived Growth Factor","Point Mutation","Protein Processing, Post-Translational","Protein Structure, Tertiary","Proto-Oncogene Proteins c-fos","Receptors, Platelet-Derived Growth Factor","Recombinant Fusion Proteins","Signal Transduction","Trans-Activators","Transcription Factor AP-1","Transcriptional Activation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Polypeptide growth factors, such as platelet-derived growth factor (PDGF), promote the reinitiation of DNA synthesis and cell growth through multiple intracellular signaling pathways that converge in the nucleus to regulate the activity of transcription factors, thereby controlling the expression of growth-promoting genes. Among them, the AP-1 (activating protein-1) family of transcription factors, including c-Fos and c-Jun family members, plays a key role, as AP-1 activity is potently activated by PDGF and is required to stimulate cell proliferation. However, the nature of the pathways connecting PDGF receptors to AP-1 is still poorly defined. In this study, we show that PDGF regulates AP-1 by stimulating the expression and function of c-Fos through extracellular signal-regulated kinase (ERK). The latter involves the direct phosphorylation by ERK of multiple residues in the carboxyl-terminal transactivation domain of c-Fos, which results in its increased transcriptional activity. Interestingly, the phosphorylation of c-Fos by ERK was required for the ability of PDGF and serum to stimulate the activity of c-Fos as well as AP-1-dependent transcription. Furthermore, we provide evidence that the ERK-dependent activation of c-Fos is an integral component of the mitogenic pathway by which PDGF regulates normal and aberrant cell growth.","affiliation":[]},{"pmid":"21139048","pmcid":"3047152","title":"Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.","authors":["Danielsen JM","Sylvestersen KB","Bekker-Jensen S","Szklarczyk D","Poulsen JW","Horn H","Jensen LJ","Mailand N","Nielsen ML"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular & cellular proteomics : MCP","journalShort":"Mol. Cell Proteomics","day":2,"month":3,"year":2011,"meshHeadings":["Acetylation","Amino Acid Sequence","Cell Line","Conserved Sequence","Humans","Lysine","Mass Spectrometry","Molecular Sequence Data","Sumoylation","Ubiquitin","Ubiquitinated Proteins","Ubiquitination"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The covalent attachment of ubiquitin to proteins regulates numerous processes in eukaryotic cells. Here we report the identification of 753 unique lysine ubiquitylation sites on 471 proteins using higher-energy collisional dissociation on the LTQ Orbitrap Velos. In total 5756 putative ubiquitin substrates were identified. Lysine residues targeted by the ubiquitin-ligase system show no unique sequence feature. Surface accessible lysine residues located in ordered secondary regions, surrounded by smaller and positively charged amino acids are preferred sites of ubiquitylation. Lysine ubiquitylation shows promiscuity at the site level, as evidenced by low evolutionary conservation of ubiquitylation sites across eukaryotic species. Among lysine modifications a significant overlap (20%) between ubiquitylation and acetylation at site level highlights extensive competitive crosstalk among these modifications. This site-specific crosstalk is not prevalent among cell cycle ubiquitylations. Between SUMOylation and ubiquitylation the preferred interaction is through mixed-chain conjugation. Overall these data provide novel insights into the site-specific selection and regulatory function of lysine ubiquitylation.","affiliation":[]},{"pmid":"15848800","pmcid":null,"title":"Vav family GEFs link activated Ephs to endocytosis and axon guidance.","authors":["Cowan CW","Shao YR","Sahin M","Shamah SM","Lin MZ","Greer PL","Gao S","Griffith EC","Brugge JS","Greenberg ME"],"grantIds":["HD18655","HL059561","K08 HD01384","NS43855","R01 NS045500"],"grantAgencies":["NICHD NIH HHS","NHLBI NIH HHS","NICHD NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":21,"month":4,"year":2005,"meshHeadings":["Animals","Endocytosis","Ephrins","Growth Cones","Mice","Mice, Knockout","Microscopy, Confocal","Receptors, Eph Family","Signal Transduction","Two-Hybrid System Techniques","rho GTP-Binding Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Ephrin signaling through Eph receptor tyrosine kinases can promote attraction or repulsion of axonal growth cones during development. However, the mechanisms that determine whether Eph signaling promotes attraction or repulsion are not known. We show here that the Rho family GEF Vav2 plays a key role in this process. We find that, during axon guidance, ephrin binding to Ephs triggers Vav-dependent endocytosis of the ligand-receptor complex, thus converting an initially adhesive interaction into a repulsive event. In the absence of Vav proteins, ephrin-Eph endocytosis is blocked, leading to defects in growth cone collapse in vitro and significant defects in the ipsilateral retinogeniculate projections in vivo. These findings suggest an important role for Vav family GEFs as regulators of ligand-receptor endocytosis and determinants of repulsive signaling during axon guidance.","affiliation":[]},{"pmid":"12058067","pmcid":null,"title":"Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.","authors":["Daz-Rodrguez E","Montero JC","Espars-Ogando A","Yuste L","Pandiella A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular biology of the cell","journalShort":"Mol. Biol. Cell","day":11,"month":6,"year":2002,"meshHeadings":["ADAM Proteins","Amino Acid Sequence","Binding Sites","Carrier Proteins","HeLa Cells","Humans","Membrane Proteins","Metalloendopeptidases","Mitogen-Activated Protein Kinases","Phosphorylation","Protein Kinase C","Receptor, trkA","Restriction Mapping","Retroviridae","Tetradecanoylphorbol Acetate","Threonine","Transfection"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The ectodomain of certain transmembrane proteins can be released by the action of cell surface proteases, termed secretases. Here we have investigated how mitogen-activated protein kinases (MAPKs) control the shedding of membrane proteins. We show that extracellular signal-regulated kinase (Erk) acts as an intermediate in protein kinase C-regulated TrkA cleavage. We report that the cytosolic tail of the tumor necrosis factor alpha-converting enzyme (TACE) is phosphorylated by Erk at threonine 735. In addition, we show that Erk and TACE associate. This association is favored by Erk activation and by the presence of threonine 735. In contrast to the Erk route, the p38 MAPK was able to stimulate TrkA cleavage in cells devoid of TACE activity, indicating that other proteases are also involved in TrkA shedding. These results demonstrate that secretases are able to discriminate between the different stimuli that trigger membrane protein ectodomain cleavage and indicate that phosphorylation by MAPKs may regulate the proteolytic function of membrane secretases.","affiliation":[]},{"pmid":"15126357","pmcid":null,"title":"The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells.","authors":["Nakada M","Niska JA","Miyamori H","McDonough WS","Wu J","Sato H","Berens ME"],"grantIds":["NS042262"],"grantAgencies":["NINDS NIH HHS"],"retractions":[],"journal":"Cancer research","journalShort":"Cancer Res.","day":1,"month":5,"year":2004,"meshHeadings":["Animals","Astrocytoma","Brain Neoplasms","Cell Adhesion","Cell Line, Tumor","Cell Movement","Glioblastoma","Glioma","Humans","Male","Phosphorylation","RNA, Messenger","Rats","Rats, Wistar","Receptor, EphB2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph receptor tyrosine kinases and their ligands, ephrins, mediate neurodevelopmental processes such as boundary formation, axon guidance, vasculogenesis, and cell migration. We determined the expression profiles of the Eph family members in five glioma cell lines under migrating and nonmigrating conditions. EphB2 mRNA was overexpressed in all five during migration (1.2-2.8-fold). We found abundant EphB2 protein as well as strong phosphorylation of EphB2 in migrating U87 cells. Confocal imaging showed EphB2 localized in lamellipodia of motile U87 cells. Treatment with ephrin-B1/Fc chimera stimulated migration and invasion of U87, whereas treatment with a blocking EphB2 antibody significantly inhibited migration and invasion. Forced expression of EphB2 in U251 cells stimulated cell migration and invasion and diminished adhesion concomitant with the tyrosine phosphorylation of EphB2. U251 stably transfected with EphB2 showed more scattered and more pronounced invasive growth in an ex vivo rat brain slice. In human brain tumor specimens, EphB2 expression was higher in glioblastomas than in low-grade astrocytomas or normal brain; patterns of phosphorylated EphB2 matched the expression levels. Laser capture microdissection of invading glioblastoma cells revealed elevated EphB2 mRNA (1.5-3.5-fold) in 7 of 7 biopsy specimens. Immunohistochemistry demonstrated EphB2 localization primarily in glioblastoma cells (56 of 62 cases) and not in normal brain. This is the first demonstration that migrating glioblastoma cells overexpress EphB2 in vitro and in vivo; glioma migration and invasion are promoted by activation of EphB2 or inhibited by blocking EphB2. Dysregulation of EphB2 expression or function may underlie glioma invasion.","affiliation":[]},{"pmid":"12136247","pmcid":null,"title":"Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer.","authors":["Kataoka H","Tanaka M","Kanamori M","Yoshii S","Ihara M","Wang YJ","Song JP","Li ZY","Arai H","Otsuki Y","Kobayashi T","Konno H","Hanai H","Sugimura H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of cancer research and clinical oncology","journalShort":"J. Cancer Res. Clin. Oncol.","day":23,"month":7,"year":2002,"meshHeadings":["Base Sequence","DNA Primers","Ephrin-B1","Ephrin-B2","Humans","Ligands","Membrane Proteins","Neoplasm Staging","Polymerase Chain Reaction","Receptor Protein-Tyrosine Kinases","Receptor, EphB2","Reference Values","Reverse Transcriptase Polymerase Chain Reaction","Stomach","Stomach Neoplasms"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"PURPOSE: We have previously reported that EPHB2 is overexpressed in gastric cancer; however, the expression profiles of its ligands, EFNB1 and EFNB2, are unknown. This study was designed to investigate the expression of EPHB2 and its ligands, EFNB1 and EFNB2, in human gastric cancer. METHODS: Semi-quantitative RT-PCR using (32)P was performed on human gastric cancer tissues and corresponding normal tissues (29 gastric cancer patients). RESULTS: EPHB2 was more highly expressed in tumor tissues than in normal tissues in 21 out of 29 (72.4%), in gastric cancer patients ( P = 0.01); EFNB1 and EFNB2 were highly expressed in 21 out of 29 (72.4%) ( P = 0.037) and 14 out of 29 (48.3%) patients, respectively. The overexpression of EPHB2 was frequently detected in both well-differentiated adenocarcinoma and poorly differentiated adenocarcinoma [10/13 (76.9%) and 9/14 (64.3%), respectively]. On the other hand, the overexpression of EFNB1 was more frequently detected in poorly differentiated adenocarcinoma than in well-differentiated adenocarcinoma [12/14 (85.7%) and 7/13 (53.8%), respectively. P =0.027]. Elevated levels of EPHB2 and EFNB1 were detected in substantial subsets of early gastric cancers. Genomic alterations to these three genes in gastric cancer specimens were either not found or rarely found except for several rare variations of EPHB2. CONCLUSIONS: These findings suggest that not only the expression of EPHB2, but the expression of its ligand EFNB1 may have some relation with the oncogenesis of gastric cancer.","affiliation":[]},{"pmid":"15973414","pmcid":null,"title":"EphB receptor activity suppresses colorectal cancer progression.","authors":["Batlle E","Bacani J","Begthel H","Jonkheer S","Jonkeer S","Gregorieff A","van de Born M","Malats N","Sancho E","Boon E","Pawson T","Gallinger S","Pals S","Clevers H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature","journalShort":"Nature","day":23,"month":6,"year":2005,"meshHeadings":["Adenoma","Animals","Cell Line, Tumor","Colorectal Neoplasms","Disease Progression","Down-Regulation","Gene Expression Regulation, Neoplastic","Genes, APC","Genes, Dominant","Humans","Intercellular Signaling Peptides and Proteins","Mice","Mice, Transgenic","Mutation","RNA, Messenger","Receptors, Eph Family","Signal Transduction","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Most sporadic colorectal cancers are initiated by activating Wnt pathway mutations, characterized by the stabilization of beta-catenin and constitutive transcription by the beta-catenin/T cell factor-4 (Tcf-4) complex. EphB guidance receptors are Tcf4 target genes that control intestinal epithelial architecture through repulsive interactions with Ephrin-B ligands. Here we show that, although Wnt signalling remains constitutively active, most human colorectal cancers lose expression of EphB at the adenoma-carcinoma transition. Loss of EphB expression strongly correlates with degree of malignancy. Furthermore, reduction of EphB activity accelerates tumorigenesis in the colon and rectum of Apc(Min/+) mice, and results in the formation of aggressive adenocarcinomas. Our data demonstrate that loss of EphB expression represents a critical step in colorectal cancer progression.","affiliation":[]},{"pmid":"16166419","pmcid":null,"title":"EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.","authors":["Lugli A","Spichtin H","Maurer R","Mirlacher M","Kiefer J","Huusko P","Azorsa D","Terracciano L","Sauter G","Kallioniemi OP","Mousses S","Tornillo L"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","journalShort":"Clin. Cancer Res.","day":15,"month":9,"year":2005,"meshHeadings":["Colorectal Neoplasms","Female","Gastrointestinal Neoplasms","Humans","Immunohistochemistry","Male","Neoplasm Staging","Neoplasms","Receptor, EphB2","Survival Analysis","Tissue Array Analysis"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"PURPOSE: To comprehensively evaluate ephrin receptor B2 (EphB2) expression in normal and neoplastic tissues. EphB2 is a tyrosine kinase recently implicated in the deregulation of cell-to-cell communication in many tumors. EXPERIMENTAL DESIGN: EphB2 protein expression was analyzed by immunohistochemistry on tissue microarrays that included 76 different normal tissues, >4,000 samples from 138 different cancer types, and 1,476 samples of colon cancer with clinical follow-up data. RESULTS: We found most prominent EphB2 expression in the intestinal epithelium (colonic crypts) with cancer of the colorectum displaying the highest EphB2 positivity of all tumors. Positivity was found in 100% of 118 colon adenomas but in 33.3% of 45 colon carcinomas. EphB2 expression was also observed in 75 tumor categories, including serous carcinoma of the endometrium (34.8%), adenocarcinoma of the esophagus (33.3%), intestinal adenocarcinoma of the stomach (30.2%), and adenocarcinoma of the small intestine (70%). The occasional finding of strong EphB2 positivity in tumors without EphB2 positivity in the corresponding normal cells [adenocarcinoma of the lung (4%) and pancreas (2.2%)] suggests that deregulation of EphB2 signaling may involve up-regulation of the protein expression. In colon carcinoma, loss of EphB2 expression was associated with advanced stage (P < 0.0001) and was an indicator of poor overall survival (P = 0.0098). CONCLUSIONS: Our results provide an overview on the EphB2 protein expression in normal and neoplastic tissues. Deregulated EphB2 expression may play a role in several cancer types with loss of EphB2 expression serving as an indicator of the possible pathogenetic role of EphB2 signaling in the maintenance of tissue architecture of colon epithelium.","affiliation":[]},{"pmid":"15951569","pmcid":null,"title":"Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.","authors":["Zhang Y","Wolf-Yadlin A","Ross PL","Pappin DJ","Rush J","Lauffenburger DA","White FM"],"grantIds":["CA96504","DK070172","DK42816","GM68762"],"grantAgencies":["NCI NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIGMS NIH HHS"],"retractions":[],"journal":"Molecular & cellular proteomics : MCP","journalShort":"Mol. Cell Proteomics","day":14,"month":9,"year":2005,"meshHeadings":["Blotting, Western","Cell Culture Techniques","Cell Line","Chromatography, Liquid","Computational Biology","Epithelial Cells","Female","Humans","Kinetics","Ligands","Mammary Glands, Human","Mass Spectrometry","Phosphorylation","Precipitin Tests","Receptor, Epidermal Growth Factor","Reproducibility of Results","Signal Transduction","Tyrosine"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Ligand binding to cell surface receptors initiates a cascade of signaling events regulated by dynamic phosphorylation events on a multitude of pathway proteins. Quantitative features, including intensity, timing, and duration of phosphorylation of particular residues, may play a role in determining cellular response, but experimental data required for analysis of these features have not previously been available. To understand the dynamic operation of signaling cascades, we have developed a method enabling the simultaneous quantification of tyrosine phosphorylation of specific residues on dozens of key proteins in a time-resolved manner, downstream of epidermal growth factor receptor (EGFR) activation. Tryptic peptides from four different EGFR stimulation time points were labeled with four isoforms of the iTRAQ reagent to enable downstream quantification. After mixing of the labeled samples, tyrosine-phosphorylated peptides were immunoprecipitated with an anti-phosphotyrosine antibody and further enriched by IMAC before LC/MS/MS analysis. Database searching and manual confirmation of peptide phosphorylation site assignments led to the identification of 78 tyrosine phosphorylation sites on 58 proteins from a single analysis. Replicate analyses of a separate biological sample provided both validation of this first data set and identification of 26 additional tyrosine phosphorylation sites and 18 additional proteins. iTRAQ fragment ion ratios provided time course phosphorylation profiles for each site. The data set of quantitative temporal phosphorylation profiles was further characterized by self-organizing maps, which resulted in identification of several cohorts of tyrosine residues exhibiting self-similar temporal phosphorylation profiles, operationally defining dynamic modules in the EGFR signaling network consistent with particular cellular processes. The presence of novel proteins and associated tyrosine phosphorylation sites within these modules indicates additional components of this network and potentially localizes the topological action of these proteins. Additional analysis and modeling of the data generated in this study are likely to yield more sophisticated models of receptor tyrosine kinase-initiated signal transduction, trafficking, and regulation.","affiliation":[]},{"pmid":"15722342","pmcid":null,"title":"EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.","authors":["Koolpe M","Burgess R","Dail M","Pasquale EB"],"grantIds":["CA82713","HD25938"],"grantAgencies":["NCI NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":29,"month":4,"year":2005,"meshHeadings":["Amino Acid Motifs","Animals","Binding Sites","Binding, Competitive","COS Cells","Cell Line","Cell Line, Tumor","Dose-Response Relationship, Drug","Enzyme-Linked Immunosorbent Assay","Ephrins","Humans","Immunoblotting","Immunoprecipitation","Ligands","Microscopy, Fluorescence","Peptide Library","Peptides","Protein Binding","Protein Structure, Tertiary","Receptor, EphB1","Receptor, EphB2","Receptor, EphB4","Receptors, Eph Family"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph receptor tyrosine kinases are overexpressed in many pathologic tissues and have therefore emerged as promising drug target candidates. However, there are few molecules available that can selectively bind to a single Eph receptor and not other members of this large receptor family. Here we report the identification by phage display of peptides that bind selectively to different receptors of the EphB class, including EphB1, EphB2, and EphB4. Peptides with the same EphB receptor specificity compete with each other for binding, suggesting that they have partially overlapping binding sites. In addition, several of the peptides contain amino acid motifs found in the G-H loop of the ephrin-B ligands, which is the region that mediates high-affinity interaction with the EphB receptors. Consistent with targeting the ephrin-binding site, the higher affinity peptides antagonize ephrin binding to the EphB receptors. We also designed an optimized EphB4-binding peptide with affinity comparable with that of the natural ligand, ephrin-B2. These peptides should be useful as selective inhibitors of the pathological activities of EphB receptors and as targeting agents for imaging probes and therapeutic drugs.","affiliation":[]},{"pmid":"15300251","pmcid":null,"title":"Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.","authors":["Huusko P","Ponciano-Jackson D","Wolf M","Kiefer JA","Azorsa DO","Tuzmen S","Weaver D","Robbins C","Moses T","Allinen M","Hautaniemi S","Chen Y","Elkahloun A","Basik M","Bova GS","Bubendorf L","Lugli A","Sauter G","Schleutker J","Ozcelik H","Elowe S","Pawson T","Trent JM","Carpten JD","Kallioniemi OP","Mousses S"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature genetics","journalShort":"Nat. Genet.","day":1,"month":9,"year":2004,"meshHeadings":["Cell Line, Tumor","Codon, Nonsense","Emetine","Genes, Tumor Suppressor","Humans","Male","Molecular Sequence Data","Mutation","Oligonucleotide Array Sequence Analysis","Prostatic Neoplasms","RNA Stability","Receptor, EphB2","Transfection"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The identification of tumor-suppressor genes in solid tumors by classical cancer genetics methods is difficult and slow. We combined nonsense-mediated RNA decay microarrays and array-based comparative genomic hybridization for the genome-wide identification of genes with biallelic inactivation involving nonsense mutations and loss of the wild-type allele. This approach enabled us to identify previously unknown mutations in the receptor tyrosine kinase gene EPHB2. The DU 145 prostate cancer cell line, originating from a brain metastasis, carries a truncating mutation of EPHB2 and a deletion of the remaining allele. Additional frameshift, splice site, missense and nonsense mutations are present in clinical prostate cancer samples. Transfection of DU 145 cells, which lack functional EphB2, with wild-type EPHB2 suppresses clonogenic growth. Taken together with studies indicating that EphB2 may have an essential role in cell migration and maintenance of normal tissue architecture, our findings suggest that mutational inactivation of EPHB2 may be important in the progression and metastasis of prostate cancer.","affiliation":[]},{"pmid":"16840724","pmcid":null,"title":"EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.","authors":["Salvucci O","de la Luz Sierra M","Martina JA","McCormick PJ","Tosato G"],"grantIds":[],"grantAgencies":["Intramural NIH HHS"],"retractions":[],"journal":"Blood","journalShort":"Blood","day":1,"month":11,"year":2006,"meshHeadings":["Cell Movement","Cells, Cultured","Chemokine CXCL12","Chemokines, CXC","Chemotaxis","Endothelium, Vascular","Humans","Microcirculation","RNA","Receptor, EphB4","Receptor, EphB5","Receptors, Eph Family","Recombinant Proteins","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Skin","Umbilical Veins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The complex molecular mechanisms that drive endothelial cell movement and the formation of new vessels are poorly understood and require further investigation. Eph receptor tyrosine kinases and their membrane-anchored ephrin ligands regulate cell movements mostly by cell-cell contact, whereas the G-protein-coupled receptor CXCR4 and its unique SDF-1 chemokine ligand regulate cell movement mostly through soluble gradients. By using biochemical and functional approaches, we investigated how ephrinB and SDF-1 orchestrate endothelial cell movement and morphogenesis into capillary-like structures. We describe how endogenous EphB2 and EphB4 signaling are required for the formation of extracellular matrix-dependent capillary-like structures in primary human endothelial cells. We further demonstrate that EphB2 and EphB4 activation enhance SDF-1-induced signaling and chemotaxis that are also required for extracellular matrix-dependent endothelial cell clustering. These results support a model in which SDF-1 gradients first promote endothelial cell clustering and then EphB2 and EphB4 critically contribute to subsequent cell movement and alignment into cord-like structures. This study reveals a requirement for endogenous Eph signaling in endothelial cell morphogenic processes, uncovers a novel link between EphB forward signaling and SDF-1-induced signaling, and demonstrates a mechanism for cooperative regulation of endothelial cell movement.","affiliation":[]},{"pmid":"16155194","pmcid":null,"title":"A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.","authors":["Kittles RA","Baffoe-Bonnie AB","Moses TY","Robbins CM","Ahaghotu C","Huusko P","Pettaway C","Vijayakumar S","Bennett J","Hoke G","Mason T","Weinrich S","Trent JM","Collins FS","Mousses S","Bailey-Wilson J","Furbert-Harris P","Dunston G","Powell IJ","Carpten JD"],"grantIds":["1-HG-75418","1U54CA91431-01","CA-06927"],"grantAgencies":["NHGRI NIH HHS","NCI NIH HHS","NCI NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Journal of medical genetics","journalShort":"J. Med. Genet.","day":2,"month":6,"year":2006,"meshHeadings":["Adult","African Americans","Aged","Alleles","Codon, Nonsense","Genetic Predisposition to Disease","Genetic Testing","Humans","Male","Middle Aged","Polymorphism, Genetic","Prostatic Neoplasms","Receptor, EphB2","Risk Factors","United States"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: The EphB2 gene was recently implicated as a prostate cancer (PC) tumour suppressor gene, with somatic inactivating mutations occurring in approximately 10% of sporadic tumours. We evaluated the contribution of EphB2 to inherited PC susceptibility in African Americans (AA) by screening the gene for germline polymorphisms. METHODS: Direct sequencing of the coding region of EphB2 was performed on 72 probands from the African American Hereditary Prostate Cancer Study (AAHPC). A case-control association analysis was then carried out using the AAHPC probands and an additional 183 cases of sporadic PC compared with 329 healthy AA male controls. In addition, we performed an ancestry adjusted association study where we adjusted for individual ancestry among all subjects, in order to rule out a spurious association due to population stratification. RESULTS: Ten coding sequence variants were identified, including the K1019X (3055A-->T) nonsense mutation which was present in 15.3% of the AAHPC probands but only 1.7% of 231 European American (EA) control samples. We observed that the 3055A-->T mutation significantly increased risk for prostate cancer over twofold (Fisher's two sided test, p = 0.003). The T allele was significantly more common among AAHPC probands (15.3%) than among healthy AA male controls (5.2%) (odds ratio 3.31; 95% confidence interval 1.5 to 7.4; p = 0.008). The ancestry adjusted analyses confirmed the association. CONCLUSIONS: Our data show that the K1019X mutation in the EphB2 gene differs in frequency between AA and EA, is associated with increased risk for PC in AA men with a positive family history, and may be an important genetic risk factor for prostate cancer in AA.","affiliation":[]},{"pmid":"16582626","pmcid":null,"title":"p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation.","authors":["Eymin B","Claverie P","Salon C","Brambilla C","Brambilla E","Gazzeri S"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cell cycle (Georgetown, Tex.)","journalShort":"Cell Cycle","day":25,"month":4,"year":2006,"meshHeadings":["Cell Cycle Proteins","Enzyme Activation","Extracellular Signal-Regulated MAP Kinases","G2 Phase","Gene Expression","Humans","MAP Kinase Kinase Kinases","MAP Kinase Signaling System","Phosphorylation","Phosphoserine","Proteasome Endopeptidase Complex","Protein Binding","Protein Processing, Post-Translational","Tumor Cells, Cultured","Tumor Suppressor Protein p14ARF","Ubiquitin","cdc25 Phosphatases"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Cdc25C phosphatase is a key regulator of mitotic entry which activity is tightly regulated by phosphorylation. In response to DNA damage, phosphorylation at serine 216 induces the cytosolic retention of Cdc25C through 14-3-3 binding. We previously reported the ability of the p14ARF tumor suppressor to induce the accumulation of inactive phospho-Cdc25C(Ser216) protein as well as a decrease of Cdc25C steady state level and correlated these events with a p53-independent G2 arrest. The aim of this study was to investigate the cellular signaling pathways involved in this process. By using specific pharmacological inhibitors, we demonstrate that activation of the ERK1/2 MAP kinases pathway is involved in the p53-independent G2 checkpoint induced by p14ARF Moreover, we show that activated P-ERK1/2 bind and phosphorylate Cdc25C on its ser216 residue following p14ARF expression, thereby identifying Cdc25C as a new ERK1/2 target. Importantly, we further show that phosphorylation at Ser216 by phospho-ERK1/2 promotes Cdc25C ubiquitination and proteasomal degradation, suggesting that Cdc25C proteolysis is required for a sustained G2 arrest in response to p14ARF. Taken together, these results demonstrate that the MAPK ERK signaling pathway contributes to the p53-independent antiproliferative functions of p14ARF. Furthermore, they identify a new mechanism by which phosphorylation at serine 216 participates to Cdc25C inactivation.","affiliation":[]},{"pmid":"17192257","pmcid":null,"title":"Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.","authors":["Wissing J","Jnsch L","Nimtz M","Dieterich G","Hornberger R","Kri G","Wehland J","Daub H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular & cellular proteomics : MCP","journalShort":"Mol. Cell Proteomics","day":15,"month":3,"year":2007,"meshHeadings":["Cell Line, Tumor","Chromatography, Liquid","Humans","Phosphopeptides","Phosphorylation","Protein Kinase Inhibitors","Protein Kinases","Proteomics","Tandem Mass Spectrometry"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Protein kinases constitute a large superfamily of enzymes with key regulatory functions in nearly all signal transmission processes of eukaryotic cells. However, due to their relatively low abundance compared with the vast majority of cellular proteins, currently available proteomics techniques do not permit the comprehensive biochemical characterization of protein kinases. To address these limitations, we have developed a prefractionation strategy that uses a combination of immobilized low molecular weight inhibitors for the selective affinity capture of protein kinases. This approach resulted in the direct purification of cell type-specific sets of expressed protein kinases, and more than 140 different members of this enzyme family could be detected by LC-MS/MS. Furthermore the enrichment technique combined with phosphopeptide fractionation led to the identification of more than 200 different phosphorylation sites on protein kinases, which often remain occluded in global phosphoproteome analysis. As the phosphorylation states of protein kinases can provide a readout for the signaling activities within a cellular system, kinase-selective phosphoproteomics based on the procedures described here has the potential to become an important tool in signal transduction analysis.","affiliation":[]},{"pmid":"15718372","pmcid":null,"title":"Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.","authors":["Diehl S","Bruno R","Wilkinson GA","Loose DA","Wilting J","Schweigerer L","Klein R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Pediatric research","journalShort":"Pediatr. Res.","day":24,"month":4,"year":2005,"meshHeadings":["Adult","Animals","Arteriovenous Malformations","Biological Markers","Blood Vessels","Child","Endothelial Cells","Endothelium, Vascular","Ephrin-B2","Humans","Immunohistochemistry","Infant","Infant, Newborn","Mice","Receptor, EphB2","Receptor, EphB4","Umbilical Cord"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Vascular malformations cause discomfort and pain in children and are often associated with skeletal hypertrophy. Their molecular basis is poorly understood. Ephrin ligands and Eph receptor tyrosine kinases are involved in embryonic vascular development. In mice, some ephrin/Eph family members show a complementary expression pattern in blood vessels, with ephrinB2 being expressed on arterial and EphB4 on venous endothelium. Targeted deletions of the genes reveal their essential roles for conduit vessel development in mice, suggesting similar functions during human vascular development and deregulation in vascular malformations. Here, we have defined the expression patterns of human ephrinB2, EphB4, and EphB2 in normal vessels of neonates (i.e. umbilici) and adults and compared them with those in congenital venous malformations. In adults, normal vessels of the skin, muscle, and legs express ephrinB2 and EphB2 on arterial endothelial cells (ECs), whereas EphB4 is found in arteries and veins. In the umbilicus, EphB2 is a specific marker of arterial ECs, whereas ephrinB2 is additionally expressed in venous ECs, suggesting an arterial function of the veins. In venous malformations, the expression of EphB4 is not altered, but both ephrinB2 and EphB2 are ectopically expressed in venous ECs. This may reflect a nonphysiologic arterialization of malformed veins. Our study shows that the arterial markers ephrin B2 and EphB2 are expressed in a subset of veins, and it remains to be studied whether this is cause or consequence of an altered vascular identity.","affiliation":[]},{"pmid":"16740153","pmcid":"1513590","title":"EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.","authors":["Kokko A","Laiho P","Lehtonen R","Korja S","Carvajal-Carmona LG","Jrvinen H","Mecklin JP","Eng C","Schleutker J","Tomlinson IP","Vahteristo P","Aaltonen LA"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"BMC cancer","journalShort":"BMC Cancer","day":24,"month":7,"year":2006,"meshHeadings":["Adolescent","Adult","Aged","Aged, 80 and over","Colorectal Neoplasms","Female","Gene Expression Regulation, Neoplastic","Genes, Tumor Suppressor","Genetic Variation","Germ-Line Mutation","Humans","Intestinal Polyposis","Male","Middle Aged","Polymorphism, Genetic","Precancerous Conditions","Prostatic Neoplasms","Receptor, EphB2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Ephrin receptor B2 (EPHB2) has recently been proposed as a novel tumor suppressor gene in colorectal cancer (CRC). Inactivation of the gene has been shown to correlate with progression of colorectal tumorigenesis, and somatic mutations have been reported in both colorectal and prostate tumors. METHODS: Here we have analyzed the EPHB2 gene for germline alterations in 101 individuals either with 1) CRC and a personal or family history of prostate cancer (PC), or 2) intestinal hyperplastic polyposis (HPP), a condition associated with malignant degeneration such as serrated adenoma and CRC. RESULTS: Four previously unknown missense alterations were observed, which may be associated with the disease phenotype. Two of the changes, I361V and R568W, were identified in Finnish CRC patients, but not in over 300 Finnish familial CRC or PC patients or more than 200 population-matched healthy controls. The third change, D861N, was observed in a UK HPP patient, but not in additional 40 UK HPP patients or in 200 UK healthy controls. The fourth change R80H, originally identified in a Finnish CRC patient, was also found in 1/106 familial CRC patients and in 9/281 healthy controls and is likely to be a neutral polymorphism. CONCLUSION: We detected novel germline EPHB2 alterations in patients with colorectal tumors. The results suggest a limited role for these EPHB2 variants in colon tumor predisposition. Further studies including functional analyses are needed to confirm this.","affiliation":[]},{"pmid":"16272170","pmcid":null,"title":"Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.","authors":["Guo DL","Zhang J","Yuen ST","Tsui WY","Chan AS","Ho C","Ji J","Leung SY","Chen X"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Carcinogenesis","journalShort":"Carcinogenesis","day":27,"month":3,"year":2006,"meshHeadings":["Adenoma","Adult","Aged","Aged, 80 and over","Cell Survival","Cell Transformation, Neoplastic","Colon","Colorectal Neoplasms","Disease-Free Survival","Down-Regulation","Female","Gene Expression Profiling","Humans","Liver Neoplasms","Lymphatic Metastasis","Male","Middle Aged","Neoplasm Invasiveness","Neoplasm Metastasis","Neoplasm Staging","Prognosis","Receptor, EphB2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"EphB2, a receptor tyrosine kinase regulated by the beta-catenin/Tcf4 complex, is expressed in the proliferative compartment of mouse intestine and regulates bidirectional migration of intestinal precursor cells in the crypt-villus axis through repulsive interaction with Ephrin-B ligands. Recently, it has been shown that reduction of EphB activity accelerates colon tumour progression in the Apc(Min/+) mice. In this study, we examined the expression of EphB2 in normal colon, adenomas, primary colorectal cancers (CRCs), lymph node metastases and liver metastases using immunohistochemistry on tissue microarrays. In addition, EphB2 was overexpressed in SW480 colon cancer cells to study its effect in vitro. We found that EphB2 was expressed in 100% of normal colon crypt base cells, 78% of adenomas, 55.4% of primary CRCs, 37.8% of lymph node metastases and 32.9% of liver metastases (all differences were statistically significant at P < 0.001 compared with primary CRCs). Patients with CRCs that lose EphB2 expression had more advanced tumour stage (P = 0.005), poor differentiation (P < 0.001), poor overall survival (P = 0.005) and disease-free survival (P = 0.001), with the latter being independent of tumour stage. In vitro studies showed that overexpression of EphB2 inhibited colon cancer cell growth in colony formation assay and activation of EphB2 receptor inhibited colon cancer cell adhesion and migration. Our data demonstrated a progressive loss of EphB2 expression in each critical step of colon carcinogenesis, including the onset of invasion, dedifferentiation and metastasis which are paralleled by adverse patient outcome. EphB2 may achieve its tumour suppressor function through regulation of cell survival, adhesion and migration.","affiliation":[]},{"pmid":"16710414","pmcid":null,"title":"The DNA sequence and biological annotation of human chromosome 1.","authors":["Gregory SG","Barlow KF","McLay KE","Kaul R","Swarbreck D","Dunham A","Scott CE","Howe KL","Woodfine K","Spencer CC","Jones MC","Gillson C","Searle S","Zhou Y","Kokocinski F","McDonald L","Evans R","Phillips K","Atkinson A","Cooper R","Jones C","Hall RE","Andrews TD","Lloyd C","Ainscough R","Almeida JP","Ambrose KD","Anderson F","Andrew RW","Ashwell RI","Aubin K","Babbage AK","Bagguley CL","Bailey J","Beasley H","Bethel G","Bird CP","Bray-Allen S","Brown JY","Brown AJ","Buckley D","Burton J","Bye J","Carder C","Chapman JC","Clark SY","Clarke G","Clee C","Cobley V","Collier RE","Corby N","Coville GJ","Davies J","Deadman R","Dunn M","Earthrowl M","Ellington AG","Errington H","Frankish A","Frankland J","French L","Garner P","Garnett J","Gay L","Ghori MR","Gibson R","Gilby LM","Gillett W","Glithero RJ","Grafham DV","Griffiths C","Griffiths-Jones S","Grocock R","Hammond S","Harrison ES","Hart E","Haugen E","Heath PD","Holmes S","Holt K","Howden PJ","Hunt AR","Hunt SE","Hunter G","Isherwood J","James R","Johnson C","Johnson D","Joy A","Kay M","Kershaw JK","Kibukawa M","Kimberley AM","King A","Knights AJ","Lad H","Laird G","Lawlor S","Leongamornlert DA","Lloyd DM","Loveland J","Lovell J","Lush MJ","Lyne R","Martin S","Mashreghi-Mohammadi M","Matthews L","Matthews NS","McLaren S","Milne S","Mistry S","Moore MJ","Nickerson T","O'Dell CN","Oliver K","Palmeiri A","Palmer SA","Parker A","Patel D","Pearce AV","Peck AI","Pelan S","Phelps K","Phillimore BJ","Plumb R","Rajan J","Raymond C","Rouse G","Saenphimmachak C","Sehra HK","Sheridan E","Shownkeen R","Sims S","Skuce CD","Smith M","Steward C","Subramanian S","Sycamore N","Tracey A","Tromans A","Van Helmond Z","Wall M","Wallis JM","White S","Whitehead SL","Wilkinson JE","Willey DL","Williams H","Wilming L","Wray PW","Wu Z","Coulson A","Vaudin M","Sulston JE","Durbin R","Hubbard T","Wooster R","Dunham I","Carter NP","McVean G","Ross MT","Harrow J","Olson MV","Beck S","Rogers J","Bentley DR","Banerjee R","Bryant SP","Burford DC","Burrill WD","Clegg SM","Dhami P","Dovey O","Faulkner LM","Gribble SM","Langford CF","Pandian RD","Porter KM","Prigmore E"],"grantIds":["G0000107"],"grantAgencies":["Medical Research Council","Wellcome Trust"],"retractions":[],"journal":"Nature","journalShort":"Nature","day":18,"month":5,"year":2006,"meshHeadings":["Base Sequence","Chromosomes, Human, Pair 1","DNA Replication Timing","Disease","Gene Duplication","Genes","Genetic Variation","Genomics","Humans","Molecular Sequence Data","Open Reading Frames","Pseudogenes","Recombination, Genetic","Selection, Genetic","Sequence Analysis, DNA"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The reference sequence for each human chromosome provides the framework for understanding genome function, variation and evolution. Here we report the finished sequence and biological annotation of human chromosome 1. Chromosome 1 is gene-dense, with 3,141 genes and 991 pseudogenes, and many coding sequences overlap. Rearrangements and mutations of chromosome 1 are prevalent in cancer and many other diseases. Patterns of sequence variation reveal signals of recent selection in specific genes that may contribute to human fitness, and also in regions where no function is evident. Fine-scale recombination occurs in hotspots of varying intensity along the sequence, and is enriched near genes. These and other studies of human biology and disease encoded within chromosome 1 are made possible with the highly accurate annotated sequence, as part of the completed set of chromosome sequences that comprise the reference human genome.","affiliation":[]},{"pmid":"17255949","pmcid":null,"title":"Mxi2 promotes stimulus-independent ERK nuclear translocation.","authors":["Casar B","Sanz-Moreno V","Yazicioglu MN","Rodrguez J","Berciano MT","Lafarga M","Cobb MH","Crespo P"],"grantIds":["DK34128","R37 DK034128"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"The EMBO journal","journalShort":"EMBO J.","day":7,"month":2,"year":2007,"meshHeadings":["Active Transport, Cell Nucleus","Animals","Cell Line","Cell Nucleus","Cercopithecus aethiops","Dogs","Fluorescent Antibody Technique","Humans","Immunoblotting","Immunoprecipitation","Intracellular Signaling Peptides and Proteins","Mitogen-Activated Protein Kinase 14","Mitogen-Activated Protein Kinase 3","Models, Biological","Nuclear Pore Complex Proteins","Phosphoproteins","RNA Interference"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Spatial regulation of ERK1/2 MAP kinases is an essential yet largely unveiled mechanism for ensuring the fidelity and specificity of their signals. Mxi2 is a p38alpha isoform with the ability to bind ERK1/2. Herein we show that Mxi2 has profound effects on ERK1/2 nucleocytoplasmic distribution, promoting their accumulation in the nucleus. Downregulation of endogenous Mxi2 by RNAi causes a marked reduction of ERK1/2 in the nucleus, accompanied by a pronounced decline in cellular proliferation. We demonstrate that Mxi2 functions in nuclear shuttling of ERK1/2 by enhancing the nuclear accumulation of both phosphorylated and unphosphorylated forms in the absence of stimulation. This process requires the direct interaction of both proteins and a high-affinity binding of Mxi2 to ERK-binding sites in nucleoporins, In this respect, Mxi2 acts antagonistically to PEA15, displacing it from ERK1/2 complexes. These results point to Mxi2 as a key spatial regulator for ERK1/2 and disclose an unprecedented stimulus-independent mechanism for ERK nuclear import.","affiliation":[]},{"pmid":"17295683","pmcid":null,"title":"Genetic and epigenetic analysis of the EPHB2 gene in gastric cancers.","authors":["Song JH","Kim CJ","Cho YG","Kwak HJ","Nam SW","Yoo NJ","Lee JY","Park WS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","journalShort":"APMIS","day":13,"month":2,"year":2007,"meshHeadings":["Adult","Aged","Aged, 80 and over","Disease Progression","Epigenesis, Genetic","Female","Gene Expression Regulation, Neoplastic","Humans","Male","Middle Aged","Mutation","Receptor, EphB2","Stomach Neoplasms"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"EPHB2 is a member of the Eph receptor tyrosine kinase family and a direct transcriptional target of beta-catenin/TCF. EPHB2 plays an important role in maintaining the correct positioning of the proliferative compartment in the crypt-villous axis. A loss of EPHB2 expression has been observed in human tumors, particularly in colonic adenomas and carcinomas. A search was made for mutations at the A9 tract in exon 17, an allelic loss at the EPHB2 gene locus, and promoter hypermethylation of the EPHB2 gene in 81 sporadic gastric cancers in order to determine if genetic or epigenetic alterations of the EPHB2 gene are involved in the development and/or progression of gastric cancer. Unexpectedly, no frameshift mutation was found and there was a low frequency (20.8%) of allelic loss. In addition, promoter hypermethylation was detected in only one gastric cancer tissue sample. Therefore, genetic or epigenetic alterations of the EPHB2 gene might be an uncommon event in the development or progression of gastric cancers.","affiliation":[]},{"pmid":"17318185","pmcid":null,"title":"Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1.","authors":["Toyofuku T","Yabuki M","Kamei J","Kamei M","Makino N","Kumanogoh A","Hori M"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The EMBO journal","journalShort":"EMBO J.","day":7,"month":3,"year":2007,"meshHeadings":["Animals","Cell Adhesion","Cell Adhesion Molecules, Neuronal","Cell Movement","Cells, Cultured","Chick Embryo","Chickens","Endothelial Cells","Humans","Immunity, Cellular","Immunohistochemistry","Immunoprecipitation","In Situ Hybridization","Mice","Mice, Transgenic","Mutation","Neovascularization, Physiologic","Protein Binding","RNA Interference","Semaphorins","Signal Transduction","Surface Plasmon Resonance","T-Lymphocytes","Vascular Endothelial Growth Factor A"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Originally identified as axon guidance molecules, semaphorins are now known to be widely expressed mediators that play significant roles in immune responses and organ morphogenesis. However, not much is known about the signaling pathways via which they exert their organ-specific effects. Here we demonstrate that Sema4A, previously identified as an activator of T-cell-mediated immunity, is expressed in endothelial cells, where it suppresses vascular endothelial growth factor (VEGF)-mediated endothelial cell migration and proliferation in vitro and angiogenesis in vivo. Mice lacking Sema4A exhibit enhanced angiogenesis in response to VEGF or inflammatory stimuli. In addition, binding and functional experiments revealed Plexin-D1 to be a receptor for Sema4A on endothelial cells, indicating that Sema4A exerts organ-specific activities via different receptor-mediated signaling pathways: via Plexin-D1 in the endothelial cells and via T-cell immunoglobulin and mucin domain-2 in T cells. The effects of Sema4A on endothelial cells are dependent on its ability to suppress VEGF-mediated Rac activation and integrin-dependent cell adhesion. It thus appears that Sema4A-Plexin-D1 signaling negatively regulates angiogenesis.","affiliation":[]},{"pmid":"20838624","pmcid":"2935892","title":"Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.","authors":["Corbo V","Ritelli R","Barbi S","Funel N","Campani D","Bardelli A","Scarpa A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":14,"month":9,"year":2010,"meshHeadings":["Adult","Aged","Aged, 80 and over","Ampulla of Vater","Base Sequence","Carcinoma, Pancreatic Ductal","Cell Line, Tumor","Common Bile Duct Neoplasms","Female","Humans","Male","Middle Aged","Molecular Sequence Data","Mutation","Pancreatic Neoplasms","Protein Kinases"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Protein kinases are key regulators of cellular processes (such as proliferation, apoptosis and invasion) that are often deregulated in human cancers. Accordingly, kinase genes have been the first to be systematically analyzed in human tumors leading to the discovery that many oncogenes correspond to mutated kinases. In most cases the genetic alterations translate in constitutively active kinase proteins, which are amenable of therapeutic targeting. Tumours of the pancreas are aggressive neoplasms for which no effective therapeutic strategy is currently available. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a DNA-sequence analysis of a selected set of 35 kinase genes in a panel of 52 pancreatic exocrine neoplasms, including 36 pancreatic ductal adenocarcinoma, and 16 ampulla of Vater cancer. Among other changes we found somatic mutations in ATM, EGFR, EPHA3, EPHB2, and KIT, none of which was previously described in cancers. CONCLUSIONS/SIGNIFICANCE: Although the alterations identified require further experimental evaluation, the localization within defined protein domains indicates functional relevance for most of them. Some of the mutated genes, including the tyrosine kinases EPHA3 and EPHB2, are clearly amenable to pharmacological intervention and could represent novel therapeutic targets for these incurable cancers.","affiliation":[]},{"pmid":"18713744","pmcid":null,"title":"Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion.","authors":["Lin KT","Sloniowski S","Ethell DW","Ethell IM"],"grantIds":["MH67121","R01 MH067121","R01 MH067121-05"],"grantAgencies":["NIMH NIH HHS","NIMH NIH HHS","NIMH NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":24,"month":10,"year":2008,"meshHeadings":["Animals","Cell Proliferation","Ephrin-B2","Hippocampus","Humans","Ligands","Matrix Metalloproteinase 7","Matrix Metalloproteinase 9","Matrix Metalloproteinases","Mice","Models, Biological","Neurons","Protein Structure, Tertiary","Receptor, EphB2","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"EphB receptors provide crucial adhesive and repulsive signals during cell migration and axon guidance, but it is unclear how they switch between these opposing responses. Here we provide evidence of an important role for matrix metalloproteinases (MMPs) in repulsive EphB2 signaling. We found that EphB2 is cleaved by MMPs both in vitro and in vivo, and that this cleavage is induced by interaction with its ligand ephrin-B2. Our findings demonstrate that MMP-2/MMP-9-specific inhibition or cleavage-resistant mutations in the ectodomain of EphB2 can prevent EphB2-mediated cell-cell repulsion in HEK293 cells, and block ephrin-B1-induced growth cone withdrawal in cultured hippocampal neurons. Transient expression of wtEphB2, but not noncleavable EphB2-4/5 mutant, restored ephrin-B1-induced growth cone collapse and withdrawal in EphB-deficient neurons. The inhibition of EphB2 cleavage also had potent regulatory effects on EphB2 activity. This study provides the first evidence that MMP-mediated cleavage of EphB2 is induced by receptor-ligand interactions at the cell surface and that this event triggers cell-repulsive responses.","affiliation":[]},{"pmid":"16298995","pmcid":null,"title":"EphB receptors regulate dendritic spine morphogenesis through the recruitment/phosphorylation of focal adhesion kinase and RhoA activation.","authors":["Moeller ML","Shi Y","Reichardt LF","Ethell IM"],"grantIds":["MH67121","NS19090","R01 MH067121","R01 MH067121-04"],"grantAgencies":["NIMH NIH HHS","NINDS NIH HHS","NIMH NIH HHS","NIMH NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":20,"month":1,"year":2006,"meshHeadings":["Animals","Dendritic Spines","Embryo, Mammalian","Focal Adhesion Protein-Tyrosine Kinases","Hippocampus","Ligands","Mice","Neurons","Phosphorylation","Receptors, Eph Family","rhoA GTP-Binding Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Dendritic filopodia are small protrusions on the surface of neuronal dendrites that transform into dendritic spines upon synaptic contact with axon terminals. The formation of dendritic spines is a critical aspect of synaptic development. Dendritic spine morphogenesis is characterized by filopodia shortening followed by the formation of mature mushroom-shaped spines. Here we show that activation of the EphB receptor tyrosine kinases in cultured hippocampal neurons by their ephrinB ligands induces morphogenesis of dendritic filopodia into dendritic spines. This appears to occur through assembly of an EphB-associated protein complex that includes focal adhesion kinase (FAK), Src, Grb2, and paxillin and the subsequent activations of FAK, Src, paxillin, and RhoA. Furthermore, Cre-mediated knock-out of loxP-flanked fak or RhoA inhibition blocks EphB-mediated morphogenesis of dendritic filopodia. Finally, EphB-mediated RhoA activation is disrupted by FAK knock-down. These data suggest that EphB receptors are upstream regulators of FAK in dendritic filopodia and that FAK-mediated RhoA activation contributes to assembly of actin filaments in dendritic spines.","affiliation":[]},{"pmid":"16819508","pmcid":null,"title":"High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.","authors":["Davalos V","Dopeso H","Velho S","Ferreira AM","Cirnes L","Daz-Chico N","Bilbao C","Ramrez R","Rodrguez G","Falcn O","Len L","Niessen RC","Keller G","Dallenbach-Hellweg G","Espn E","Armengol M","Plaja A","Perucho M","Imai K","Yamamoto H","Gebert JF","Daz-Chico JC","Hofstra RM","Woerner SM","Seruca R","Schwartz S","Arango D"],"grantIds":["R37 CA63585"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":11,"month":1,"year":2007,"meshHeadings":["DNA Mutational Analysis","DNA, Neoplasm","Endometrial Neoplasms","Female","Frameshift Mutation","Humans","Microsatellite Instability","Microsatellite Repeats","Polymerase Chain Reaction","Polymorphism, Single-Stranded Conformational","Receptor, EphB2","Stomach Neoplasms"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The EPH/EFN family of receptor tyrosine kinases regulates cell adhesion and migration and has an important role in controlling cell positioning in the normal intestinal epithelium. Inactivation of EPHB2 has recently been shown to accelerate tumorigenesis in the colon and rectum, and we have previously demonstrated frequent frameshift mutations (41%) in an A9 coding microsatellite repeat in exon 17 of EPHB2 in colorectal tumors with microsatellite instability (MSI). In this study, we extended these analyses to extracolonic MSI cancers, and found frameshift EPHB2 mutations in 39% (25/64) of gastric tumors and 14% (8/56) of endometrial tumors. Regression analysis of these EPHB2 mutation data on the basis of our previously proposed statistical model identified EPHB2 as a selective target of frameshift mutations in MSI gastric cancers but not in MSI endometrial carcinomas. These results suggest a functional role for EPHB2 in gastric tumor progression, and emphasize the differences between the tumorigenic processes in MSI gastrointestinal and endometrial cancer.","affiliation":[]},{"pmid":"18628988","pmcid":"2442653","title":"Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.","authors":["Li Y","Rowland C","Xiromerisiou G","Lagier RJ","Schrodi SJ","Dradiotis E","Ross D","Bui N","Catanese J","Aggelakis K","Grupe A","Hadjigeorgiou G"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":16,"month":7,"year":2008,"meshHeadings":["Adult","Age of Onset","Aged","Aged, 80 and over","Axons","Female","Genetic Predisposition to Disease","Humans","Male","Middle Aged","Models, Genetic","Models, Statistical","Parkinson Disease","Polymorphism, Single Nucleotide","Risk"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Susceptibility to sporadic Parkinson's disease (PD) is thought to be influenced by both genetic and environmental factors and their interaction with each other. Statistical models including multiple variants in axon guidance pathway genes have recently been purported to be capable of predicting PD risk, survival free of the disease and age at disease onset; however the specific models have not undergone independent validation. Here we tested the best proposed risk panel of 23 single nucleotide polymorphisms (SNPs) in two PD sample sets, with a total of 525 cases and 518 controls. By single marker analysis, only one marker was significantly associated with PD risk in one of our sample sets (rs6692804: P = 0.03). Multi-marker analysis using the reported model found a mild association in one sample set (two sided P = 0.049, odds ratio for each score change = 1.07) but no significance in the other (two sided P = 0.98, odds ratio = 1), a stark contrast to the reported strong association with PD risk (P = 4.64x10(-38), odds ratio as high as 90.8). Following a procedure similar to that used to build the reported model, simulated multi-marker models containing SNPs from randomly chosen genes in a genome wide PD dataset produced P-values that were highly significant and indistinguishable from similar models where disease status was permuted (3.13x10(-23) to 4.90x10(-64)), demonstrating the potential for overfitting in the model building process. Together, these results challenge the robustness of the reported panel of genetic markers to predict PD risk in particular and a role of the axon guidance pathway in PD genetics in general.","affiliation":[]},{"pmid":"18682749","pmcid":"2483346","title":"Germline EPHB2 receptor variants in familial colorectal cancer.","authors":["Zogopoulos G","Jorgensen C","Bacani J","Montpetit A","Lepage P","Ferretti V","Chad L","Selvarajah S","Zanke B","Hudson TJ","Pawson T","Gallinger S"],"grantIds":["CA-96-011"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":6,"month":8,"year":2008,"meshHeadings":["Adenomatous Polyposis Coli","Base Sequence","Colorectal Neoplasms","Colorectal Neoplasms, Hereditary Nonpolyposis","DNA, Neoplasm","Exons","Female","Genetic Variation","Germ-Line Mutation","Humans","Male","Pedigree","Polymorphism, Single Nucleotide","Receptor, EphB2","Reference Values","Registries"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Familial clustering of colorectal cancer occurs in 15-20% of cases, however recognized cancer syndromes explain only a small fraction of this disease. Thus, the genetic basis for the majority of hereditary colorectal cancer remains unknown. EPHB2 has recently been implicated as a candidate tumor suppressor gene in colorectal cancer. The aim of this study was to evaluate the contribution of EPHB2 to hereditary colorectal cancer. We screened for germline EPHB2 sequence variants in 116 population-based familial colorectal cancer cases by DNA sequencing. We then estimated the population frequencies and characterized the biological activities of the EPHB2 variants identified. Three novel nonsynonymous missense alterations were detected. Two of these variants (A438T and G787R) result in significant residue changes, while the third leads to a conservative substitution in the carboxy-terminal SAM domain (V945I). The former two variants were found once in the 116 cases, while the V945I variant was present in 2 cases. Genotyping of additional patients with colorectal cancer and control subjects revealed that A438T and G787R represent rare EPHB2 alleles. In vitro functional studies show that the G787R substitution, located in the kinase domain, causes impaired receptor kinase activity and is therefore pathogenic, whereas the A438T variant retains its receptor function and likely represents a neutral polymorphism. Tumor tissue from the G787R variant case manifested loss of heterozygosity, with loss of the wild-type allele, supporting a tumor suppressor role for EPHB2 in rare colorectal cancer cases. Rare germline EPHB2 variants may contribute to a small fraction of hereditary colorectal cancer.","affiliation":[]},{"pmid":"17443671","pmcid":null,"title":"M-CSF-mediated macrophage differentiation but not proliferation is correlated with increased and prolonged ERK activation.","authors":["Suzu S","Hiyoshi M","Yoshidomi Y","Harada H","Takeya M","Kimura F","Motoyoshi K","Okada S"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of cellular physiology","journalShort":"J. Cell. Physiol.","day":4,"month":8,"year":2007,"meshHeadings":["Cell Differentiation","Cell Line, Tumor","Cell Proliferation","Cell Shape","Dose-Response Relationship, Drug","Enzyme Activation","Extracellular Signal-Regulated MAP Kinases","Gene Products, nef","Humans","Macrophage Colony-Stimulating Factor","Macrophages","Phagocytosis","Tetradecanoylphorbol Acetate","Time Factors","Transfection","nef Gene Products, Human Immunodeficiency Virus"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"M-CSF is a cytokine essential for both the proliferation and differentiation of monocytes/macrophages. In this study, we established a new M-CSF-mediated differentiation-inducing system, and examined how the level and duration of the activation of ERK preceded M-CSF-mediated differentiation. TF-1-fms human leukemia cells rapidly proliferated in response to M-CSF. However, in the presence of a phorbol ester, TPA, TF-1-fms cells definitely switched their responsiveness to M-CSF from proliferation to differentiation, as evidenced by a more drastic morphological change and the appearance of cells with a higher level of phagocytic activity. In TF-1-fms cells expressing HIV-1 Nef protein in a conditionally active-manner, both M-CSF-mediated proliferation and M-CSF/TPA-mediated differentiation were inhibited by the activation of Nef. The Nef-active cells showed perturbed patterns of ERK activation. Under the proliferation-inducing conditions (TPA-free), parental or Nef-inactive cells showed modest ERK activation following M-CSF stimulation, whereas Nef-active cells showed an earlier and transient ERK activation, despite a decrease in their proliferation rate. Under the differentiation-inducing conditions, parental or Nef-inactive cells showed increased and prolonged ERK activation following M-CSF stimulation, whereas Nef-active cells showed transient ERK activation. These results supported the idea that the increased and prolonged ERK activation led to M-CSF-mediated macrophage differentiation but not to proliferation.","affiliation":[]},{"pmid":"19366806","pmcid":null,"title":"Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.","authors":["Kumar SR","Scehnet JS","Ley EJ","Singh J","Krasnoperov V","Liu R","Manchanda PK","Ladner RD","Hawes D","Weaver FA","Beart RW","Singh G","Nguyen C","Kahn M","Gill PS"],"grantIds":["R01CA79218"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"Cancer research","journalShort":"Cancer Res.","day":1,"month":5,"year":2009,"meshHeadings":["Animals","Cell Line, Tumor","Colorectal Neoplasms","Disease Progression","Fluorescent Antibody Technique","HT29 Cells","Humans","Immunoblotting","Male","Mice","Mice, Inbred BALB C","Mice, Nude","Mutation","RNA, Small Interfering","Receptor, EphB2","Receptor, EphB4","Transfection","Transplantation, Heterologous","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The receptor tyrosine kinase EphB2 is expressed by colon progenitor cells; however, only 39% of colorectal tumors express EphB2 and expression levels decline with disease progression. Conversely, EphB4 is absent in normal colon but is expressed in all 102 colorectal cancer specimens analyzed, and its expression level correlates with higher tumor stage and grade. Both EphB4 and EphB2 are regulated by the Wnt pathway, the activation of which is critically required for the progression of colorectal cancer. Differential usage of transcriptional coactivator cyclic AMP-responsive element binding protein-binding protein (CBP) over p300 by the Wnt/beta-catenin pathway is known to suppress differentiation and increase proliferation. We show that the beta-catenin-CBP complex induces EphB4 and represses EphB2, in contrast to the beta-catenin-p300 complex. Gain of EphB4 provides survival advantage to tumor cells and resistance to innate tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death. Knockdown of EphB4 inhibits tumor growth and metastases. Our work is the first to show that EphB4 is preferentially induced in colorectal cancer, in contrast to EphB2, whereby tumor cells acquire a survival advantage.","affiliation":[]},{"pmid":"20634891","pmcid":"2901336","title":"Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.","authors":["Jugessur A","Shi M","Gjessing HK","Lie RT","Wilcox AJ","Weinberg CR","Christensen K","Boyles AL","Daack-Hirsch S","Nguyen TT","Christiansen L","Lidral AC","Murray JC"],"grantIds":["DE08559","N01-HG-65403","P30 ES05605","P60 DE13076","R01 DE-11948-04","R37 DE008559"],"grantAgencies":["NIDCR NIH HHS","NHGRI NIH HHS","NIEHS NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":16,"month":7,"year":2010,"meshHeadings":["Case-Control Studies","Cleft Lip","Cleft Palate","Contractile Proteins","DNA-Binding Proteins","Female","Filamins","Genotype","Humans","Kruppel-Like Transcription Factors","Microfilament Proteins","Mothers","Polymorphism, Single Nucleotide","Scandinavian and Nordic Countries","Software"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Fetal conditions can in principle be affected by the mother's genotype working through the prenatal environment. METHODOLOGY/PRINCIPAL FINDINGS: Genotypes for 1536 SNPs in 357 cleft candidate genes were available from a previous analysis in which we focused on fetal gene effects. After data-cleaning, genotypes for 1315 SNPs in 334 autosomal genes were available for the current analysis of maternal gene effects. Two complementary statistical methods, TRIMM and HAPLIN, were used to detect multi-marker effects in population-based samples from Norway (562 case-parent and 592 control-parent triads) and Denmark (235 case-parent triads). We analyzed isolated cleft lip with or without cleft palate (iCL/P) and isolated cleft palate only (iCP) separately and assessed replication by looking for genes detected in both populations by both methods. In iCL/P, neither TRIMM nor HAPLIN detected more genes than expected by chance alone; furthermore, the selected genes were not replicated across the two methods. In iCP, however, FLNB was identified by both methods in both populations. Although HIC1 and ZNF189 did not fully satisfy our stringency criterion for replication, they were strongly associated with iCP in TRIMM analyses of the Norwegian triads. CONCLUSION/SIGNIFICANCE: Except for FLNB, HIC1 and ZNF189, maternal genes did not appear to influence the risk of clefting in our data. This is consistent with recent epidemiological findings showing no apparent difference between mother-to-offspring and father-to-offspring recurrence of clefts in these two populations. It is likely that fetal genes make the major genetic contribution to clefting risk in these populations, but we cannot rule out the possibility that maternal genes can affect risk through interactions with specific teratogens or fetal genes.","affiliation":[]},{"pmid":"19661068","pmcid":null,"title":"Peptide EphB2/CTF2 generated by the gamma-secretase processing of EphB2 receptor promotes tyrosine phosphorylation and cell surface localization of N-methyl-D-aspartate receptors.","authors":["Xu J","Litterst C","Georgakopoulos A","Zaganas I","Robakis NK"],"grantIds":["AG-05138","AG-08200","AG-17926","P50 AG005138","P50 AG005138-25","R01 AG008200","R01 AG008200-18","R37 AG017926","R37 AG017926-09"],"grantAgencies":["NIA NIH HHS","NIA NIH HHS","NIA NIH HHS","NIA NIH HHS","NIA NIH HHS","NIA NIH HHS","NIA NIH HHS","NIA NIH HHS","NIA NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":2,"month":10,"year":2009,"meshHeadings":["Amyloid Precursor Protein Secretases","Animals","Cell Line","Cytosol","Gene Expression Regulation","Humans","Mice","Neurons","Peptide Fragments","Phosphorylation","Protein Subunits","Protein Transport","Protein-Tyrosine Kinases","Rats","Rats, Wistar","Receptor, EphB2","Receptors, N-Methyl-D-Aspartate","Tyrosine"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Presenilin 1, a protein involved in the development of familial Alzheimer disease, is an important functional component of the gamma-secretase complex that processes many cell surface receptors including the EphB2 tyrosine kinase receptors (Litterst, C., Georgakopoulos, A., Shioi, J., Ghersi, E., Wisniewski, T., Wang, R., Ludwig, A., and Robakis, N. K. (2007) J. Biol. Chem. 282, 16155-16163). Recent evidence reveals that cytosolic peptides produced by the combined metalloproteinase/gamma-secretase processing of cell surface proteins function in signal transduction and protein phosphorylation. Here we show that peptide EphB2/CTF2 released to the cytosol by the gamma-secretase processing of EphB2 receptor, has tyrosine kinase activity, and directly phosphorylates the N-methyl-d-aspartate receptor (NMDAR) subunits in both cell lines and primary neuronal cultures. This phosphorylation occurs in the absence of Src kinases and is resistant to Src inhibitors revealing a novel pathway of NMDAR tyrosine phosphorylation independent of Src activity. EphB2/CTF2, but not a kinase-deficient mutant of EphB2/CTF2, promotes the cell surface expression of NMDAR. Because NMDAR plays central roles in synaptic plasticity and function, our results provide a potential link between the gamma-secretase function of presenilin 1 and learning and memory.","affiliation":[]},{"pmid":"17655843","pmcid":null,"title":"EGF receptor transactivation and PI3-kinase mediate stimulation of ERK by alpha(2A)-adrenoreceptor in intestinal epithelial cells: a role in wound healing.","authors":["Buffin-Meyer B","Crassous PA","Delage C","Denis C","Schaak S","Paris H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"European journal of pharmacology","journalShort":"Eur. J. Pharmacol.","day":28,"month":11,"year":2007,"meshHeadings":["ADAM Proteins","Caco-2 Cells","Enzyme Activation","Extracellular Signal-Regulated MAP Kinases","Heparin-binding EGF-like Growth Factor","Humans","Intercellular Signaling Peptides and Proteins","Intestinal Mucosa","Matrix Metalloproteinases","Phosphatidylinositol 3-Kinases","Proto-Oncogene Proteins c-akt","Quinoxalines","Receptor, Epidermal Growth Factor","Receptors, Adrenergic, alpha-2","Wound Healing"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Intestinal cells express alpha(2A)-adrenoreceptors that stimulate sodium and peptide absorption and promote cell proliferation. Involved mechanisms are poorly understood and are not fully related to inhibition of cAMP production. Previous study using a clone of CaCo2 cells expressing the human alpha(2A)-adrenoreceptor (CaCo2-3B) showed that alpha(2)-adrenoreceptor agonists cause extracellular signal-regulated kinase (ERK) phosphorylation. Present work examines the signaling pathway triggering ERK activation and investigates the consequence of alpha(2A)-adrenoreceptor stimulation on cell migration. Treatment of CaCo2-3B with the alpha(2)-adrenoreceptor agonist 5-bromo-6-(2-imidazolin-2-ylamino) quinoxaline (UK14304) induces not only ERK, but also Akt phosphorylation. Both effects are strongly attenuated by inhibition or desensitization of epidermal growth factor (EGF) receptor, matrix metalloproteinase (MMP) blockade, heparin-binding-EGF neutralization or phosphatidylinositol 3-kinase (PI3-kinase) inhibitors. Conditioned medium from UK14304-treated CaCo2-3B stimulates ERK in parental CaCo2 by a mechanism sensitive to EGF receptor and PI3-kinase inhibitors. Exposure of CaCo2-3B to UK14304 accelerates the wound healing. This effect is abolished by heparin-binding-EGF neutralization but not by mitomycin C, indicating that it results probably from increased cell spreading and/or migration. In conclusion, alpha(2A)-adrenoreceptor activates ERK and Akt in intestinal cells by a common pathway which depends on PI3-kinase activation and results from EGF receptor transactivation, via an autocrine/paracrine pathway implying MMP activation and heparin-binding-EGF shedding. Therefore, alpha(2A)-adrenoreceptor could have a positive role in intestinal regeneration in vivo.","affiliation":[]},{"pmid":"18695888","pmcid":null,"title":"Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.","authors":["Oshima T","Akaike M","Yoshihara K","Shiozawa M","Yamamoto N","Sato T","Akihito N","Nagano Y","Fujii S","Kunisaki C","Wada N","Rino Y","Tanaka K","Masuda M","Imada T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"International journal of oncology","journalShort":"Int. J. Oncol.","day":12,"month":9,"year":2008,"meshHeadings":["Adenocarcinoma","Aged","Colorectal Neoplasms","Female","Gene Expression","Humans","Liver Neoplasms","Male","RNA, Messenger","Receptor, EphA4","Receptor, EphB2","Reverse Transcriptase Polymerase Chain Reaction","Tumor Markers, Biological"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph receptors, members of a large family of transmembrane receptor tyrosine kinases, play important roles in a variety of biological functions. Recent studies have suggested that EphA4 and EphB2 participate in the growth and development of various carcinomas. This study examined the relationship of EphA4 and EphB2 gene expression to clinicopathological factors, especially metastasis, in patients with colorectal cancer. We studied surgical specimens of cancer tissue and adjacent normal mucosa obtained from 205 patients with untreated colorectal cancer. The relative expression levels of EphA4 and EphB2 mRNA in the specimens were measured by quantitative real-time, reverse-transcription polymerase chain reaction. The relative expression level of EphA4 mRNA was higher in the presence than in the absence of liver metastasis, whereas the relative expression levels of EphB2 mRNA were similar. Analysis of the relationship between clinicopathological features and gene expression showed that high expression of the EphA4 gene and low expression of the EphB2 gene correlated with liver metastasis. There was no correlation between EphA4 and EphB2 gene expression. Our results suggest that overexpression of the EphA4 gene and reduced expression of the EphB2 gene might promote liver metastasis in colorectal cancer. Overexpression of the EphA4 gene and reduced expression of the EphB2 gene may thus be a useful predictor of liver metastasis in patients with colorectal cancer.","affiliation":[]},{"pmid":"18957513","pmcid":null,"title":"Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.","authors":["Pfaff D","Hroult M","Riedel M","Reiss Y","Kirmse R","Ludwig T","Korff T","Hecker M","Augustin HG"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of cell science","journalShort":"J. Cell. Sci.","day":15,"month":11,"year":2008,"meshHeadings":["Animals","Cell Adhesion","Cell Line","Cell Movement","Cells, Cultured","Endothelium, Vascular","Ephrin-B2","Gene Expression","Humans","Mice","Mice, Inbred C57BL","Monocytes","Protein Binding","Receptor, EphB2","Receptor, EphB4"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The vascular endothelium is a crucial interface that controls the recruitment of circulating leukocytes. Based on the luminal expression of the ephrin-B2 ligand by endothelial cells (ECs) and the expression of EphB receptors (EphBRs) by circulating monocytes, we hypothesized that EphBR-ephrinB interactions are involved in monocyte adhesion. Adhesion experiments with monocytic cells were performed on ECs that overexpressed either full-length ephrin-B2 or cytoplasmically truncated ephrin-B2 (DeltaC-ephrin-B2). Atomic force microscopy confirmed similar adhesive strengths of EphBR-expressing J774 cells to ECs that either overexpressed full-length ephrin-B2 or truncated DeltaC-ephrin-B2 (1-minute interaction). Yet, adhesion experiments under static or flow conditions for 30 minutes demonstrated the preferential adhesion of monocytic cells to ECs that overexpressed full-length ephrin-B2 but not to DeltaC-ephrin-B2 or to ECs that had been mock transduced. Adhesion was blocked by ephrin-B2-specific and EphBR-specific antibodies. Correspondingly, adhesion of EphB4-receptor-overexpressing monocytes to ephrin-B2-positive ECs was further augmented. Trafficking experiments of cell-surface molecules revealed that, prior to internalization, the resulting EphB4-receptor-ephrin-B2 complex translocated from the luminal surface to inter-endothelial junctions. Lastly, full-length ephrin-B2 in ECs was also involved in monocyte transmigration. Collectively, our study identifies a role of EphBR-ephrinB interactions as a new step in the cascade of events leading to monocyte adhesion and transmigration through the vascular endothelium.","affiliation":[]},{"pmid":"19597185","pmcid":null,"title":"The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.","authors":["Pennisi A","Ling W","Li X","Khan S","Shaughnessy JD","Barlogie B","Yaccoby S"],"grantIds":["CA-093897","R01 CA093897"],"grantAgencies":["NCI NIH HHS","NCI NIH HHS"],"retractions":[],"journal":"Blood","journalShort":"Blood","day":27,"month":8,"year":2009,"meshHeadings":["Animals","Bone Diseases","Bone Marrow Cells","Bone Neoplasms","Cell Differentiation","Ephrin-B2","Gene Expression Regulation, Neoplastic","Humans","Mice","Mice, SCID","Models, Biological","Multiple Myeloma","Osteoblasts","Receptor, EphB4","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Myeloma bone disease is caused by uncoupling of osteoclastic bone resorption and osteoblastic bone formation. Bidirectional signaling between the cell-surface ligand ephrinB2 and its receptor, EphB4, is involved in the coupling of osteoblastogenesis and osteoclastogenesis and in angiogenesis. EphrinB2 and EphB4 expression in mesenchymal stem cells (MSCs) from myeloma patients and in bone cells in myelomatous bones was lower than in healthy counterparts. Wnt3a induced up-regulation of EphB4 in patient MSCs. Myeloma cells reduced expression of these genes in MSCs, whereas in vivo myeloma cell-conditioned media reduced EphB4 expression in bone. In osteoclast precursors, EphB4-Fc induced ephrinB2 phosphorylation with subsequent inhibition of NFATc1 and differentiation. In MSCs, EphB4-Fc did not induce ephrinB2 phosphorylation, whereas ephrinB2-Fc induced EphB4 phosphorylation and osteogenic differentiation. EphB4-Fc treatment of myelomatous SCID-hu mice inhibited myeloma growth, osteoclastosis, and angiogenesis and stimulated osteoblastogenesis and bone formation, whereas ephrinB2-Fc stimulated angiogenesis, osteoblastogenesis, and bone formation but had no effect on osteoclastogenesis and myeloma growth. These chimeric proteins had similar effects on normal bone. Myeloma cells expressed low to undetectable ephrinB2 and EphB4 and did not respond to the chimeric proteins. The ephrinB2/EphB4 axis is dysregulated in MM, and its activation by EphB4-Fc inhibits myeloma growth and bone disease.","affiliation":[]},{"pmid":"20628086","pmcid":"2945168","title":"Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.","authors":["Bailey SD","Xie C","Do R","Montpetit A","Diaz R","Mohan V","Keavney B","Yusuf S","Gerstein HC","Engert JC","Anand S","DREAM investigators"],"grantIds":["RG/08/012/25941"],"grantAgencies":["British Heart Foundation","Canadian Institutes of Health Research"],"retractions":[],"journal":"Diabetes care","journalShort":"Diabetes Care","day":29,"month":10,"year":2010,"meshHeadings":["Diabetes Mellitus, Type 2","Edema","Female","Humans","Hypoglycemic Agents","Male","NFATC Transcription Factors","Polymorphism, Single Nucleotide","Ramipril","Thiazolidinediones"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"OBJECTIVE: Thiazolidinediones are used to treat type 2 diabetes. Their use has been associated with peripheral edema and congestive heart failure-outcomes that may have a genetic etiology. RESEARCH DESIGN AND METHODS: We genotyped 4,197 participants of the multiethnic DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) trial with a 50k single nucleotide polymorphisms (SNP) array, which captures 2000 cardiovascular, inflammatory, and metabolic genes. We tested 32,088 SNPs for an association with edema among Europeans who received rosiglitazone (n = 965). RESULTS: One SNP, rs6123045, in NFATC2 was significantly associated with edema (odds ratio 1.89 [95% CI 1.47-2.42]; P = 5.32  10(-7), corrected P = 0.017). Homozygous individuals had the highest edema rate (hazard ratio 2.89, P = 4.22  10(-4)) when compared with individuals homozygous for the protective allele, with heterozygous individuals having an intermediate risk. The interaction between the SNP and rosiglitazone for edema was significant (P = 7.68  10(-3)). Six SNPs in NFATC2 were significant in both Europeans and Latin Americans (P < 0.05). CONCLUSIONS: Genetic variation at the NFATC2 locus contributes to edema among individuals who receive rosiglitazone.","affiliation":[]},{"pmid":"23000965","pmcid":null,"title":"Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.","authors":["Povlsen LK","Beli P","Wagner SA","Poulsen SL","Sylvestersen KB","Poulsen JW","Nielsen ML","Bekker-Jensen S","Mailand N","Choudhary C"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature cell biology","journalShort":"Nat. Cell Biol.","day":3,"month":10,"year":2012,"meshHeadings":["Carrier Proteins","Cell Line","DNA Damage","DNA Repair","DNA Replication","DNA-Directed DNA Polymerase","Humans","Lysine","Proteasome Endopeptidase Complex","S Phase","Signal Transduction","Ubiquitination","Ultraviolet Rays"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Protein ubiquitylation has emerged as a key regulatory mechanism in DNA-damage signalling and repair pathways. We report a proteome-wide, site-specific survey of ubiquitylation changes after ultraviolet irradiation, identifying numerous upregulated and downregulated ubiquitylation sites on known components of DNA-damage signalling, as well as on proteins not previously implicated in this process. Our results uncover a critical role for PCNA-associated factor PAF15 (p15(PAF)/KIAA0101) ubiquitylation during DNA replication. During unperturbed S phase, chromatin-associated PAF15 is modified by double mono-ubiquitylation of Lys 15 and 24 templated through PCNA binding. Replication blocks trigger rapid, proteasome-dependent removal of Lys 15/24-ubiquitylated PAF15 from PCNA, facilitating bypass of replication-fork-blocking lesions by allowing recruitment of translesion DNA synthesis polymerase pol to mono-ubiquitylated PCNA at stalled replisomes. Our findings demonstrate widespread involvement of ubiquitin signalling in genotoxic-stress responses and identify a critical function for dynamic PAF15 ubiquitylation in safeguarding genome integrity when DNA replication is challenged.","affiliation":[]},{"pmid":"20339854","pmcid":null,"title":"Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line.","authors":["Senior PV","Zhang BX","Chan ST"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"International journal of colorectal disease","journalShort":"Int J Colorectal Dis","day":3,"month":6,"year":2010,"meshHeadings":["Animals","Caspase 3","Cell Line, Tumor","Cell Membrane","Cell Movement","Cell Proliferation","Colonic Neoplasms","Enzyme Activation","Gene Expression Regulation, Neoplastic","Humans","Kaplan-Meier Estimate","Mice","Mitosis","Neoplasm Invasiveness","RNA, Messenger","Receptor, EphB2","Tetracycline","Xenograft Model Antitumor Assays"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"PURPOSE: In normal colonic epithelium, the receptor tyrosine kinase, EphB2 interacts with ephrinB1 ligand to maintain the integrity and architecture of the colonic crypt. Loss of EphB2 is seen in most colorectal cancers and correlates with poor prognosis. In this study, we investigated the effects of two levels of EphB2 expression on cell migration and invasion in a colon cancer cell line and on the growth of tumour xenografts. METHODS: An EphB2-negative colon cancer cell line (LIM2405) was transfected with a full-length EphB2 cDNA in a vector designed to respond to the drug tetracycline. The effect of two levels of EphB2 expression on the ability of cells to migrate through a porous barrier in response to a chemo-attractant and to invade through artificial basement membranes was tested in vitro. Finally, the effects of two expression levels of EphB2 on tumour growth using an in vivo model of colonic tumour xenograft in a mouse model were assessed. RESULTS: Expression of moderate levels of EphB2 significantly reduced the migration of tumour cells compared to control (p < 0.05, Kruskal-Wallis test). Expression of high levels of EphB2 further reduced migration of tumour cells (p < 0.05, Kruskal-Wallis test). Similarly, expression of EphB2 markedly reduces the invasive ability of tumour cells. The in vivo model of tumour growth showed that tumours with the highest level of EphB2 expression had a reduced risk of reaching a 10-mm size (defined event) compared with the control group (Cox regression, hazard ratio (HR) = 0.052, 95% CI 0.005-0.550; p = 0.014). Tumours derived from EphB2 expressing cells had a significantly reduced number of mitotic figures (p < 0.05) and an increased number of apoptotic cells (p < 0.05) compared to tumours from control cells. CONCLUSION: Even a moderate level of EphB2 expression has effects on tumour cells which results in reduced migration and invasiveness and slows the growth of colonic tumour implants in an in vivo model.","affiliation":[]},{"pmid":"19962662","pmcid":null,"title":"Proliferation and tumor suppression: not mutually exclusive for Eph receptors.","authors":["Noberini R","Pasquale EB"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cancer cell","journalShort":"Cancer Cell","day":8,"month":12,"year":2009,"meshHeadings":["Adenoma","Animals","Cell Proliferation","Humans","Intestinal Neoplasms","Mice","Mice, Knockout","Receptor, EphB2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph receptors are important but controversial regulators of cancer development. A recent study reported in Cell reveals that in the intestinal epithelium, EphB2 enhances proliferation through a kinase-dependent pathway and inhibits migration independent of its kinase activity. These separate pathways simultaneously promote proliferation but suppress invasive growth of intestinal adenomas.","affiliation":[]},{"pmid":"19913121","pmcid":null,"title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","authors":["Talmud PJ","Drenos F","Shah S","Shah T","Palmen J","Verzilli C","Gaunt TR","Pallas J","Lovering R","Li K","Casas JP","Sofat R","Kumari M","Rodriguez S","Johnson T","Newhouse SJ","Dominiczak A","Samani NJ","Caulfield M","Sever P","Stanton A","Shields DC","Padmanabhan S","Melander O","Hastie C","Delles C","Ebrahim S","Marmot MG","Smith GD","Lawlor DA","Munroe PB","Day IN","Kivimaki M","Whittaker J","Humphries SE","Hingorani AD","ASCOT investigators","NORDIL investigators","BRIGHT Consortium"],"grantIds":["33014","AG13196","FS/05/065/19497","FS/2005/125","G0100222","G0600705","G19/35","G8802774","G9521010","G9521010D","HL36310","HS06516","PG/02/128","PG/07/131/24254","PG/07/133/24260","RG/07/005/23633","RG/07/008/23674","RG/08/008","RG/08/008/25291","SP/07/007/23671","SP/08/005/25115"],"grantAgencies":["PHS HHS","NIA NIH HHS","British Heart Foundation","British Heart Foundation","Medical Research Council","Medical Research Council","Medical Research Council","Medical Research Council","Medical Research Council","Medical Research Council","NHLBI NIH HHS","AHRQ HHS","British Heart Foundation","British Heart Foundation","British Heart Foundation","British Heart Foundation","British Heart Foundation","British Heart Foundation","British Heart Foundation","British Heart Foundation","British Heart Foundation","Department of Health"],"retractions":[],"journal":"American journal of human genetics","journalShort":"Am. J. Hum. Genet.","day":16,"month":11,"year":2009,"meshHeadings":["Adult","Alleles","Apolipoprotein A-I","Apolipoproteins","Apolipoproteins A","Apolipoproteins B","Apolipoproteins E","Cardiovascular Diseases","Cholesterol, HDL","Cholesterol, LDL","Cohort Studies","Computer Simulation","European Continental Ancestry Group","Female","Genetic Variation","Humans","Lipids","Male","Middle Aged","Polymorphism, Single Nucleotide","Probability","Risk Factors","Triglycerides"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Blood lipids are important cardiovascular disease (CVD) risk factors with both genetic and environmental determinants. The Whitehall II study (n=5592) was genotyped with the gene-centric HumanCVD BeadChip (Illumina). We identified 195 SNPs in 16 genes/regions associated with 3 major lipid fractions and 2 apolipoprotein components at p<10(-5), with the associations being broadly concordant with prior genome-wide analysis. SNPs associated with LDL cholesterol and apolipoprotein B were located in LDLR, PCSK9, APOB, CELSR2, HMGCR, CETP, the TOMM40-APOE-C1-C2-C4 cluster, and the APOA5-A4-C3-A1 cluster; SNPs associated with HDL cholesterol and apolipoprotein AI were in CETP, LPL, LIPC, APOA5-A4-C3-A1, and ABCA1; and SNPs associated with triglycerides in GCKR, BAZ1B, MLXIPL, LPL, and APOA5-A4-C3-A1. For 48 SNPs in previously unreported loci that were significant at p<10(-4) in Whitehall II, in silico analysis including the British Women's Heart and Health Study, BRIGHT, ASCOT, and NORDIL studies (total n>12,500) revealed previously unreported associations of SH2B3 (p<2.2x10(-6)), BMPR2 (p<2.3x10(-7)), BCL3/PVRL2 (flanking APOE; p<4.4x10(-8)), and SMARCA4 (flanking LDLR; p<2.5x10(-7)) with LDL cholesterol. Common alleles in these genes explained 6.1%-14.7% of the variance in the five lipid-related traits, and individuals at opposite tails of the additive allele score exhibited substantial differences in trait levels (e.g., >1 mmol/L in LDL cholesterol [approximately 1 SD of the trait distribution]). These data suggest that multiple common alleles of small effect can make important contributions to individual differences in blood lipids potentially relevant to the assessment of CVD risk. These genes provide further insights into lipid metabolism and the likely effects of modifying the encoded targets therapeutically.","affiliation":[]},{"pmid":"20233847","pmcid":null,"title":"Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding.","authors":["Bochenek ML","Dickinson S","Astin JW","Adams RH","Nobes CD"],"grantIds":["G117/410"],"grantAgencies":["Medical Research Council","Cancer Research UK","Medical Research Council"],"retractions":[],"journal":"Journal of cell science","journalShort":"J. Cell. Sci.","day":15,"month":4,"year":2010,"meshHeadings":["Adaptor Proteins, Signal Transducing","Amino Acid Motifs","Cell Movement","Cell Shape","Cell Surface Extensions","Endocytosis","Endothelial Cells","Ephrin-B2","Humans","Oncogene Proteins","Organ Specificity","Protein Binding","Protein Structure, Tertiary","Receptor, EphA1","Umbilical Veins","rac GTP-Binding Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The transmembrane protein ephrin-B2 regulates angiogenesis, i.e. the formation of new blood vessels through endothelial sprouting, proliferation and remodeling processes. In addition to essential roles in the embryonic vasculature, ephrin-B2 expression is upregulated in the adult at sites of neovascularization, such as tumors and wounds. Ephrins are known to bind Eph receptor family tyrosine kinases on neighboring cells and trigger bidirectional signal transduction downstream of both interacting molecules. Here we show that ephrin-B2 dynamically modulates the motility and cellular morphology of isolated endothelial cells. Even in the absence of Eph-receptor binding, ephrin-B2 stimulates repeated cycling between actomyosin-dependent cell contraction and spreading episodes, which requires the presence of the C-terminal PDZ motif. Our results show that ephrin-B2 is a potent regulator of endothelial cell behavior, and indicate that the control of cell migration and angiogenesis by ephrins might involve both receptor-dependent and receptor-independent activities.","affiliation":[]},{"pmid":"21809346","pmcid":null,"title":"Eph-2B, acting as an extracellular ligand, induces differentiation markers in epidermal keratinocytes.","authors":["Walsh R","Blumenberg M"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of cellular physiology","journalShort":"J. Cell. Physiol.","day":27,"month":6,"year":2012,"meshHeadings":["Biological Markers","Cell Differentiation","Cell Movement","Cells, Cultured","Ephrin-A4","Epidermis","Gene Expression Profiling","Gene Expression Regulation","Humans","Keratinocytes","Ligands","Oligonucleotide Array Sequence Analysis","Receptor, EphB2","Signal Transduction","Time Factors","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In the bi-directional signaling system comprising ephrins (EFNs) and ephrin receptors (Ephs), both EFNs and Ephs simultaneously function both as ligands and as receptors. Importantly, the EFN/Eph system is deregulated in human cancers and has been implicated in the metastatic processes because of its effects on the adhesion and migration of epithelial cells. The idiosyncratic function of Ephs, membrane-bound receptor kinases, as extracellular signaling ligands, has not been extensively studied. This prompted us to explore the transcriptional targets regulated by Ephs acting solely as ligands. To define the ligand function of EphB2 in human epidermal keratinocytes, we treated these cells with EphB2 as Fc-conjugate dimmers, which thus act exclusively as extracellular ligands. We compared the EphB2 and EFNA4 effects during a 48h time course, using transcriptional profiling. We found that EphB2, acting as a ligand, promotes epidermal differentiation. For example, EphB2 induces expression of markers of epidermal differentiation, including keratins KRT1 and KRT10, SPRRs, desmosomal proteins and cell cycle inhibitors, while suppressing basal layer markers, integrins and cell cycle proteins. The effects of EphB2 are delayed relative to those of EFNA4. Unlike EFNA4, EphB2 did not induce lipid metabolism proteins, this particular aspect of epidermal differentiation seems not to be regulated by EphB2. Our results define the transcriptional targets of the reverse signaling by EphB2 acting exclusively as a ligand and begin to characterize this intriguing function of Ephs.","affiliation":[]},{"pmid":"20046096","pmcid":null,"title":"The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways.","authors":["Kandouz M","Haidara K","Zhao J","Brisson ML","Batist G"],"grantIds":[],"grantAgencies":["Canadian Institutes of Health Research"],"retractions":[],"journal":"Cell cycle (Georgetown, Tex.)","journalShort":"Cell Cycle","day":15,"month":1,"year":2010,"meshHeadings":["Adenine","Autophagy","Cell Line","Flavonoids","Humans","Microtubule-Associated Proteins","Mitogen-Activated Protein Kinase 1","Mitogen-Activated Protein Kinase 3","Phosphatidylinositol 3-Kinases","RNA Interference","Receptor, EphB2","Signal Transduction","Ubiquitin-Activating Enzymes","bcl-X Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"EphB2 is a tyrosine kinase receptor that has been shown to be a tumor suppressor gene in various cancers. However the mechanisms of this function are unknown. We report that EphB2 induces a form of cell death that does not involve the formation of apoptotic bodies or nuclear fragmentation and is instead accompanied by extensive vacuolization. Transmission electron microscopy demonstrates cytoplasmic vacuoles in EphB2-overexpressing cells that resembled autophagosomes. Using an EYFP-LC3 fusion protein and immunoblotting, we detected LC3 aggregation and conversion from form I to form II, both hallmarks of autophagy, in EphB2-transfected cells. Silencing of the autophagy regulating genes ATG5 or ATG7 using shRNAs, strongly prevented EphB2-induced cell death, further confirming its autophagic nature. EphB2 expression results in mitochondrial depolarization and translocation of cytochrome c from the mitochondria to the cytosol. Mapping of signaling pathways revealed novel information about the mechanisms of action of EphB2. We demonstrated that the MAPK pathway is important in the pro-death action of EphB2, through ERK1/2 phosphorylation and inhibition of this pathway using PD98059 counters EphB2-driven cell death. In addition, we found that inhibition of class III PI3K pathway, using the autophagy inhibitor 3MA, but not class I PI3K inhibition using LY294002, also effectively blocks EphB2- induced cell death. Finally, EphB2 expression inactivates Akt, which is a known inhibitor of autophagy. In conclusion, the EphB2 receptor induces an autophagic cell death that is mediated through the ERK1/2 and PI3K/Akt pathways.","affiliation":[]},{"pmid":"23383108","pmcid":"3559347","title":"Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1.","authors":["Denner J","Eschricht M","Lauck M","Semaan M","Schlaermann P","Ryu H","Akyz L"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":5,"month":2,"year":2013,"meshHeadings":["Amino Acid Sequence","Cytokines","Enzyme-Linked Immunosorbent Assay","Gene Expression Regulation","HIV Envelope Protein gp41","HIV-1","Humans","Leukocytes, Mononuclear","Microarray Analysis","Molecular Sequence Data","Peptides","Polymorphism, Single Nucleotide","Protein Structure, Tertiary","Real-Time Polymerase Chain Reaction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The transmembrane envelope protein gp41 of the human immunodeficiency virus HIV-1 plays an important role during infection allowing fusion of the viral and cellular membrane. In addition, there is increasing evidence that gp41 may contribute to the immunodeficiency induced by HIV-1. Recombinant gp41 and a synthetic peptide corresponding to a highly conserved domain in gp41, the immunosuppressive (isu) domain, have been shown to inhibit mitogen-induced activation of human peripheral blood mononuclear cells (PBMCs) and to increase release of IL-6 and IL-10 from these cells. We recently reported that a single mutation in the isu domain of gp41 abrogated the immunosuppressive properties and that HIV-1 sequences containing such abrogating mutations had never been isolated from infected individuals. Here, we studied the influence of the isu peptide on the release of 66 cytokines and the expression of 27,000 genes in PBMCs. Incubation of PBMCs with isu peptide homopolymers increased the expression of 16 cytokines among them IL-6 and IL-10, and decreased that of IL-2 and CXCL9. Interestingly, the extend of cytokine modulation was donor-dependent. Among the genes up-regulated were IL-6, IL-8, IL-10 but also MMP-1, TREM-1 and IL-1beta. Most importantly, genes involved in innate immunity such as FCN1 and SEPP1 were found down-regulated. Many changes in cytokine expression demonstrated in our experiments were also found in HIV-1 infected individuals. These data indicate that the isu domain of gp41 has a broad impact on gene expression and cytokine release and therefore may be involved in HIV-1 induced immunopathogenesis.","affiliation":[]},{"pmid":"19454503","pmcid":null,"title":"Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.","authors":["Rabiau N","Thiam MO","Satih S","Guy L","Kemeny JL","Boiteux JP","Fontana L","Bignon YJ","Bernard-Gallon D"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"In vivo (Athens, Greece)","journalShort":"In Vivo","day":20,"month":5,"year":2009,"meshHeadings":["Base Sequence","DNA Methylation","DNA Primers","Genes, BRCA1","Glutathione S-Transferase pi","Humans","Male","Polymerase Chain Reaction","Promoter Regions, Genetic","Prostatic Neoplasms","Receptor, EphB2","Tumor Suppressor Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Prostate cancer is the most common cancer among men and the second leading cause of cancer-related deaths in the United States. CpG island methylation causes gene silencing and could be decisive in prostate carcinogenesis and progression. Its role was investigated at multiple gene sites during prostate carcinogenesis. Methylation-specific polymerase chain reaction (MS-PCR) was used to analyze 4 interest gene promoter status in 12 patients with adenocarcinoma, 7 patients with prostate intraepithelial neoplasia, 3 patients with peritumor tissues and 15 healthy patients, so a total of 37 prostate biopsy samples constituted the cohort of the study. Despite the biopsy histology, the results have confirmed that BRCA1, RASSF1, GSTP1 and EPHB2 promoter methylation was found in each sample, except two.","affiliation":[]},{"pmid":"22723427","pmcid":null,"title":"EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.","authors":["Sikkema AH","den Dunnen WF","Hulleman E","van Vuurden DG","Garcia-Manero G","Yang H","Scherpen FJ","Kampen KR","Hoving EW","Kamps WA","Diks SH","Peppelenbosch MP","de Bont ES"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Neuro-oncology","journalShort":"Neuro-oncology","day":22,"month":9,"year":2012,"meshHeadings":["Apoptosis","Blotting, Western","Cell Adhesion","Cell Movement","Cell Proliferation","Cerebellar Neoplasms","Child","DNA Methylation","Ephrin-B1","Gene Expression Regulation, Neoplastic","Humans","Medulloblastoma","Phosphorylation","Promoter Regions, Genetic","RNA, Messenger","RNA, Small Interfering","Real-Time Polymerase Chain Reaction","Receptor, EphB2","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Tumor Cells, Cultured"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Eph/ephrin signaling has been implicated in various types of key cancer-enhancing processes, like migration, proliferation, and angiogenesis. In medulloblastoma, invading tumor cells characteristically lead to early recurrence and a decreased prognosis. Based on kinase-activity profiling data published recently, we hypothesized a key role for the Eph/ephrin signaling system in medulloblastoma invasion. In primary medulloblastoma samples, a significantly higher expression of EphB2 and the ligand ephrin-B1 was observed compared with normal cerebellum. Furthermore, medulloblastoma cell lines showed high expression of EphA2, EphB2, and EphB4. Stimulation of medulloblastoma cells with ephrin-B1 resulted in a marked decrease in in vitro cell adhesion and an increase in the invasion capacity of cells expressing high levels of EphB2. The cell lines that showed an ephrin-B1-induced phenotype possessed increased levels of phosphorylated EphB2 and, to a lesser extent, EphB4 after stimulation. Knockdown of EphB2 expression by short hairpin RNA completely abolished ephrin ligand-induced effects on adhesion and migration. Analysis of signal transduction identified p38, Erk, and mTOR as downstream signaling mediators potentially inducing the ephrin-B1 phenotype. In conclusion, the observed deregulation of Eph/ephrin expression in medulloblastoma enhances the invasive phenotype, suggesting a potential role in local tumor cell invasion and the formation of metastases.","affiliation":[]},{"pmid":"21987572","pmcid":null,"title":"Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels.","authors":["Lee KA","Hammerle LP","Andrews PS","Stokes MP","Mustelin T","Silva JC","Black RA","Doedens JR"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":2,"month":12,"year":2011,"meshHeadings":["Arthritis, Rheumatoid","HeLa Cells","Humans","Phosphorylation","Protein Processing, Post-Translational","Proteome","Proteomics","Ubiquitin","Ubiquitin-Protein Ligases","Ubiquitination"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Protein ubiquitination is a key regulatory process essential to life at a cellular level; significant efforts have been made to identify ubiquitinated proteins through proteomics studies, but the level of success has not reached that of heavily studied post-translational modifications, such as phosphorylation. HRD1, an E3 ubiquitin ligase, has been implicated in rheumatoid arthritis, but no disease-relevant substrates have been identified. To identify these substrates, we have taken both peptide and protein level approaches to enrich for ubiquitinated proteins in the presence and absence of HRD1. At the protein level, a two-step strategy was taken using cells expressing His(6)-tagged ubiquitin, enriching proteins first based on their ubiquitination and second based on the His tag with protein identification by LC-MS/MS. Application of this method resulted in identification and quantification of more than 400 ubiquitinated proteins, a fraction of which were found to be sensitive to HRD1 and were therefore deemed candidate substrates. In a second approach, ubiquitinated peptides were enriched after tryptic digestion by peptide immunoprecipitation using an antibody specific for the diglycine-labeled internal lysine residue indicative of protein ubiquitination, with peptides and ubiquitination sites identified by LC-MS/MS. Peptide immunoprecipitation resulted in identification of over 1800 ubiquitinated peptides on over 900 proteins in each study, with several proteins emerging as sensitive to HRD1 levels. Notably, significant overlap exists between the HRD1 substrates identified by the protein-based and the peptide-based strategies, with clear cross-validation apparent both qualitatively and quantitatively, demonstrating the effectiveness of both strategies and furthering our understanding of HRD1 biology.","affiliation":[]},{"pmid":"23835497","pmcid":null,"title":"MicroRNA-128 promotes cell-cell adhesion in U87 glioma cells via regulation of EphB2.","authors":["Lin L","Chen X","Peng X","Zhou J","Kung HF","Lin MC","Jiang S"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncology reports","journalShort":"Oncol. Rep.","day":24,"month":9,"year":2013,"meshHeadings":["3' Untranslated Regions","Blotting, Western","Brain Neoplasms","Cell Adhesion","Cell Movement","Cell Proliferation","Gene Expression Regulation, Neoplastic","Glioma","Humans","Lentivirus","Luciferases","MicroRNAs","RNA, Messenger","Real-Time Polymerase Chain Reaction","Receptor, EphB2","Reverse Transcriptase Polymerase Chain Reaction","Tumor Cells, Cultured","Wound Healing"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"MicroRNAs (miRNAs) are small, non-coding RNAs which regulate gene expression at the post-transcriptional level. Abnormal expression of miRNAs occurs frequently in human tumors. Despite the fact that reduced expression of miR-128 has been observed in glioma tissues and cells, the role of miR-128 in tumors has not been fully characterized. In the present study, cell adhesion assays indicated that overexpression of miR-128 can promote cell-cell adhesion. Target site prediction algorithms indicated that miR-128 binds the 3'-untranslated regions of erythropoietin-producing hepatocellular receptor (Eph)B1 and EphB2 mRNAs. Luciferase reporter assays confirmed that miR-128 binds and regulates EphB1 and EphB2 mRNAs. Overexpression of EphB2 reduced the ability of miR-128 to promote cell-cell adhesion. The wound-healing assay indicated that miR-128 significantly inhibited cell migration via EphB2. This study revealed the novel functions of miR-128 in cell-cell adhesion and cell migration in glioma cells through the regulation of EphB2, and identified EphB1 and EphB2 as novel miR-128 targets.","affiliation":[]},{"pmid":"22233626","pmcid":null,"title":"Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia.","authors":["Benzinou M","Clermont FF","Letteboer TG","Kim JH","Espejel S","Harradine KA","Arbelaez J","Luu MT","Roy R","Quigley D","Higgins MN","Zaid M","Aouizerat BE","van Amstel JK","Giraud S","Dupuis-Girod S","Lesca G","Plauchu H","Hughes CC","Westermann CJ","Akhurst RJ"],"grantIds":["R01 CA116019","R01 GM060514","R01 HL078564","R01-HL078564"],"grantAgencies":["NCI NIH HHS","NIGMS NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Nature communications","journalShort":"Nat Commun","day":11,"month":1,"year":2012,"meshHeadings":["Activin Receptors, Type I","Activin Receptors, Type II","Animals","Chromosome Mapping","Ephrin-B2","Exons","Female","Genetic Variation","Haplotypes","Humans","Male","Mice","Mice, Congenic","Mice, Inbred C57BL","Mice, Transgenic","Models, Genetic","Mutation","Phenotype","Protein Tyrosine Phosphatases, Non-Receptor","Species Specificity","Telangiectasia, Hereditary Hemorrhagic","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hereditary haemorrhagic telangiectasia (HHT) [corrected] is a vascular dysplasia syndrome caused by mutations in transforming growth factor-/bone morphogenetic protein pathway genes, ENG and ACVRL1. HHT [corrected] shows considerable variation in clinical manifestations, suggesting environmental and/or genetic modifier effects. Strain-specific penetrance of the vascular phenotypes of Eng(+/-) and Tgfb1(-/-) mice provides further support for genetic modification of transforming growth factor- pathway deficits. We previously identified variant genomic loci, including Tgfbm2, which suppress prenatal vascular lethality of Tgfb1(-/-) mice. Here we show that human polymorphic variants of PTPN14 within the orthologous TGFBM2 locus influence clinical severity of HHT, [corrected] as assessed by development of pulmonary arteriovenous malformation. We also show that PTPN14, ACVRL1 and EFNB2, encoding EphrinB2, show interdependent expression in primary arterial endothelial cells in vitro. This suggests an involvement of PTPN14 in angiogenesis and/or arteriovenous fate, acting via EphrinB2 and ACVRL1/activin receptor-like kinase 1. These findings contribute to a deeper understanding of the molecular pathology of HHT [corrected] in particular and to angiogenesis in general.","affiliation":[]},{"pmid":"21737611","pmcid":null,"title":"A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.","authors":["Fox BP","Kandpal RP"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cancer genomics & proteomics","journalShort":"Cancer Genomics Proteomics","day":8,"month":7,"year":2011,"meshHeadings":["Breast Neoplasms","Carcinoma","Cell Line, Tumor","Dimerization","Female","Gene Expression","Humans","Neoplasm Invasiveness","Receptor Protein-Tyrosine Kinases","Receptor, EphA2","Receptor, EphB2","Receptors, Eph Family","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"EPH receptors are the largest known family of receptor tyrosine kinases characterized in humans. These proteins are involved in axon guidance, tissue organization, synaptic plasticity, vascular development and the progression of various diseases including cancer. The varied biological effects of EPH receptors are mediated in part by the expression of these proteins and their intracellular binding proteins. The ability of EPH molecules to form heterodimers within their own class has been suggested, although not exhaustively characterized. We have clarified this phenomenon by showing that EPHB6, a kinase-deficient receptor, can interact with EPHB2 in mammalian cells, and more significantly EPHB6 interacts with EPHA2. However, EPHB6 does not interact with another kinase-deficient receptor, EPHA10. The interaction between EPHB6 and EPHA2 is the first demonstration of an A-type receptor interacting with a B-type receptor. Furthermore, we correlated relative expression of EPHB6, EPHB2 and EPHA2 with non-invasive and invasive phenotypes of breast tumor cell lines. Our results indicate that tumor invasiveness-suppressing activity of EPHB6 is mediated by its ability to sequester other kinase-sufficient and oncogenic EPH receptors. These observations suggest that cellular phenotypes may, in part, be attributed to a combinatorial expression of EPH receptors and heteromeric interactions among the same class, as well as between two classes, of EPH receptors. Our results also suggest that EPHA10 may transduce signals by interacting with other kinase-sufficient receptors in a similar manner.","affiliation":[]},{"pmid":"22374425","pmcid":null,"title":"Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.","authors":["Tu Y","He S","Fu J","Li G","Xu R","Lu H","Deng J"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","journalShort":"Clin Transl Oncol","day":29,"month":3,"year":2012,"meshHeadings":["Adult","Aged","Brain Neoplasms","Disease Progression","Ephrin-B2","Female","Glioblastoma","Glioma","Humans","Immunohistochemistry","Male","Middle Aged","Neoplasm Staging","Prognosis","Receptor, EphB4","Tissue Distribution","Tumor Markers, Biological"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"OBJECTIVE: The ligand EphrinB2 and the corresponding receptor EphB4 are up-regulated and involved in tumour growth in various human cancers. However, little is known about how this receptor-ligand complex contributes to the progression of glioma. This prompted us to study the association between the expressions of EphrinB2 and EphB4, clinicopathological variables, and glioma patient outcome. METHODS: Immunohistochemical staining was performed to detect the expression patterns of EphrinB2 and EphB4 in the biopsies from 96 patients with primary gliomas. Kaplan-Meier survival and Cox regression analyses were performed to evaluate the prognosis of patients. RESULTS: Immunohistochemical analysis revealed that the expression of EphrinB2 was significantly correlated with that of EphB4 (r=0.86, p=0.002). EphrinB2 and EphB4 were significantly associated with the Karnofsky performance scale (KPS) score and World Health Organization grades of patients with gliomas, respectively. Especially, the positive expression rates of EphrinB2 and EphB4 were significantly higher in patients with higher grade (both p=0.001) and lower KPS score (p=0.002 and 0.003, respectively). Multivariate Cox regression analysis revealed that EphrinB2 and EphB4 expressions were both independent prognostic factors for progress-free survival of glioblastoma patients (both p=0.02). CONCLUSION: Our data indicated for the first time that EphrinB2 and EphB4 expressions increase according to the histopathological grade and KPS score of glioma, and their expression levels are related to the progression-free survival of glioblastoma patients.","affiliation":[]},{"pmid":"22310282","pmcid":"3349801","title":"EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.","authors":["Wang SD","Rath P","Lal B","Richard JP","Li Y","Goodwin CR","Laterra J","Xia S"],"grantIds":["NS43987","R01 NS043987","R01 NS043987-01A1"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":13,"month":12,"year":2012,"meshHeadings":["Animals","Brain Neoplasms","Cell Adhesion","Cell Growth Processes","Cell Line, Tumor","Cell Movement","Female","Focal Adhesion Kinase 1","Focal Adhesion Protein-Tyrosine Kinases","Glioblastoma","Humans","Mice","Mice, SCID","Neoplasm Invasiveness","Receptor, EphB2","Signal Transduction","Xenograft Model Antitumor Assays"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumors in adults. Uncontrolled proliferation and abnormal cell migration are two prominent spatially and temporally disassociated characteristics of GBMs. In this study, we investigated the role of the receptor tyrosine kinase EphB2 in controlling the proliferation/migration dichotomy of GBM. We studied EphB2 gain of function and loss of function in glioblastoma-derived stem-like neurospheres, whose in vivo growth pattern closely replicates human GBM. EphB2 expression stimulated GBM neurosphere cell migration and invasion, and inhibited neurosphere cell proliferation in vitro. In parallel, EphB2 silencing increased tumor cell proliferation and decreased tumor cell migration. EphB2 was found to increase tumor cell invasion in vivo using an internally controlled dual-fluorescent xenograft model. Xenografts derived from EphB2-overexpressing GBM neurospheres also showed decreased cellular proliferation. The non-receptor tyrosine kinase focal adhesion kinase (FAK) was found to be co-associated with and highly activated by EphB2 expression, and FAK activation facilitated focal adhesion formation, cytoskeleton structure change and cell migration in EphB2-expressing GBM neurosphere cells. Taken together, our findings indicate that EphB2 has pro-invasive and anti-proliferative actions in GBM stem-like neurospheres mediated, in part, by interactions between EphB2 receptors and FAK. These novel findings suggest that tumor cell invasion can be therapeutically targeted by inhibiting EphB2 signaling, and that optimal antitumor responses to EphB2 targeting may require concurrent use of anti-proliferative agents.","affiliation":[]},{"pmid":"21603658","pmcid":"3095601","title":"EphB2 SNPs and sporadic prostate cancer risk in African American men.","authors":["Robbins CM","Hooker S","Kittles RA","Carpten JD"],"grantIds":["R01CA122009"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":23,"month":5,"year":2011,"meshHeadings":["African Americans","Case-Control Studies","Ephrin-B2","Genetic Predisposition to Disease","Genotype","Humans","Linkage Disequilibrium","Male","Polymorphism, Single Nucleotide","Prostatic Neoplasms","Receptor, EphB2","Risk","Tumor Markers, Biological"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The EphB2 gene has been implicated as a tumor suppressor gene somatically altered in both prostate cancer (PC) and colorectal cancer. We have previously shown an association between an EphB2 germline nonsense variant and risk of familial prostate cancer among African American Men (AAM). Here we set out to test the hypothesis that common variation within the EphB2 locus is associated with increased risk of sporadic PC in AAM. We genotyped a set of 341 single nucleotide polymorphisms (SNPs) encompassing the EphB2 locus, including known and novel coding and noncoding variants, in 490 AA sporadic PC cases and 567 matched controls. Single marker-based logistical regression analyses revealed seven EphB2 SNPs showing statistically significant association with prostate cancer risk in our population. The most significant association was achieved for a novel synonymous coding SNP, TGen-624, (Odds Ratio (OR) =0.22; 95% Confidence Interval (CI) 0.08-0.66, p=110(-5)). Two other SNPs also show significant associations toward a protective effect rs10465543 and rs12090415 (p=110(-4)), OR=0.49 and 0.7, respectively. Two additional SNPs revealed trends towards an increase in risk of prostate cancer, rs4612601 and rs4263970 (p=0.001), OR=1.35 and 1.31, respectively. Furthermore, haplotype analysis revealed low levels of linkage disequilibrium within the region, with two blocks being associated with prostate cancer risk among our population. These data suggest that genetic variation at the EphB2 locus may increase risk of sporadic PC among AAM.","affiliation":[]},{"pmid":"23887168","pmcid":null,"title":"Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior.","authors":["Goparaju C","Donington JS","Hsu T","Harrington R","Hirsch N","Pass HI"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","journalShort":"J Thorac Oncol","day":15,"month":9,"year":2013,"meshHeadings":["Apoptosis","Blotting, Western","Case-Control Studies","Cell Movement","Cell Proliferation","Cells, Cultured","Epithelium","Fluorescent Antibody Technique","Humans","Immunoenzyme Techniques","Lung Neoplasms","Mesothelioma","Peritoneum","Prognosis","RNA, Messenger","RNA, Small Interfering","Real-Time Polymerase Chain Reaction","Receptor, EphB2","Reverse Transcriptase Polymerase Chain Reaction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"INTRODUCTION: Malignant pleural mesothelioma (MM) is an aggressive asbestos-associated malignancy with limited therapeutic options. This study describes the overexpression of Ephrin B2 receptor (EPHB2) in MM cell lines and tumors, and the effect of its manipulation on proliferative and invasive qualities of the disease. METHODS: Using expression arrays, we investigated EPHB2 in MM tumors compared with normal mesothelium. EPHB2 and downstream target expression were evaluated using reverse-transcriptase polymerase chain reaction and immunoblotting methods. The biological significance of EPHB2 in MM was evaluated using in vitro functional assays with and without targeting by EPHB2-short hairpin RNA or blocking peptide in two mesothelioma cell lines, HP-1 and H2595. RESULTS: EPHB2 is overexpressed in all MM cell lines, but not in benign mesothelial cells, and is significantly elevated in MM tumor tissue compared with matched normal peritoneum. Targeted knockdown of EPHB2 in HP-1 and H2595 cell lines reduced its expression and that of EPHB2 downstream targets such as matrix metalloproteinase (MMP-2) and vascular endothelial growth factor, whereas caspase 2 and caspase 8 had increased expression. Inhibition of EPHB2 resulted in a significant decrease in scratch closure (1.25-fold-1.8-fold), proliferation (1.5-fold), and invasion (1.7-fold-1.8-fold) compared with the controls. Most notably, however, EPHB2 silencing resulted in a significant increase in apoptotic proteins and activity. CONCLUSION: EPHB2 seems to play an important role in MM pathogenesis and these findings indicate that EPHB2 could serve as a potential novel therapeutic target for treatment of the disease.","affiliation":[]},{"pmid":"22010211","pmcid":null,"title":"Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia.","authors":["Azab F","Azab AK","Maiso P","Calimeri T","Flores L","Liu Y","Quang P","Roccaro AM","Sacco A","Ngo HT","Zhang Y","Morgan BL","Carrasco RD","Ghobrial IM"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","journalShort":"Clin. Cancer Res.","day":1,"month":1,"year":2012,"meshHeadings":["Animals","Apoptosis","Blotting, Western","Bone Marrow","Case-Control Studies","Cell Adhesion","Cell Cycle","Cell Movement","Cell Proliferation","Cells, Cultured","Ephrin-B2","Human Umbilical Vein Endothelial Cells","Humans","Immunoenzyme Techniques","Immunoprecipitation","Mice","Mice, SCID","Neovascularization, Physiologic","RNA, Messenger","RNA, Small Interfering","Real-Time Polymerase Chain Reaction","Receptors, Eph Family","Stromal Cells","Waldenstrom Macroglobulinemia"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"PURPOSE: The ephrin receptors (Eph) are found in a wide range of cancers and correlate with metastasis. In this study, we characterized the role of Eph-B2 receptor in the interaction of Waldenstrom's macroglobulinemia (WM) cells with the bone marrow microenvironment. EXPERIMENTAL DESIGN: We screened the activity of different receptor tyrosine kinases in WM patients and found that Eph-B2 was overexpressed compared with control. Also, we tested the expression of ephrin-B2 ligand on endothelial cells and bone marrow stromal cells (BMSC) isolated from WM patients. We then tested the role of Eph-B2/Ephrin-B2 interaction in the adhesion of WM cells to endothelial cells and BMSCs; the cell signaling induced by the coculture in both the WM cells and the endothelial cells; WM cell proliferation, apoptosis, and cell cycle in vitro and tumor progression in vivo; and in angiogenesis. RESULTS: Eph-B2 receptor was found to be activated in WM patients compared with control, with a 5-fold increase in CD19(+) WM cells, and activated cell adhesion signaling, including focal adhesion kinase, Src, P130, paxillin, and cofilin, but decreased WM cell chemotaxis. Ephrin-B2 ligand was highly expressed on endothelial cells and BMSCs isolated from WM patients and on human umbilical vein endothelial cells and induced signaling in the endothelial cells promoting adhesion and angiogenesis. Blocking of ephrin-B2 or Eph-B2 inhibited adhesion, cytoskeletal signaling, proliferation, and cell cycle in WM cells, which was induced by coculture with endothelial cells and decreased WM tumor progression in vivo. CONCLUSION: Ephrin-B2/Eph-B2 axis regulates adhesion, proliferation, cell cycle, and tumor progression in vivo through the interaction of WM with the cells in the bone marrow microenvironment.","affiliation":[]},{"pmid":"24439224","pmcid":null,"title":"EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition.","authors":["Gao Q","Liu W","Cai J","Li M","Gao Y","Lin W","Li Z"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Human pathology","journalShort":"Hum. Pathol.","day":20,"month":2,"year":2014,"meshHeadings":["Adult","Animals","Carcinoma, Squamous Cell","Cervical Intraepithelial Neoplasia","Cervix Uteri","Disease Progression","Epithelial-Mesenchymal Transition","Female","Gene Expression Regulation, Neoplastic","Genes, ras","HeLa Cells","Humans","Mice","Middle Aged","Neoplasm Metastasis","Receptor, EphB2","Signal Transduction","Stem Cells","Uterine Cervical Neoplasms"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"EphB2, a receptor tyrosine kinase for ephrin ligands, is overexpressed in various cancers and plays an important role in tumor progression. However, the expression and functions of EphB2 in cervical cancer remain unknown. In this study, we performed immunohistochemistry in clinical cervical specimens and found that EphB2 was overexpressed in the cervical cancer specimens, and its expression correlated with cancer progression. The percentage of EphB2-positive cells increased gradually from 28% in the normal cervix to 40% in high-grade squamous intraepithelial lesions, and ultimately to 69.8% in squamous cell carcinomas (P < .05). We overexpressed EphB2 in HeLa cells and silenced EphB2 in cervical cancer (C33A) cells, which expressed low and high levels of EphB2, respectively. Exogenous EphB2 promoted cell migration, invasion, and an epithelial-mesenchymal transition (EMT) signature, which is a complex process that occurs during organogenesis and cancer metastasis, whereas EphB2 silencing had the opposite effect (P < .05). Furthermore, HeLa cells with exogenous EphB2 exhibited a stem cell-like state that promoted tumorsphere formation in vitro and exhibited tumorigenesis potential in vivo (P < .05), whereas EphB2 silencing in C33A cells inhibited these stem cell properties (P < .05). In addition, we investigated the intracellular signaling pathways in cervical cancer and found that R-Ras expression correlated positively with EphB2 in clinical samples, and its activity was regulated by EphB2 in cervical cancer. These findings demonstrate that EphB2 plays an important role in cervical cancer progression by orchestrating an EMT program through R-Ras activation.","affiliation":[]},{"pmid":"23413357","pmcid":null,"title":"EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool.","authors":["Colletti E","El Shabrawy D","Soland M","Yamagami T","Mokhtari S","Osborne C","Schlauch K","Zanjani ED","Porada CD","Almeida-Porada G"],"grantIds":["HL073737","HL097623","P20 GM103440","P20 RR-016464","P20 RR016464","R01 HL073737","R01 HL097623"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NIGMS NIH HHS","NCRR NIH HHS","NCRR NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","journalShort":"FASEB J.","day":31,"month":6,"year":2013,"meshHeadings":["Animals","Biological Markers","Cell Lineage","Female","Fetus","Green Fluorescent Proteins","Humans","Intestinal Mucosa","Intestine, Small","Mesenchymal Stem Cell Transplantation","Mesenchymal Stromal Cells","Nerve Tissue Proteins","Pregnancy","RNA-Binding Proteins","Receptor, EphB2","Receptors, G-Protein-Coupled","Sheep","Stem Cell Niche","Transcriptome","Transplantation, Heterologous"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"To identify human bone marrow stromal cell (BMSC) subsets with enhanced ability to engraft/contribute to the resident intestinal cellular pool, we transplanted clonally derived BMSCs into fetal sheep. Analysis at 75 d post-transplantation showed 2 of the 6 clones engrafting the intestine at 4- to 5-fold higher levels (5.030.089 and 5.040.15%, respectively) than the other clones (P<0.01), correlating with the percentage of donor-derived Musashi-1(+) (12.01-14.17 vs. 1.2-3.8%; P<0.01) or leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5)(+) cells within the intestinal stem cell (ISC) region. Phenotypic and transcriptome analysis determined that the clones with enhanced intestinal contribution expressed high levels of Ephrin type B receptor 2 (EphB2). Intestinal explants demonstrated proliferation of the engrafted cells and ability to generate crypt-like structures in vitro still expressing EphB2. Additional transplants based on BMSC EphB2 expression demonstrated that, at 7 d post-transplant, the EphB2(high) BMSCs engrafted in the ISC region at levels of 2.1  0.2%, while control EphB2(low) BMSCs engrafted at 0.3  0.1% (P<0.01). Therefore we identified a marker for isolating and culturing an expandable subpopulation of BMSCs with enhanced intestinal homing and contribution to the ISC region.","affiliation":[]},{"pmid":"23711177","pmcid":null,"title":"EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.","authors":["Nguyen TM","Arthur A","Hayball JD","Gronthos S"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Stem cells and development","journalShort":"Stem Cells Dev.","day":15,"month":10,"year":2013,"meshHeadings":["Cell Proliferation","Coculture Techniques","Ephrin-B2","Gene Expression Regulation","Humans","Indoleamine-Pyrrole 2,3,-Dioxygenase","Interferon-gamma","Interleukin-17","Interleukin-2","Lymphocyte Activation","Lymphocyte Culture Test, Mixed","Mesenchymal Stromal Cells","Nitric Oxide Synthase Type II","Phosphorylation","Primary Cell Culture","RNA, Small Interfering","Receptor, EphB2","Receptor, EphB4","Signal Transduction","T-Lymphocytes","Transforming Growth Factor beta1"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Mesenchymal stromal/stem cells (MSC) express the contact-dependent erythropoietin-producing hepatocellular (Eph) receptor tyrosine kinase family and their cognate ephrin ligands, which are known to regulate thymocyte maturation and selection, T-cell transendothelial migration, activation, co-stimulation, and proliferation. However, the contribution of Eph/ephrin molecules in mediating human MSC suppression of activated T-cells remains to be determined. In the present study, we showed that EphB2 and ephrin-B2 are expressed by ex vivo expanded MSC, while the corresponding ligands, ephrin-B1 and EphB4, respectively, are highly expressed by T-cells. Initial studies demonstrated that EphB2-Fc and ephrin-B2-Fc molecules suppressed T-cell proliferation in allogeneic mixed lymphocyte reaction (MLR) assays compared with human IgG-treated controls. While the addition of a third-party MSC population demonstrated dramatic suppression of T-cell proliferation responses in the MLR, blocking the function of EphB2 or EphB4 receptors using inhibitor binding peptides significantly increased T-cell proliferation. Consistent with these observations, shRNA EphB2 or ephrin-B2 knockdown expression in MSC reduced their ability to inhibit T-cell proliferation. Importantly, the expression of immunosuppressive factors, indoleamine 2, 3-dioxygenase, transforming growth factor-1, and inducible nitric oxide synthase expressed by MSC, was up-regulated after stimulation with EphB4 and ephrin-B1 in the presence of interferon (IFN)-, compared with untreated controls. Conversely, key factors involved in T-cell activation and proliferation, such as interleukin (IL)-2, IFN-, tumor necrosis factor-, and IL-17, were down-regulated by T-cells treated with EphB2 or ephrin-B2 compared with untreated controls. Studies utilizing signaling inhibitors revealed that inhibition of T-cell proliferation is partly mediated through EphB2-induced ephrin-B1 reverse signaling or ephrin-B2-mediated EphB4 forward signaling by activating Src, PI3Kinase, Abl, and JNK kinase pathways, activated by tyrosine phosphorylation. Taken together, these observations suggest that EphB/ephrin-B interactions play an important role in mediating human MSC inhibition of activated T cells.","affiliation":[]},{"pmid":"24211352","pmcid":null,"title":"Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells.","authors":["Chukkapalli S","Amessou M","Dilly AK","Dekhil H","Zhao J","Liu Q","Bejna A","Thomas RD","Bandyopadhyay S","Bismar TA","Neill D","Azoulay L","Batist G","Kandouz M"],"grantIds":["P30CA022453"],"grantAgencies":["NCI NIH HHS","Canadian Institutes of Health Research"],"retractions":[],"journal":"Experimental cell research","journalShort":"Exp. Cell Res.","day":15,"month":1,"year":2014,"meshHeadings":["Animals","Apoptosis","Autophagy","Breast Neoplasms","Cells, Cultured","Disease Progression","Female","Humans","MCF-7 Cells","Mice","Mice, Nude","Neoplasm Invasiveness","Receptor, EphB2","Tumor Cells, Cultured"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Eph and Ephrin proteins, which constitute the largest family of receptor tyrosine kinases, are involved in normal tissue development and cancer progression. Here, we examined the expression and role of the B-type Eph receptor EphB2 in breast cancers. By immunohistochemistry using a progression tissue microarray of human clinical samples, we found EphB2 to be expressed in benign tissues, but strongly increased in cancers particularly in invasive and metastatic carcinomas. Subsequently, we found evidence that EphB2, whose expression varies in established cell breast lines, possesses multiple functions. First, the use of a DOX-inducible system to restore EphB2 function to low expressers resulted in decreased tumor growth in vitro and in vivo, while its siRNA-mediated silencing in high expressers increased growth. This function involves the onset of apoptotic death paralleled by caspases 3 and 9 activation. Second, EphB2 was also found to induce autophagy, as assessed by immunofluorescence and/or immunoblotting examination of the LC3, ATG5 and ATG12 markers. Third, EphB2 also has a pro-invasive function in breast cancer cells that involves the regulation of MMP2 and MMP9 metalloproteases and can be blocked by treatment with respective neutralizing antibodies. Furthermore, EphB2-induced invasion is kinase-dependent and is impeded in cells expressing a kinase-dead mutant EphB2. In summary, we identified a mechanism involving a triple role for EphB2 in breast cancer progression, whereby it regulates apoptosis, autophagy, and invasion.","affiliation":[]},{"pmid":"24803541","pmcid":null,"title":"EphB2 contributes to human naive B-cell activation and is regulated by miR-185.","authors":["Yu M","Liang W","Wen S","Zhao T","Zhu MX","Li HH","Long Q","Wang M","Cheng X","Liao YH","Yuan J"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","journalShort":"FASEB J.","day":1,"month":8,"year":2014,"meshHeadings":["B-Lymphocytes","Ephrin-B1","Ephrin-B2","Humans","Immunoglobulin G","Immunoglobulin M","Lymphocyte Activation","MicroRNAs","RNA Interference","RNA, Messenger","RNA, Small Interfering","Receptor, EphB2","Receptor, Notch1","Signal Transduction","Tumor Necrosis Factor-alpha"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"EphB2 is an important member of the receptor tyrosine kinases. Recently, EphB2 was shown to facilitate T-cell migration and monocyte activation. However, the effects of EphB2 on B cells remain unknown. In this study, the expression of EphB2 on B cells was tested by Western blot, and the roles of EphB2 in B-cell proliferation, cytokine secretion, and immunoglobulin (Ig) production were evaluated using EphB2 siRNA interference in human B cells from healthy volunteers. Our study revealed that EphB2 was distributed on naive B cells and was up-regulated on activated B cells. Moreover, B-cell proliferation (decreased by 22%, P<0.05), TNF- secretion (decreased by 40%, P<0.01) and IgG production (decreased by 26%, P < 0.05) were depressed concordantly with the down-regulated EphB2 expression. Subsequently, we screened microRNAs that could regulate EphB2 expression in B cells, and discovered that miR-185 directly targeted to EphB2 mRNA and suppressed its expression. Furthermore, miR-185 overexpression inhibited B-cell activation, and the inhibitor of miR-185 enhanced B-cell activation. Moreover, abatement of EphB2 through miR-185 mimics or EphB2 siRNA attenuated the activation of Src-p65 and Notch1 signaling pathways in human B cells. Our study first suggested that EphB2 was involved in human naive B cell activation through Src-p65 and Notch1 signaling pathways and could be regulated by miR-185.","affiliation":[]},{"pmid":"24222164","pmcid":null,"title":"A9 region in EPHB2 mutation is frequent in tumors with microsatellite instability. Analysis of prognosis.","authors":["Rafael S","Vidaurreta M","Veganzones S","De La Orden V","Mediero B","Gutierrez ML","Maestro ML"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Anticancer research","journalShort":"Anticancer Res.","day":13,"month":11,"year":2013,"meshHeadings":["Adenocarcinoma","Adenocarcinoma, Mucinous","Aged","Colorectal Neoplasms","Female","Follow-Up Studies","Humans","Male","Microsatellite Instability","Mutation","Neoplasm Staging","Prognosis","Prospective Studies","Receptor, EphB2","Survival Rate","Tumor Markers, Biological"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"AIM: The aim of the present study was to determine the relation of EPH tyrosine kinase receptor B2 (EPHB2) A9 region mutation and microsatellite instability (MSI); and to analyze their influence in prognosis of patients with sporadic colorectal cancer (CRC). PATIENTS AND METHODS: A total of 481 patients with CRC were examined. MSI (NCI criteria) and EPHB2 were analyzed using PCR and fragment analysis software. RESULTS: EPHB2 mutation was detected in 3.1% of patients. Mutation of EPHB2 was associated with location and with MSI status. We considered low instability (L-MSI) when only one marker showed instability, high instability (H-MSI) when two or more markers were positive and microsatelllite stable (MSS) when no instability was detected. The stratified analysis of overall survival (OS) and disease-free survival (DFS) in MSI according to EPHB2 status revealed no statistically significant differences. However, the risk of recurrence of H-MSI tumors with EPHB2 mutation carriers was 3.6-times higher than in non-mutation carriers. CONCLUSION: The frequency of EPHB2 mutation is higher in patients with H-MSI than MSS tumors. Promising results were found regarding the prognostic influence of EPHB2 in H-MSI.","affiliation":[]}]}